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ABSTRACT 
 
Aby Grabon: Atomistic and Cellular Analysis of START Phosphatidylinositol Transfer Proteins in 
the Context of the Phospholipid Extraction Mechanism and Phosphoinositide Signaling in the 
Parasite Toxoplasma  
(Under the direction of Vytas Bankaitis) 
 
Phosphatidylinositol transfer proteins (PITPs) are essential regulators of the interface 
between phosphoinositide (PIP) signaling and membrane trafficking in eukaryotic cells. Genetic 
derangement of PITPs in multicellular organisms results in pathologies such as 
neurodegeneration, metabolic diseases, and vision and neurosensory defects. How PITPs 
sense multiple metabolic inputs to specify a membrane signaling event is key to our 
understanding of these pathologies and of PIP networks in general. To that end, we describe a 
novel multi-domain PITP of the START structural family: PITP Multidomain Protein (PIMP) is 
encoded by the eukaryotic parasite Toxoplasma, and associated with specialized parasite 
organelles called dense granules. Dense granules are secretory organelles that traffic 
Toxoplasma proteins during parasite infection of the mammalian host. PIMP links a PITP 
domain to an oxysterol binding protein (OSBP) domain. PITP and OSBP orthologs in other 
eukaryotes are expressed as separate proteins known to antagonize each other in specific PIP 
signaling pathways. We report that PIMP is a bona fide PITP in vivo and in vitro, and its binding 
and extraction of phosphatidylinositol (PtdIns) from membranes is required for this function. 
Furthermore, PIMP binds phosphatidylcholine as a counter-ligand to PtdIns, and senses specific 
higher order PIPs, PtdIns4P and PtdIns(4,5)P2 through a conserved plekstrin homology (PH) 
domain. We describe how Toxoplasma codes its secretory system with unique PtdIns4P pools, 
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and define PIMP as a sensor of PIP pools on dense granules. Thus PIMP is a dense granule 
protein that represents a novel platform for the integration of multiple metabolic inputs with 
PtdIns4P signaling. 
The mechanism by which the PIMP PITP domain, or indeed any START PITP, extracts 
phospholipids from bilayers is unknown. We performed molecular dynamics simulations using 
the mammalian PITPα as a START PITP model. We report atomistic detail of the trajectory of 
phospholipids into the START PITP binding pocket. Overall, this work analyzes START PITP 
function on the atomistic and cellular levels, and offers possible explanations for how these 
proteins organize specific PIP signaling events.   
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PREFACE 
 
Chapter 1 is adapted from a published review: 
Grabon, A., Khan, D., & Bankaitis, V. A. (2015). Phosphatidylinositol transfer proteins 
and instructive regulation of lipid kinase biology. Biochimica et Biophysica Acta (BBA)-
Molecular and Cell Biology of Lipids, 1851(6), 724-735. 
 
Chapter 2 represents work that will eventually be solicited for publication with an as-of-yet 
undetermined journal.  
 
Chapter 3 is adapted and modified from a manuscript in revision at Journal of Lipid Research, 
as a co-author work with Adam Orłowski (Department of Physics, Tampere University of 
Technology Korkeakoulunkatu 10, FI-33720 Tampere, Finland; 4Department of Physics and 
Energy, University of Limerick Limerick, Ireland). 
 
Chapter 4 is written specifically for this dissertation, though some of its content will be adapted 
for publication as part of a larger review for Critical Reviews in Biochemistry and Molecular 
Biology. 
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CHAPTER 1: PHOSPHATIDYLINOSITOL TRANSFER PROTEINS AND 
INSTRUCTURE REGULATION OF LIPID KINASE BIOLOGY 
 
Introduction 
Inositol (Ins) and phosphoinositide signaling pathways are major intracellular regulatory 
systems of eukaryotic cells, and their derangements are underlying causes of many diseases. In 
spite of how much we have learned about phosphoinositide signaling and its regulation, central 
mechanisms for how phosphoinositide signaling is diversified are still poorly understood. This 
chapter addresses one such major gap by focusing on PITPs and their mechanisms for 
specifying biological outcomes of phosphoinositide signaling. That PITP-deficiencies are 
relevant to neurological diseases, metabolic syndromes and cancer (e.g. as a pro-angiogenic 
factor in breast cancer) testifies to the biomedical impact of these proteins. At the cellular levels, 
evidence that PITPs regulate membrane trafficking, lipid droplet metabolism, developmental 
programs of polarized membrane biogenesis, and growth factor/morphogen receptor signaling 
identify exciting areas for inquiry. Yet, it is remarkable how little we know about what cellular 
processes are controlled by PITPs, or about the mechanistic details for how the conformational 
dynamics of lipid-exchange reactions catalyzed by these proteins govern the actions of PITPs 
as regulators of phosphoinositide signaling. This chapter discusses the mechanisms by which 
PITPs execute novel modes of signal control, i.e. by instructing biological outcomes of PtdIns 
kinases. Studies of the Sec14-like PITPs provide an accurate picture of what is known, and 
what remains unknown, regarding mechanisms for how PITPs interface with phosphoinositide 
signaling in eukaryotic cells. We focus in this chapter primarily on Sec14-like PITPs to illustrate 
progress that has been made, and what progress still needs to be made, regarding PITPs and 
how these proteins are integrated into the larger network of phosphoinositide signaling. 
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Inositol as a versatile signaling scaffold 
Roles for phosphorylated D-myo-inositols (Ins-phosphates) and phosphoinositides 
(PIPs) in signal transduction are well documented (Michell 2008; Fruman et al. 1998; Di Paolo 
and De Camilli 2006; Balla 2013), and phosphoinositides fulfill dual signaling roles in this 
capacity. First, phosphoinositides are metabolic precursors whose hydrolysis by phospholipases 
C (PLC) initiates production of the potent second messengers diacylglycerol and soluble Ins-
phosphates. Historically, the most celebrated such case is PLC-mediated hydrolysis of 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2)  to produce diacylglycerol and the soluble 
Ins-1,4,5-trisphosphate (IP3) (Suh et al. 1997; Rhee 2001). The former lipid second messenger 
regulates activities of protein kinases C, whereas this particular isomer of IP3 both gates 
intracellular calcium channels and serves as the obligate precursor of the other soluble Ins-
phosphates and Ins-pyrophosphates (Berridge and Irvine 1984; Odom et al. 2000).   
The chemical diversity of the Ins-phosphates, and the relationship of that diversity to the 
signaling capacities of these second messengers, lays the groundwork for arguments that Ins is 
evolution’s favorite molecule. As each position of the 6-member Ins ring can be phosphorylated 
(and, for some positions, pyro-phosphorylated), the potential Ins-phosphate cabal is a large one 
indeed. A simple binary code allows for 63 distinct molecules monophosphorylated at any 
position, and a trinary code balloons that potential to 728 distinct molecules if both mono- and 
pyro-phosphorylation is allowed at any position. Thus, the Ins headgroup is a versatile chemical 
scaffold upon which can be written a large set of unique signaling states, each distinguished 
from the others on the basis of how phosphates (or pyro-phosphates) are arranged around the 
Ins ring. It is therefore not surprising that the large numbers of chemically distinct Ins-
phosphates produced by cells translate to diverse biological effects. These soluble compounds 
regulate a wide spectrum of cellular functions ranging from mRNA transcription, to mRNA 
transport across nuclear pores, to protein folding, and to regulation of enzyme activities 
(Alcázar-Román et al. 2006; Macbeth et al. 2005; Tan et al. 2007; Lee et al. 2007).   
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Second, the phosphoinositide molecules themselves have intrinsic signaling capabilities 
independent of their roles as precursors for other second messenger molecules. This realization 
came from the discovery that phosphoinositides carrying phosphates on the 3-OH position of 
the Ins headgroup are not substrates for PLCs. As is the case for the Ins-phosphates, there are 
distinct phosphoinositide classes that differ in the position and number of phosphate groups that 
decorate the Ins ring. This chemical information is also decoded by proteins, and this 
recognition mechanism enables protein recruitment to membranes, and their subsequent 
activation, with spatial and temporal specificity. Phosphoinositides have roles in addition to 
recruitment of proteins to membranes. We now appreciate these lipids are important allosteric 
co-factors that modulate the activities of various enzymes and ion channels (Di Paolo and De 
Camilli 2006; Hilgemann et al. 2001). 
The chemical diversity of the soluble Ins-phosphates is not matched by that of the 
phosphoinositides. That is, the phosphoinositide cabal is far simpler. Yeast produce only five 
phosphoinositides (PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,5)P2, and PtdIns(4,5)P2), of which 
only the two 4-OH phosphorylated species are essential for viability (Fruman et al. 1998; Di 
Paolo and De Camilli 2006; Balla 2013). Higher eukaryotes produce seven -- the five listed for 
yeast with the addition of PtdIns(3,4)P2 and PtdIns(3,4,5)P3. The chemical simplicity of 
phosphoinositides notwithstanding, the biological outcomes of phosphoinositide signaling 
remain exceedingly diverse. How this diversity in functional outcome is achieved from such a 
restricted set of molecules remains an important question in contemporary cell biology. It seems 
clear that solution of the diversification paradox requires a high degree of functional 
compartmentalization of phosphoinositide signaling pools. 
 
Coincidence detection and phosphoinositide signaling  
Functional diversification of phosphoinositide signaling is primarily attributed to the 
deciphering of phosphoinositide chemical codes by specific phosphoinositide-binding modules 
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(e.g. PH-, ENTH-, FYVE-, BAR-domains, etc). Binding of a specific phosphoinositide species by 
such modules is subsequently translated to biological action by register of secondary effector 
binding cues – thereby generating a combinatorial coincidence detection code that confers 
signaling specificity Figure 1.1A. There is no question that cells employ this post-production, or 
‘back-loaded’, strategy to diversify biological outcomes for phosphoinositide signaling.   
Yet, the ‘back-loaded’ concept does not satisfactorily account for the remarkable 
diversity in biological outcomes for phosphoinositide signaling. This shortcoming reflects the 
failure of this model to address compartmentation of phosphoinositide pools other than by rather 
low resolutions mechanisms involving differential intracellular localization of lipid kinases, etc.  A 
striking example of the inadequacy of strictly ‘back-loaded’ mechanisms for diversifying 
phosphoinositide signaling is provided by the yeast Saccharomyces cerevisiae. In the example 
illustrated in Figure 1.1B, Stt4 PtdIns 4-OH kinase signaling in this organism has at least six 
distinct biological outcomes, and each outcome tracks with a specific PITP.  This example, on 
stark display in a simple unicellular eukaryote, clearly reports that the biological outcomes of 
phosphoinositide signaling are neither exclusively determined by the chemical nature of the 
phosphoinositide, nor by identities of the PtdIns kinases that produce it (Bankaitis et al. 1990; 
Wu et al. 2000; Routt et al. 2005; Desfougeres et al. 2005; Ren et al. 2014). Rather, PITPs help 
determine the biological outcomes for phosphoinositide signaling via what we term a ‘front-
loaded’ mechanism (Figure 1.1C). How might ‘front-loaded’ mechanisms work? Herein, we 
explore the concept that PITPs specify biological outcomes for PtdIns kinase activities via 
mechanisms that are coupled to the very act of phosphoinositide synthesis. 
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Figure 1.1. Diversity of PtdIns 4-OH kinase signaling in a unicellular cell. (A) Back-loaded 
models for diversifying phosphoinositide signaling interpret determination of biological outcome 
via a dual coincidence mechanism. In such models, distinction of phosphoinositide chemical 
identity is linked to recognition of some other effector after phosphoinositide synthesis has 
occurred (PtdIns 4-OH kinase signaling shown as example here). This combination specifies 
biological outcome. (B) Yeast have two essential PtdIns 4-OH kinases to which can be assigned 
a larger number of biological outcomes of which seven are shown. Each biological outcome 
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tracks with a specific Sec14-like PITP. (C) PITP-mediated front-loaded model for diversifying 
phosphoinositide signaling. Front-loaded models for diversifying phosphoinositide signaling 
interpret determination of biological outcome via a primed channeling of PtdIns to an 
appropriate kinase (4-OH kinase signaling shown here). The channeling is determined at the 
synthesis event itself and is determined by the identity of the PITP interacting with the kinase. 
The differential lipid binding specificities of individual PITPs define the source of metabolic input 
to the PtdIns kinase, and the PITPs themselves could assemble distinct phosphoinositide 
binding effectors at the site where the signaling phosphoinositide is (or will be) produced. Such 
a strategy produces highly integrated signaling circuits with point resolution (dimensions of 
single protein complexes). This model also identifies PtdIns 4-OH kinases as fundamentally 
biologically insufficient enzymes, even as wild-type enzymes with all accessory subunits 
present. Combination of both front- and back-loaded strategies greatly amplifies the simple 
phosphoinositide chemical code into a large biological outcome space. 
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Phosphatidylinositol transfer proteins   
PITPs are not enzymes, but proteins that mobilize energy-independent transfer of 
PtdIns, PtdCho and other lipids between membranes in vitro, and are therefore also inferred to 
transfer lipids in a manner not energized by ATP hydrolysis in vivo (Karel and Wirtz 2006; 
Cockcroft and Carvou 2007). PITPs are efficient in this regard as these proteins stimulate cell-
free rates of PtdIns transfer between membranes by several orders of magnitude. It is by this 
operational ‘transfer-assay’ that PITPs are historically defined.  But is this an unfortunate 
definition that miscasts PITPs as physiologically relevant inter-membrane lipid carriers, thereby 
sentencing interpretations of these activities to the prison of a superficial and essentially 
untestable model? We argue such is the case. It is our view that, after some four decades, the 
lipid transfer protein field still languishes under the conceptual straightjacket imposed upon it by 
the direct and rather uncritical linkage of in vitro transfer activities to in vivo functions as lipid 
carriers. We discuss alternative interpretations for the lipid-exchange activities, and these ideas 
suggest powerful new insights into how signaling can be highly compartmentalized – even in 
circumstances where similar enzymatic reactions are arranged in close quarters on the same 
membrane surface. 
The biochemical and functional questions surrounding these proteins notwithstanding, 
PITPs are highly conserved across the eukaryotic kingdom. This property implies biological 
importance, and these proteins fall into 2 families. The Sec14-like PITPs define a superfamily 
that includes retinaldehyde binding proteins, Ras-GAPs, Rho-GEFs, tyrosine phosphatases, 
and other phosphoinositide-binding proteins (Phillips et al. 2006; Saito et al. 2007; Bankaitis et 
al. 2010). The founding member is the major yeast PITP Sec14 (Bankaitis et al. 1990; Bankaitis 
et al. 1989; Cleves et al. 1991a). Sec14 studies are driving the PITP and lipid transfer protein 
fields because structural, computational, biochemical and genetic approaches are being 
productively applied towards elucidation of functional mechanisms. The START-like PITPs 
belong to the STAR-related lipid transfer protein superfamily and are less well understood. 
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These proteins are the primary subjects of recent reviews and readers are referred to those 
summaries for further details (Cockcroft 2007; Cockcroft and Garner 2011; Shadan 2008). 
Herein, we limit discussion of the START-like PITPs to the question of whether these proteins 
might also channel PtdIns kinase activities to dedicated biological outcomes (Bankaitis et al. 
2010; Schaaf et al. 2008). 
 
PITPs and phosphoinositide signaling from a historical perspective 
The experimental origins of lipid transfer proteins lie in studies that identified vesicle-
trafficking-independent mechanisms of lipid trafficking in cells. These studies were of various 
designs, but all relied on measuring inter-compartmental trafficking of lipids in the face of some 
chemical or conditional inhibition of secretory pathway activity (Sleight and Pagano 1983; 
Kaplan and Simoni 1985; Vance et al. 1991; Wirtz 1991). Many of the experimental strategies 
also rested on necessarily rapid purifications of plasma membrane from endoplasmic reticulum 
using panning techniques. Rapid recoveries of highly purified plasma membrane fractions were 
absolutely required for interpretation of the data. With the benefit of hindsight informed by the 
advent of sensitive technologies with which to monitor membrane purity, and the newly 
rediscovered significance of such complicating structures as intermembrane contact sites (Prinz 
2014), it is now apparent that rapid methods for membrane separation and purification were 
inadequate for the task at hand. The membrane fractions used for readout were not pure, and 
membrane contaminants preclude confident interpretation of the data. So, the experimental 
foundation for lipid trafficking via soluble protein carriers is less compelling than previously 
believed. 
With regard to functional interpretations of PITPs, biochemical studies subsequently 
intersected with theoretical considerations stemming from the knowledge that the metabolic 
cycle for regenerating phosphoinositide molecules after their consumption by PLC during the 
course of agonist-stimulated signaling required navigation of a problem of biochemical 
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compartmentation. This problem is grounded on the central presumption that the compartments 
where PtdIns, the metabolic precursor of all phosphoinositides, is synthesized is physically 
distant from the location where phosphoinositides are consumed. The specific case under 
discussion considers replenishment of PtdIns(4,5)P2 pools in the plasma membrane upon 
agonist stimulation of PLC activity. With respect to synthesis, PtdIns is produced de novo by the 
enzyme PtdIns synthase which converts Ins and cytidine-diphospho-diacylglycerol (CDP-DAG) 
to produce PtdIns and cytidine-monophosphate. CDP-DAG is produced from phosphatidic acid 
(PtdOH) and cytidine-trisphosphate. Both PtdIns- and CDP-DAG-synthases are integral 
membrane proteins of the endoplasmic reticulum. A solution to this topological problem was 
suggested where soluble lipid carrier proteins ferry PtdIns from the endoplasmic reticulum to the 
plasma membrane, and return DAG or PtdOH from the plasma membrane to the endoplasmic 
reticulum in a retrograde arm of the cycle (Michell 1975; Figure 1.2). This conjecture set a 
framework for translating the biochemical properties of PITPs to physiological functions in 
support of phosphoinositide signaling (Paridon et al. 1987). Results from permeabilized cells 
claiming an obligatory role for soluble PITPs in growth factor receptor signaling were 
subsequently taken as evidence in support of this basic concept (Kauffmann-Zeh et al. 1995; 
see below). However, the veracity of such claims in in vivo settings is now uncertain.  Recent 
studies using sophisticated vital imaging studies reveal that the PtdIns synthase enzyme itself 
may be mobilized from the endoplasmic reticulum via a COPII vesicle-like mechanism, and 
positioned in the direct proximity of the plasma membrane (Kim et al. 2011). Moreover, available 
genetic studies with PITP mutant animals and cells also do not support the central predictions of 
the PtdIns supply model (Alb et al. 2002; Alb et al. 2003; Alb et al. 2007; see below). 
Nonetheless, the interpretation of PITPs as lipid carriers remains the prevailing concept 
for how PITPs execute cellular functions (Prinz 2010; Lev 2010). We view acceptance of this 
idea to be faith-based because there is no direct evidence that PITPs physically remove a 
PtdIns monomer from the endoplasmic reticulum and then transport it to the plasma membrane 
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in cells where it is preferentially channeled into phosphoinositide synthesis. The experiment to 
appropriately test this model in cells is a technically difficult one of course, but there are other 
reasons to consider alternative ideas. For example, the first PITPs characterized were PtdIns 
and phosphatidylcholine (PtdCho) transfer proteins and it is for this reason that proteins with 
those particular properties are often referred to as classical (or canonical) PITPs. In the several 
cases where the integrity of robust PLC signaling pathways has been interrogated in cells or 
organisms lacking individual classical PITPs, the results are not consistent with the predictions 
of the PtdIns transfer cycle (see below). 
The designation of PtdIns/PtdCho transfer proteins as classical PITPs will ultimately 
prove to be an awkward designation as non-classical PITPs (i.e. proteins that transfer PtdIns 
and some other ligand distinct from PtdCho) have been discovered, and these proteins 
outnumber the classical PITPs (Saito et al. 2007; Schaaf et al. 2008).  Nonetheless, the non-
classical PITPs are intriguing in part because the most parsimonious property of a PITP 
involved in the PtdIns supply cycle illustrated in Figure 1.2 is that of a non-classical PtdIns/DAG 
or PtdIns/PtdOH transfer protein. Support for PITPs being involved in a PtdIns carrier cycle 
would additionally involve two experimental demonstrations: (i) that acute loss of a 
PtdIns/PtdOH transfer protein inhibits sustained PLC signaling, and (ii) that loss of the PITP also 
reduces flux through the PtdIns biosynthetic pathway. While demonstrations that satisfy both 
criteria have not been reported to date, PITPs with the appropriate biochemical properties are 
now identified (see below). 
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Figure 1.2. A lipid transfer cycle for coupling PtdIns synthesis to phosphoinositide 
signaling.   Lipid-transfer proteins are proposed to drive a cycle of anterograde PtdIns transfer 
from the endoplasmic reticulum to the plasma membrane, and balanced retrograde transfer of 
either diacylglycerol (DAG) or phosphatidic acid (PtdOH), to fuel phosphoinositide synthesis and 
signaling. The model in its simplest and most integrated form predicts PITP deficits will result in 
reduced phosphoinositide signaling at the plasma membrane with diminished resynthesis of 
PtdIns at the endoplasmic reticulum. 
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The anatomy of the Sec14 phospholipid exchange cycle 
To understand the functions of PITPs as molecules, no matter in what specific 
physiological settings these functions are discharged, it is essential to understand the complex 
dynamics associated with how PITPs execute lipid exchange. Structural and biophysical studies 
are contributing strongly in this regard.  The superficial shape of the exchange cycle is simple. 
The PITP homes onto a membrane surface where it undergoes a conformational change to 
expose the hydrophobic pocket so that lipid exchange can ensue. Electron spin-labeling studies 
demonstrate the hydrophobicity gradient across the Sec14 lipid-binding pocket closely mimics 
that of a membrane leaflet (Smirnova et al. 2007). The exchange process, when viewed in basic 
terms, therefore rests on the concept that phospholipid (either bound or to be bound) is 
presented with a choice of partitioning into one of two chemically equivalent environments. That 
is, from the membrane into the hydrophobic pocket and vice-versa. A simple partitioning 
mechanism neatly accounts for the energy-independence of the lipid exchange cycle. However, 
PITP binding to the membrane must evoke a highly local destabilization of the membrane 
surface in order to ‘activate’ lipid molecules for chemical partitioning -- thereby identifying those 
activated molecules as lipids competent for exchange. The various questions surrounding the 
early steps in the exchange cycle remain to be investigated. 
From the protein point of view, crystallographic studies define two major Sec14 
conformers – i.e. the ‘open’ and ‘closed’ conformers (Schaaf et al. 2008; Sha et al. 1998; 
Phillips et al. 1999). The ‘closed’ conformer is bound to a single phospholipid molecule, and this 
conformer is interpreted to represent the protein in its soluble (cytoplasmic) state. The ‘open’ 
conformer is interpreted as representing the membrane-associated PITP engaged in lipid 
exchange (Sha et al. 1998; Phillips et al. 1999). In this form, the hydrophobic pocket is exposed 
and lipid-free due to an 18Å displacement of a helical gate element that governs access to the 
lipid binding pocket (Figure 1.3A). Reversible cross-linking experiments demonstrate that the 
large rigid body motions of the helical gate are essential for lipid exchange. Moreover, these 
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conformational transitions are themselves controlled by a conformational switch element 
conserved across the Sec14-superfamily, the G-module. Survey of human disease alleles that 
involve Sec14-like proteins/domains highlight the importance of this element in the context of 
the Sec14-fold as a number of these alleles represent missense mutations that alter the G-
module itself (Ryan et al. 2007). Outstanding questions for future address include how activity of 
the G-module is regulated by membrane-binding.  Indeed, the closer one examines the Sec14 
conformational dynamics associated with lipid exchange, the more interesting these become. 
Directed evolution experiments indicate that G-module conformational transitions regulate the 
kinetics of gating of the hydrophobic pocket for lipid exchange, and that activation of the G-
module responds to water organization and dynamics within the lipid binding pocket itself 
(Schaaf et al. 2011). 
Although we are now beginning to understand the dynamics of the lipid exchange cycle 
from the Sec14 point of view, we know nothing about the cycle from the perspective of the 
phospholipid ligands.  As will become clear below, evolving concepts for Sec14-like PITP 
activities not as lipid carriers, but as novel regulators of the biological outcomes of 
phosphoinositide signaling, demand an atomistic understanding of the mechanics of lipid 
exchange from both protein and lipid points of view. The challenges include solving how Sec14-
like proteins dock onto membrane surfaces, what trajectories are drawn by PtdIns and 
secondary lipid ligands as these navigate entry and exit from the hydrophobic pocket, of the 
relative kinetics of lipid ligand entry and exit from the hydrophobic pocket, and how this relates 
to the interaction between the PITP and the PtdIns 4-OH kinase. 
 
Lipid binding by Sec14-like proteins 
Although the Sec14 conformational dynamics associated with lipid exchange provide a 
useful picture of the cycle from the protein point of view, an equally critical key to understanding 
mechanisms of PITP function demands understanding how the lipid ligands enter and exit the 
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hydrophobic pocket. The fact that PtdIns and PtdCho are chemically similar molecules (with the 
exception of their respective headgroups) would seem to suggest that the trajectories with which 
these two phospholipids enter and/or exit the Sec14 hydrophobic pocket. But, the advent of high 
resolution crystal structures of Sec14 and other closely related Sec14-like proteins indicate this 
is not at all the case (Schaaf et al. 2008). Structural studies with Sec14 and its close homolog 
Sfh1 reveal the PtdCho and PtdIns headgroups are bound at physically distant sites. Whereas 
the PtdCho headgroup and glycerol backbone are buried deep within the hydrophobic pocket, 
the corresponding regions of bound PtdIns are positioned much closer to the protein surface 
(Figure 1.3B). Although Sec14 has a much higher affinity for PtdIns than for PtdCho, the 
selectivity for PtdIns vs PtdCho is estimated to be sufficiently small in energetic terms so that 
H2O rearrangements within the hydrophobic pocket are sufficient for negotiating the energy 
barriers that confront the heterotypic phospholipid exchange cycle. Of particular mechanistic 
relevance, a functional Sec14 molecule must house both PtdCho and PtdIns binding/exchange 
capability in order to stimulate production of PtdIns4P in cells (Schaaf et al. 2008; Schaaf et al. 
2011). Those data demonstrate that both homotypic PtdCho- and homotypic PtdIns-exchange 
reactions are biologically futile activities, and that Sec14-mediated stimulation of PtdIns 4-OH 
kinase activity requires heterotypic exchange reactions (e.g. PtdIns for PtdCho or vice versa).  
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Figure 1.3. Structural engineering of Sec14-like PITPs. (A) Access to lipid binding pocket is 
controlled by the dynamics of a helical gate. The α-carbon backbones of the open (silver) and 
closed (gold) structures of Sec14 and Sfh1 are rendered in ribbon diagram and superposed. 
The respective positions of the helical element that gates access to the lipid binding pocket, and 
the displacement of the gating element between the two conformers, are highlighted. (B) 
Classical Sec14-like PITPs bind PtdIns and PtdCho at distinct sites. The binding poses of 
PtdIns (blue) and PtdCho (red) within the closed Sec14 (Sfh1) conformer are shown. The 
respective headgroups are identified by the corresponding solid colored circles. 
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Sec14-like proteins and instructive regulation of PtdIns kinase activity  
Why is a heterotypic exchange cycle essential for Sec14-mediated support of optimal 
PtdIns 4-OH kinase activity and stimulated phosphoinositide synthesis in yeast cells? It is 
difficult to argue that PtdIns transfer mechanisms are involved because PtdIns naturally 
constitutes 20-25 mol% of bulk glycerophospholipid in yeast. Why would there be an obligate 
need for a PITP-driven PtdIns supply mechanism in membranes so rich in PtdIns? Alternative 
concepts need to be considered.  In that regard, a kinetic trap model is proposed where slow 
PtdCho egress from the pocket results in abortive PtdIns entries – thereby exposing a frustrated 
PtdIns that is registered by the lipid kinase as an accessible substrate for phosphorylation 
(Bankaitis et al. 2010; Schaaf et al. 2008).   
This model has several key ideas, three of which are emphasized here. First, PITPs are 
required for biologically sufficient PtdIns4P production because PtdIns 4-OH kinases (at the 
least) are biologically inadequate interfacial enzymes when substrate PtdIns resides in a bilayer. 
This inadequacy is manifest even when PtdIns is a major bulk membrane phospholipid in the 
cell.  Second, it describes stimulation of PtdIns 4-OH kinase activity in terms of a PITP-mediated 
PtdIns presentation mechanism where effective PtdIns presentation by Sec14 requires PtdCho 
binding.  Third, the model identifies the optimal PtdIns substrate for PtdIns 4-OH kinase action 
as a lipid molecule that is frustrated in its entry into the Sec14 pocket.  That is, a PtdIns 
molecule that never successfully enters the Sec14 pocket. In this model, Sec14 operates as a 
PtdCho sensor that couples PtdCho metabolic information to activation of PtdIns as a substrate 
for production of a dedicated signaling pool of PtdIns4P. The ability of Sec14 to prime PtdIns4P 
production in response to PtdCho metabolic cues outlines the basic principle of what we term 
instructive regulation of PtdIns 4-OH kinase activity. A detailed example of this idea is presented 
in the following section using Sec14-mediated regulation of membrane trafficking through the 
TGN/endosomal system as biological context. 
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 The base concept that Sec14-like proteins specify privileged phosphoinositide signaling 
pools via instructive regulation of lipid kinases has interesting implications, and structural 
studies indicate this type of regulation might be very broad indeed. The structural signatures, or 
bar codes, that identify the elements directly involved in PtdIns headgroup coordination are 
conserved throughout the Sec14 superfamily, while the PtdCho-binding bar code is recognized 
only in a subset of these proteins (Bankaitis et al. 2010; Schaaf et al. 2008; Nile et al. 2010). 
These features portend conservation of inositol-lipid binding capacity throughout the Sec14-
superfamily with an accompanying diversification in the binding specificities for secondary lipid 
ligands. Using this idea to extend the principle of instructive lipid kinase regulation, Sec14-like 
proteins/domains can be interpreted as adaptors that interface the metabolism of diverse 
lipids/lipophiles with stimulated phosphoinositide synthesis for formation of functionally 
compartmentalized lipid signaling pools. 
 The concept of instructive regulation of inositol lipid kinases is gaining momentum from 
the recognition that naturally occurring human disease alleles of Sec14-superfamily proteins, 
including the most common inherited alleles associated with human retinal degeneration and 
acute vitamin E deficiencies, directly involve PtdIns (or phosphoinositide) binding bar-code 
residues (Bankaitis et al. 2010; Schaaf et al. 2008; Nile et al. 2010; He et al. 2009; Kono et al. 
2013). That remarkable correlation implies an inositol phospholipid is a genuine physiological 
ligand for the Sec14-like protein in question (cellular retinadehyde binding protein and α-
tocopherol transfer protein, respectively). Indeed, recent structural and functional analyses of 
the α-tocopherol transfer protein strongly reinforce this concept (Kono et al. 2013). Other Sec14-
like proteins/domains associated with human disease include caytaxin and neurofibromin, and 
loss-of-function mutations that compromise the presumptive PtdIns-binding bar-code motifs of 
these proteins have now been identified (Bankaitis et al. 2010; Schaaf et al. 2008; Nile et al. 
2010). 
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Instructive regulation from the perspective of yeast Sec14-like PITPs  
The yeast system offers strong opportunities for exploring instructive regulation of PtdIns 
kinases by Sec14-like proteins. As discussed above, each of the six Saccharomyces Sec14-like 
PITPs specify unique biological outcomes for PtdIns 4-OH kinase signaling, and four of the six 
are non-classical on the basis of failing to exhibit measurable PtdCho-transfer activities and not 
displaying recognizable PtdCho-binding bar-codes (Ren et al. 2014; Schaaf et al. 2008; Nile et 
al. 2010; Li et al. 2000). The Sfh3 PITP represents a particularly interesting case in this regard 
as, even though it is a PITP that activates PtdIns 4-OH kinase activity in a fashion analogous to 
the one discharged by Sec14 in the same cell, it nonetheless acts in a biologically antagonistic 
way to Sec14 (Ren et al. 2014). This functional antagonism reflects competing activities by 
these PITPs in channeling PtdIns 4-OH kinase activities towards disparate biological outcomes. 
Whereas Sfh3 directs PtdIns 4-OH kinase signaling towards developmental regulation of lipid 
droplet metabolism, Sec14 trains lipid kinase activity on membrane trafficking through the 
TGN/endosomal system. The idea of instructive stimulation of PtdIns 4-OH kinases by Sec14-
like proteins posits that channeling of PtdIns 4-OH kinase activity to distinct biological outcomes 
is determined in part by the binding of these two PITPs to distinct secondary ligands. Indeed, 
the dimensions and chemical environment of the Sfh3 hydrophobic pocket differ radically from 
those of the classical PITPs Sec14 and Sfh1 (Ren et al. 2014; Schaaf et al. 2008) – i.e. a 
property consistent with diverged secondary lipid binding specificities.  Identification of the 
secondary ligands hypothesized to prime PtdIns presentation to the lipid kinases is now an 
important endeavor, and there are data to suggest that such a ligand for Sfh3 may be a sterol 
(Holič et al. 2014).  
How do Sec14-like PITPs interact with PtdIns 4-OH kinases? An enzyme::PITP complex 
offers the simplest solution for PtdIns presentation. In some instances, this may well be the 
case. One such example involves the dual requirements for a Sec14-like PITP (Sfh4) and the 
Stt4 PtdIns 4-OH kinase in regulation of phosphatidylserine decarboxylation in yeast (Wu et al. 
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2000). The Sfh4 requirement shows high PITP-specificity as no other Sec14-like protein can 
operate as functional surrogate in this metabolic reaction (Routt et al. 2005), and the PITP 
specificity may reflect the need for a physical interaction between the Sfh4 and the 
decarboxylase enzyme (Riekhof et al. 2014); although the functional requirement for this 
interaction has not been shown. In other cases, a tight physical interaction does not seem 
essential.  Stimulation of yeast Pik1 and Stt4 PtdIns 4-OH kinases by Sec14 are two cases in 
point. The possibility that PITPs might present PtdIns to the lipid kinase en passant, and thereby 
facilitate a ‘drive-by’ phosphorylation of the headgroup, is consistent with demonstrations that 
the structurally unrelated vertebrate START-like PITPs can perform as functional Sec14 
surrogates in stimulating PtdIns 4-OH kinase activities when expressed at high levels in yeast 
(Skinner et al. 1993; Ile et al. 2010). 
 
Sec14 and the interface between lipid metabolism and membrane trafficking 
Why would cells employ specific Sec14-like PITPs to serve as PtdCho sensors when 
PtdCho is the most abundant cellular phospholipid? What possible signaling information could 
come from this curious design? This paradox can be examined by reviewing the results of 
genetic studies of Sec14 function in vivo, and interpreting those results through the conceptual 
lens of instructive regulation of the Pik1 PtdIns 4-OH kinase. The PITP activity of Sec14 is 
essential for yeast cell viability because this activity is required for efficient transport of secretory 
cargo from the trans-Golgi network (TGN) to the cell surface (Bankaitis et al. 1990; Bankaitis et 
al. 2010). Sec14 promotes TGN function primarily by regulating a retrograde membrane 
trafficking pathway that returns components of the anterograde trafficking machinery to the TGN 
from endosomes (Mousley et al. 2008). Seminal insights into Sec14 function in the 
TGN/endosomal system came from study of ‘bypass Sec14’ mutations that circumvent the 
normally essential Sec14 requirement for membrane trafficking and cell viability (Cleves et al. 
1989; Cleves et al. 1991b; Fang et al. 1996). All of the ‘bypass Sec14’ alleles ultimately proved 
20 
 
to be recessive – identifying these as loss-of-function mutations that inactivate functional 
antagonists of Sec14 activity.  These mutations fall into two general categories; those that 
ablate enzymes of the CDP-choline pathway for PtdCho biosynthesis (Cleves et al. 1991a; 
Cleves et al. 1991b; McGee et al. 1994), and those that ablate proteins whose activities either 
degrade (e.g. the Sac1 PtdIns4P phosphatase) or sequester (e.g. the oxysterol binding protein 
homolog Kes1/Osh4) from PtdIns4P its pro-trafficking downstream effectors  (Cleves and 
Novick 1989; Guo et al. 1999; Rivas et al. 1999; Li et al. 2002; Mousley et al. 2012; Mesmin et 
al. 2013; Figure 1.4).  Those genetic data revealed that Sec14 coordinates PtdCho metabolism 
with PtdIns4P signaling to promote membrane trafficking through TGN/endosomal 
compartments, and the PtdCho sensor function is proposed to constitute a mechanism for 
sensing metabolic flux through the CDP-choline pathway as a proxy for consumption of a pro-
trafficking lipid diacylglycerol (Bankaitis et al. 2010; Kearns et al. 1997; Ile and Schaaf 2006). 
Thus, the PtdCho sensor activity translates to activation of the Sec14 heterotypic exchange 
cycle for production of a second pro-trafficking lipid, PtdIns4P, by the Pik1 PtdIns 4-OH kinase 
(Figure 1.4). In this way, Sec14 facilitates the tuning of PtdIns4P production in response to 
PtdCho synthesis via the CDP-choline pathway and the consumption of DAG in the process.  
This model provides a coherent and physical picture for the general concept of crosstalk 
between PtdCho and PtdIns4P metabolic pathways. 
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Figure 1.4. Instructive regulation of PtdIns 4-OH kinase by Sec14 and TGN/endosomal 
membrane trafficking. A model is drawn where Sec14 interfaces PtdCho metabolism (and 
consumption of the pro-secretory lipid DAG) with the amplitude of PtdIns-4-phosphate pro-
secretory signaling in the yeast TGN/endosomal membrane trafficking pathway. Sec14 serves 
as a sensor for flux through the CDP-choline pathway for PtdCho biosynthesis and, via PtdCho 
binding and activation of heterotypic exchange cycles, stimulates activity of the Pik1 PtdIns 4-
OH kinase to produce PtdIns-4-phosphate in response to CDP-choline pathway activity. Cellular 
activities whose loss of function result in ‘bypass Sec14’ are highlighted in red (see text).   
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Metazoan START-like PITPs 
Metazoan START-like PITPs consist of either a free-standing PITP domain, or are 
multiple domain proteins (Figure 1.5). Numerous lines of evidence indicate that they also 
regulate phosphoinositide signaling. Several of those annotated physiological contexts 
recapitulate the Sec14 case in that membrane trafficking events are involved. These include 
regulated and constitutive secretory processes in neuroendocrine and mast cells (Hay and 
Martin 1993; Ohashi et al. 1995; Pinxteren et al. 2001), and non-excitatory cells (Jones et al. 
1998; Simon et al. 1998), retrograde membrane trafficking from the Golgi complex regulated by 
the START-domain protein PITPα (Carvou et al. 2010), speculation that endocytic trafficking of 
the angiotensin II receptor may be regulated by another START-domain protein PITPnc1 
(Garner et al. 2011; Garner et al. 2012), and potentiation of anterograde trafficking from the 
mammalian TGN via regulation of diacylglycerol metabolism by a multi-domain START-like 
PITP termed PITPnm1. The TGN trafficking activity of PITPnm1 is of interest in that it, like 
Sec14, counters the antagonistic effects of the CDP-choline pathway for PtdCho biosynthesis 
on vesicular transport (Litvak et al. 2005). Other signaling circuits that show START-like PITP-
dependence include the Drosophila visual and olfactory phototransduction pathways, and 
chemosensation in the worm. These sensory systems depend on activity of the multi-domain 
START-like PITPs – e.g. fly RdgB and worm pitp-1, respectively, although a requirement for 
PITP activity in PITP-1 biological function has not been demonstrated (Vihtelic et al. 1991; 
Milligan et al. 1997; Iwata et al. 2011). There are also reports of an obligate role for the START-
domain PITPα and multi-domain PITPnm1 proteins in forward signaling of the epidermal growth 
factor receptor, and for PITPα in both epidermal growth factor receptor and netrin receptor 
signaling (Kauffmann-Zeh et al. 1995; Kim et al. 2013; Larijani et al.2003; Xie et al. 2005). 
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Figure 1.5. Domain architecture of START-like PITPs. Class I PITPs include PITPα and two 
splice variants of PITPα. Class II PITPs are orthologs of the Drosophila DmRdgBα and include 
the multi-domain human and C. elegans HsPITPnm1 and CePITP-1, respectively, the single 
domain fly DmRdgBα and two splice variants of HsPITPnc1. Alternative nomenclature is 
indicated in parentheses. Spliceoforms are designated by a diagonal line, and variant C-termini 
are indicated in pink. Domain location and length of proteins is marked in superscript: PITP 
(light blue), phosphatidylinositol transfer protein; DDHD (grey); Lipin/Ned1/Smp2; LNS2; FFAT, 
diphenylalanine in an acidic tract. 
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START-like PITPs and phosphoinositide signaling   
The prevailing thought is these proteins are intracellular PtdIns carriers (Cockcroft and 
Carvou 2007; Cockcroft 2007; Prinz 2010; Lev 2010). In the case of the START-domain 
versions, these PITPs are considered to be soluble carriers while the membrane-associated 
multi-domain proteins are posited to act as shuttle factors that operate in focal areas of close 
membrane apposition – i.e. intermembrane contact sites (Prinz 2014; Holthuis and Levine 2005; 
Lev 2012). Unfortunately, the available data from model metazoan organisms – both vertebrate 
and invertebrate – are rather confusing from the perspective of offering some unified 
mechanism of function. There is little solid evidence from animal systems to show that growth 
factor or morphogen receptors obligatory require START-domain PITPs (e.g. PITPα) for forward 
signaling from the plasma membrane. In cases where the question has been put to the acid 
experimental test, soluble canonical PITPs (e.g. PITPα) do not score as significant components 
of PtdIns supply pathways for sustained phosphoinositide signaling at the plasma membrane 
(Alb et al. 2002; Alb et al. 2003; Alb et al. 2007).   
There is clear evidence of the physiological importance of the soluble START-like PITPs, 
however. Zebrafish PITPβ and PITPα hypomorphs show defects in establishment and/or 
maintenance of photoreceptor outer segments and embryogenesis, respectively (Ile et al. 2010). 
PITPα-deficient mice are born alive but suffer perinatal death brought on by multiple 
pathologies. These include a dramatic spinocerebellar neurodegenerative disease marked by a 
fulminating course of aponecrotic cell death and neuroinflammation, an inability of the animals 
to process and transport lipoproteins from the enterocyte, striking lipid homeostatic defects in 
the liver, and degeneration of pancreatic islets that leads to a catastrophic hypoglycemia (Alb et 
al. 2003).  Interestingly, the high flux phosphoinositide-driven synaptic cycle remains fully intact 
in pitpα null neurons – even in performance assays where such cells are subjected to excitation 
trains of such intensities that the synaptic capacities of the test neurons are ultimately 
overwhelmed (Alb et al. 2007). A biologically functional PITPα must bind PtdIns as evidenced by 
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the demonstration that mouse strains expressing a mutant protein specifically defective in 
PtdIns (but not PtdCho) binding, as sole source of PITPα activity in the animal, phenocopy the 
null mouse (Alb et al. 2007). Those data demonstrate an authentic role for PITPα in regulating 
inositol lipid signaling in the mouse, although there are no obvious derangements in bulk 
phosphoinositide pools in deficient cells or tissues (Alb et al. 2003). 
 Recently, the mammalian PITPnc1 and its fly cognate RdgBβ were recognized to be 
PtdIns/ PtdOH transfer proteins (Garner et al. 2012), and that the multi-domain PITPnm1 also 
binds PtdOH. In this case, PtdOH binding activity resides in a C-terminal LNS2 domain, in 
addition to PtdOH being the counter-ligand for the PITP domain (Kim et al. 2013; Cockcroft et 
al. 2016). Non-canonical proteins such as PITPnc1 display the biochemical properties expected 
of a lipid shuttling activity involved in the phosphoinositide consumption-regeneration cycles 
depicted in Figure 1.2, and PITPs such as these will be particularly interesting to analyze with 
regard to the integrity of phosphoinositide signaling and capacity for PtdIns resynthesis in 
genuine in vivo contexts. In that regard, there is growing interest in PITPnc1 from the 
perspective of cancer biology. The microRNA mir-126 exhibits tumor suppressor activity 
(Tavazoie et al. 2008; Guo et al. 2008; Feng et al. 2010), and one of its target genes is 
PITPNC1 (Png et al. 2012). Downregulation of mir-126 and consequent elevation of PITPnc1 
levels promotes recruitment of endothelial cells to tumors with subsequent increase in 
angiogenesis and increased metastatic potential (Png et al. 2012), and we will discuss this in 
more detail in Chapter 4.   
 
START-like PITPs at inter-membrane contact sites   
The multi-domain PITPs (e.g. PITPnm1) are envisioned to participate in such capacities 
via endoplasmic reticulum::plasma membrane contact sites that organize and integrate the 
calcium signaling machineries of those two membrane systems in response to cell stimulation 
(Prinz 2010; Lev 2010). The primary physiological activities of these multi-domain PITPs are 
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likely restricted to excitatory cells where the amplitudes of induced signaling are very high (e.g. 
neurons). Several observations are consistent with such a view. First, the Drosophila RdgBα is 
functionally important only in sensory organs involved in vision and olfaction. The null fly is 
otherwise viable. The PITP-1, also the sole multi-domain PITP in the worm, is similarly 
nonessential for base viability of this organism (Iwata et al. 2011). Third, siRNA-mediated 
knockdown of PITPnm1 does not affect viability of the hypomorphic mammalian cells in an ex 
vivo context (Litvak et al. 2005). This result is congruent with genetic data as the PITPnm1 null 
mice are viable – albeit with defects in cholesterol and calcium homeostasis and altered 
auditory functions (http://www.informatics.jax.org/marker/MGI:1197524; Carlisle et al. 2013). An 
obligate role for the PITP-domain in discharge of these physiological activities remains to be 
demonstrated. The cellular and animal viability data are puzzling given the reported obligatory 
roles for this protein in promoting growth factor signaling and anterograde protein trafficking 
from the TGN. It remains formally possible that there is some functional redundancy between 
PITPnm1 and its close homolog PITPnm2 (Lu et al. 2001). However, the tissue expression 
profile for PITPnm2 is restricted to retina and dentate gyrus, and is therefore much more limited 
than that of the widely expressed PITPnm1. As such, PITPnm2 is likely the true mammalian 
ortholog of fly RdgBα. However, mice lacking PITPnm2 are healthy and show no defects in 
photoreceptor function (Lu et al. 2001). 
 
START-like PITPs and instructive regulation of phosphoinositide signaling 
Sec14-like and START-like PITPs exhibit completely unrelated structural folds (Figure 
4.1) (Yoder et al. 2001; Schouten et al. 2002; Tilley et al. 2004), so it remains an open question 
as to whether or not these proteins execute mechanistically homologous activities. So, do 
START-like PITPs also instruct biological outcomes for PtdIns kinase signaling in metazoans? 
The question cannot be answered at this time because the appropriate experimental test has 
yet to be devised for the metazoan systems to which these proteins are native. The fact that the 
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START-like PITP family is far more sparse than is the Sec14 superfamily in even the most 
complex vertebrates, suggests that instructive regulation is either not a physiologically important 
activity of these PITPs, or that the biological scope of any such activity is limited for these 
proteins. However, there are indications these PITPs can execute an instructive regulation when 
interrogated under quasi-physiological conditions. That evidence comes from yeast systems 
where both zebrafish and mammalian START-like PITPs efficiently stimulate PtdIns 4-OH 
kinase activities to produce PtdIns4P under conditions of PtdIns surfeit and high-level 
expression of the PITP (Ile et al. 2010). The fact that the RdgBα PITP domain can also perform 
Sec14-like functions when expressed at high levels in yeast, although it cannot fully substitute 
for Sec14, forecasts that it too has that biochemical capability (unpublished data). 
That instructive regulation is a viable alternative for interpreting how the START-like 
PITPs function is also suggested by an old and puzzling observation. Although RdgBα is a 
multi-domain PITP of which the START-like PITP domain comprises only some 20% of the total 
protein sequence (Vihtelic et al. 1991), expression of the RdgBα PITP domain alone is sufficient 
to fully complement the dramatic retinal degeneration phenotype of null flies (Milligan et al. 
1997). By contrast, expression of PITPα in RdgBα-deficient retinal is completely ineffective in 
this regard. The non-exchangeability of these two PITP modules is also on display in domain-
swap experiments where PITPα replaced the RdgBα PITP domain in the context of the full-
length protein (Milligan et al. 1997). Perhaps the functional non-equivalence of these two PITPs 
reflects an ability of the RdgBα PITP to bind PtdOH whereas PITPα lacks this capacity (Yadev 
et al. 2015). This biological specificity of PITP action, a result usually on display when PITP 
functions are interrogated in authentic biological contexts, and a central feature of instructive 
regulation models, is not recapitulated in permeabilized cell experiments where PITP functional 
promiscuity is the dominant theme (Hay and Martin 1993; Ohashi et al. 1995; Pinxteren et al. 
2001; Jones et al. 1998; Cunningham et al. 1996). 
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That intermembrane contact sites are privileged sites of signaling and lipid transfer is an 
attractive model, and incorporation of multi-domain PITPs into such structures suggests how 
these proteins might facilitate intermembrane lipid transfer. Can instructive regulation work 
within the framework of a contact site? We suggest yes. Localization of the PITP to a contact 
site physically organizes where instructive regulation of a lipid kinase occurs in response to 
PtdOH production. In this scenario the PITP serves as a PtdOH sensor that monitors 
phosphoinositide signaling flux and couples PtdOH production to instruction of enhanced on-
demand production of phosphoinositide at a precise site on the plasma membrane.  There is 
much to be learned about the relationship between PITPs and contact sites, however. That 
expression of the PITP module alone is sufficient to satisfy the demands of the animal for multi-
domain PITP function, in the two cases where the issue has been rigorously queried (i.e. fly 
RdgBα and worm pitp-1; Milligan et al. 1997; Iwata et al. 2011), remains a remarkable and an 
altogether perplexing result. 
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PITPs as targets for chemical interference with phosphoinositide signaling 
Finally, the concept of instructive regulation of PtdIns 4-OH kinases by PITPs identifies 
these proteins as highly discriminating portals through which privileged phosphoinositide 
signaling pools can be interrogated. Proof-of-concept is provided by recent discoveries of small 
molecule inhibitors with validated specificity for Sec14 (Nile et al. 2014; Lee et al. 2014). 
Treatment of yeast with biologically active inhibitors recapitulates the phenotypes associated 
with sec14 loss-of-function mutations, and there are no obvious off-target effects. Interestingly, 
Sec14 is subject to specific inhibition by several different chemical scaffolds (Lee et al. 2014), 
and the available data show that PITP-directed small molecule inhibitors offer superior 
strategies for interfering with phosphoinositide signaling pools that interface with specific 
biological pathways. Moreover, these PITP-targeted interventions can be applied with far 
greater specificities than those afforded by even the most specific inhibition of individual PtdIns-
kinases (Figure 1.6), or even enzyme dimerization-based (e.g. rapalog) depletion of 
compartment-specific pools of individual phosphoinositides.   
Two objections against the idea of targeting PITPs for inhibition by small molecules can 
be imagined: (i) the concern that these proteins will bind lipophilic compounds nonspecifically 
due to the hydrophobic nature of the lipid binding pocket, and (ii) that candidate inhibitors will fail 
to discriminate between PITPs or even other unrelated proteins that bind lipophiles. What is 
particularly interesting is that even very closely-related Sec14-like PITPs are not inhibited by 
Sec14-active compounds. The available data indicate the biologically active small molecule 
inhibitors enter the Sec14 hydrophobic pocket in an exchange reaction and are trapped there by 
a set of specific Sec14::inhibitor interactions (Nile et al. 2014). The geometry of these 
interactions is both key to the binding mechanism and to the high specificity of these inhibitors 
for Sec14 as opposed to the other Sec14-like proteins. Inhibitor binding is not only sterically 
incompatible with Sec14::phospholipid interactions, but the interaction also effectively locks 
Sec14 into its closed conformer – thereby prohibiting lipid exchange. 
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The advent of strategies for discovery of PITP-directed inhibitors, and downstream 
exploitation of such inhibitors as experimental tool compounds, offers exciting new prospects for 
studying both PITP function and phosphoinositide signaling in a wide variety of experimental 
systems. First, the availability of appropriate and well-characterized inhibitors will enable 
functional analyses of PITPs and phosphoinositide signaling in organisms not amenable to 
application of standard genetic or gene-silencing approaches. Many eukaryotic parasites fall 
into this category. Second, PITP-directed inhibitors will facilitate genome-scale functional 
interaction screens in even the most complex cells by facilitating acute and specific inhibition of 
the target at the onset of the screen (Kampmann et al. 2013). This feature promises to 
effectively minimize the complications that arise when compensatory mechanisms come into 
play. Finally, PITP-directed inhibitors promise to facilitate resolution of biochemical systems 
where lipid signaling circuits have been biochemically reconstituted from wild-type components. 
Chemical intervention approaches obviate the need for biochemically reconstituting conditionally 
functional systems from mutant components – i.e. a strategy that, even when available, often 
proves problematic. 
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Figure 1.6. PITPs as targets for chemical inhibition of phosphoinositide signaling. A 
diversity tree for biological outcomes of signaling via a PtdIns 4-OH kinase that produces only 
PtdIns-4-phosphate but interfaces with multiple PITPs. Chemical inhibition of the kinase, even 
with absolute specificity, will compromise the entire outcome tree. Inhibition of any individual 
PITP offers a more surgical approach to dissecting phosphoinositide signaling.  
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Conclusions 
PITPs and other lipid transfer proteins, such as homologs of oxysterol binding proteins 
(Osh) and ceramide transfer proteins (CERT), have burst onto the main cell biology stage in the 
past few years. The growing interest in these enigmatic transfer proteins makes this an 
appropriate time to consider what it is that we actually know about how these proteins operate, 
what we do not know, and what has not yet been rigorously established. In this chapter, we 
used PITPs as a case study for discussing alternatives to the historical lipid carrier models that 
have dominated, and still dominate, the scene. Concepts such as instructive regulation of lipid 
metabolic enzymes, and roles for such mechanisms of metabolic control in diversifying 
biological outcomes for lipid signaling, offer new frameworks for interpreting the physiological 
actions of transfer proteins. Will there be a unifying resolution to how these various transfer 
proteins execute their biological functions? Perhaps other than general agreement for a central 
role for the lipid exchange cycle, we feel this unlikely. Whereas some proteins exhibit modes of 
action suggesting sensing roles, rather than transfer functions, others appear to be most readily 
interpreted in the context of transfer proteins. The various possibilities will need to be evaluated 
for each protein class on their own experimental merits. What is clear is that authentic 
physiological assays are needed for progress and, in the few cases where such assays have 
been exploited in detail, the results of such assays testify to the remarkable biology of these 
proteins. We anticipate that the emergence of as yet unappreciated linkages of PITPs to 
mammalian diseases will guide important future efforts. 
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CHAPTER 2: A NOVEL COUPLING OF PHOSPHATIDYLINOSITOL-TRANSFER, 
PLECKSTRIN-HOMOLOGY AND OXYSTEROL-BINDING-PROTEIN-RELATED 
DOMAINS INTO AN INTEGRATED PHOSPHOINOSITIDE SIGNALING CIRCUIT IN 
TOXOPLASMA 
 
Introduction 
Toxoplasma gondii is an obligate intracellular parasite that belongs to the eukaryotic 
phylum Apicomplexa, which is responsible for many common diseases of humans and animals, 
including malaria (Plasmodium), Cryptosporidiosis (Cryptosporidium), and Cyclosporiasis 
(Cyclospora) (Levine 1970). Toxoplasma infects one-third of humans worldwide, causing fatal 
encephalitic disease in immunocompromised individuals. In order to establish a productive 
infection, T.gondii must invade a host cell, elaborate an intracellular compartment called the 
parasitophorous vacuole (PV) in which to replicate, eventually egress from the host cell, and 
repeat the process. Toxoplasma utilizes a set of specialized late secretory organelles – the 
micronemes, rhoptries, and dense granules – at all stages of infection to secrete parasite 
effectors into the host cell or PV. Because the secretory system is unique to Apicomplexa, it 
presents a promising target for therapeutic intervention. Studies of early and late secretory 
compartments in Apicomplexa reveal that fundamental regulatory mechanisms are conserved 
as compared to other eukaryotes such as yeast or mammals, but these parasites have 
repurposed conserved molecular networks to fit their specialized secretory requirements 
(Liendo and Joiner 2000, Liendo et al. 2001, Pieperhoff et al. 2013, Tomavo 2014). 
In this work, we describe for the first time PtdIns4P pools on Toxoplasma secretory 
membranes. Distinct membranes are coded by unique PtdIns4P pools which can be identified 
by specific phosphoinositide biosensors derived from known PIP binding domains. We identify a  
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PtdIns4P pool on Golgi/ECL membranes, as well as higher order PIPs (PtdIns(4,5)P2 and 
PtdIns(3,4)P2) on the plasma membrane. Of particular interest is the identification of PtdIns4P 
pools on specialized secretory organelles, the dense granules. 
PtdIns4P in yeast is synthesized by one of two PtdIns 4-OH kinases: Pik1 on Golgi 
membranes and Stt4 at the plasma membrane. PI4Ks in yeast are biologically insufficient 
enzymes due to their inability to access PtdIns inside the lipid bilayer (Schaaf et al. 2008; Ile et 
al. 2006). The productive synthesis of PtdIns4P levels high enough to support trafficking from 
secretory membranes requires cooperation of PI4Ks with phosphatidylinositol transfer proteins 
(PITPs), particularly Sec14 in the case of yeast TGN/endosomal membranes (Bankaitis et al. 
1989). Sec14 is a coincidence detector that is primed for PI4K stimulation by binding of PtdCho, 
thereby coupling PtdCho metabolism to PtdIns4P-dependent trafficking (Fang et al. 1996; 
Mousley et al. 2008; Schaaf et al. 2008). Sec14 is antagonized specifically by a member of the 
Oxysterol binding proteins (OSBPs), Kes1/Osh4 (Li et al. 2002, Fairn et al. 2007, Stefan et al. 
2011). Kes1 blocks PtdIns4P-dependent secretion from TGN/endosomes by sequestering the 
Sec14-dependent pool of PtdIns4P, and itself integrates signals from other pathways including 
sterol, sphingolipid, and TORC1 and nitrogen signaling pathways (Mousley et al. 2012). 
 We describe the Toxoplasma cohort of PITPs in an effort to understand whether 
PtdIns4P pools on Toxoplasma secretory membranes might be subject to similar regulation. The 
Toxoplasma genome codes for three Sec14 homology (Sfh) proteins, and one unique 
multidomain START-like PITP, which we termed PITP Multidomain Protein (PIMP). The TgPIMP 
PITP domain contains the PtdIns-binding barcode of metazoan START-like PITPs, transfers 
PtdIns between membranes in a manner dependent on that barcode, and utilizes 
phosphatidylcholine (PtdCho) as a counterligand in vitro. PIMP localizes to dense granules in 
Toxoplasma but is not a secreted protein, suggesting that T.gondii has adapted a PITP signaling 
network to its specialized secretory system. PIMP harbors a PH domain that binds PtdIns4P and 
PtdIns(4,5)P2 in vivo, and this domain alone is sufficient to localize to dense granules in a PIP-
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binding dependent manner. PIMP has a C-terminal OSBP-related protein (OSBP) module, and 
the PIMP PITP domain can substitute for Sec14 in yeast, suggesting it has the capacity to 
function in instructive regulation of PtdIns 4-OH kinases, and may be subject to the same 
antagonistic signaling as the Sec14/Kes1 network in yeast. TgPIMP is thus a physical platform 
for integration of multiple lipid signaling pathways in Toxoplasma and is the first known example 
of a PITP physically coupled to an OSBP domain. 
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Materials and Methods 
Molecular biology reagents.  
All Toxoplasma expression vectors utilized the pTUB system, wherein gene expression 
is driven by the tubulin promoter and stable populations can be selected with chloramphenicol. 
In all cases, the genes were cloned between a 5’ BglII site and a 3’ AvrII site. These were 
tagged with YFP or RFP, and the nature of the tag as well as its orientation is indicated directly 
in the figure legends. The cloning primers used are as follows: Fapp1-PH (F: 5’-ga AGATCT 
aaaatggagggggtgttgtacaag-3’; R: 5’- ga CCTAGG agtccttgtatcagtcaaacatgc-3’); GOLPH3 (F: 5’-
aa AAGATCT atgacctcgctgacccag-3’; R: 5’- aaa CCTAGG ttacttggtgaacgc-3’); TgROP1 (F: 5’- 
gga AGATCT aaaatggagcaaaggctgcca -3’; R: 5’- gtt CCTAGG aaattgcgatccatcatcctg-3’); PIMP-
PH (F: 5’-aaa AGATCT cgctcagacgctggagc-3’; R: 5’-aaa CCTAGG aaaagacttggggaggaag-3’); 
full length PIMP (F: 5’-aaa AGATCT atgaaggtgttcgagtaccgcctcgtgctg-3’; R: 5’-aaa CCTAGG 
agcaggagaggcggtgactcccg-3’).  
 Site-directed mutagenesis was performed using standard techniques. Primers used for 
mutagenesis are as follows: PIMP-PITP-T65E (F: 5’-gacaccggccagtac GAA cacaagcgcatcaac-
3’; R: 5’-gttgatgcgcttgtg TTC gtactggccggtgtc-3’); PIMP-PH-R503A (F: 5’-gaatacgacgtggaacttg 
GCA tacgtcgtgctgcgaaac-3’; R: 5’-gtttcgcagcacgacgta TGC caagttccacgtcgtattc-3’); FAPP1-PH-
K7A (F: 5’-ggagggggtgttgtac GC tggaccaactatctcac-3’; R: 5’-gtgagatagttggtccac GC 
gtacaacaccccctcc-3’); FAPP1-PH-R18L (F: 5’-ctcacaggctggcagcctc T ttggtttgttttagataatgg-3’; R: 
5’-ccattatctaaaacaaaccaa A gaggctgccagcctgtgag-3’). 
 
Yeast strains and media.  
Yeast strains utilized are described in detail elsewhere (Bankaitis et al. 1989, 1990; 
Cleves et al. 1991; Ghosh et al. 2015), and included CTY182 (MATα ura3-52 lys2-801 his3Δ-
200, CTY1-1Aa SEC14+), CTY1-1A (MATa ura3-52 lys2-801 Δhis3-200 sec14-1ts), CTY558 
(MATa ade2 ade3 leu2 his3Δ ura3-52 sec14Δ1::HIS3), CTY1537 (MATa ura3-52 leu2 Gal+ 
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pik1-101ts), CTY1568 (MATα leu2 ura3 his3 trp1 ly2s suc2-Δg stt4Δ::HIS, YCp(LEU2, stt4-4ts)), 
CTY100 (CTY1-1A sac1-26), RG4 (pRS315-mss4-25ts; mss4Δ::kanR, ura3-52, his3-Δ200, 
ade2), RG5 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 vps34Δ::kanMX). 
Methods for culturing yeast in standard yeast peptone dextrose (YPD) or minimal SD 
media, for gene eviction, and standard lithium acetate transformation were as previously 
described (Sherman et al. 1983; Rothstein 1984; Ito et al. 1983). For experiments using a 
Doxycycline (Dox)-repressible expression system (pCM189), cells were grown in selective SD 
media with 10ug/mL Dox or in selective SD liquid media with 10ug/mL Dox and supplemented 
with 0.5% casamino acids. Expression from pCM189 was induced by washing cells 2X and 
incubating in Dox-free selective SD/casamino acids media for 18hrs.  
 
Homology modeling.  
Homology models of PIMP domains were generated with MOE 2013.08 Modeling 
package. The target sequence for PIMP-PITP domain was aligned to the PITPα bound to PtdIns 
(PDB I.D. 1UW5; 2.90 Å) and unbound form (1KCM, 2.00 Å resolution) with a sequence 
similarity of ~35% to generate models in closed and open conformation respectively. For PIMP-
PH domain, solution structure of pleckstrin homology domain containing protein family A 
member 5 from human (PDB I.D. 2DKP) and crystal structure of FAPP1 pleckstrin domain was 
used as a template. The ligands were included in the environment to generate induced fit 
homology models of the complexes. By default, 10 independent intermediate models were 
generated as a result of permutational selection of different loop candidates and side chain 
rotamers. The intermediate model that scored best according to the selected forcefield 
(Amber99), was chosen as the final model and was subjected to further optimization.  
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Protein purification.  
Recombinant His-tagged proteins expressed from pET28b-His8-PITPPIMP and pET28b-
His8- PITPPIMP(T65E) were produced from E.coli BL21 (RIL/DE3; New England BioLabs Inc, 
Ipswich, MA). Transformed cells were cultured overnight at 37°C, and subcultured into 8L of TB 
media supplemented with 30µg/mL kanamycin and 25µg/mL chloramphenicol. Cells were grown 
for 4hrs at 37°C, shifted to 16°C, and protein expression was subsequently induced with IPTG 
(100µM final concentration). Cultures were harvested after 18hrs and cells lysed either by bead-
beating or flash-freezing with liquid nitrogen and thaw. Clarified lysates were incubated with 
TALON metal affinity beads (Clontech, Mountain View, CA), and bound proteins were eluted 
using a 25–200mM imidazole step gradient regime. Peak fractions were identified by analyzing 
individual fractions by SDS-PAGE, pooled and dialyzed against 300mM NaCl, 25mM Na2HPO4 
(pH=7.5), 5mM 2-mercapthoethanol (Prod # 68100, Thermo Scientific, Rockford, IL). Protein 
mass was estimated by SDS-PAGE and Coomassie staining using BSA titration series as 
standards. 
 
Lipid transfer assays.  
Methods for measuring protein-mediated transfer of [3H-]PtdIns from rat liver 
microsomes to PtdCho liposomes, and transfer of [14C]-PtdCho from liposomes (98 mol% 
PtdCho, 2mol% PtdIns) to bovine heart mitochondria, have been described (Aitken et al. 1990; 
Bankaitis et al. 1990; Schaaf et al. 2008). 
 
Tissue culture and propagation of Toxoplasma cells.  
HFFs and MRC cell lines were cultured in Dulbecco’s modified Eagle’s medium with 
10% fetal bovine serum (FBS), incubated at 37°C with 5% CO2 in humidified air. All T. gondii 
strains were maintained by serial passage in MRC or HFF monolayers. Parasites were grown to 
egress and purified from host cell lysate by passage through 18G and 25G needles and 
39 
 
pelleting at 2K rpm for 5 minutes. Media for selection and maintenance of transgenic parasites 
was supplemented with chloramphenicol to a final concentration of 20µM.  
 
Production of total Toxoplasma cDNA fractions by reverse transcription.  
To generate total cDNA from Toxoplasma, parasites were cultured to egress in HFF or 
MRC monolayers, and purified passage through 18G and 25G needles and pelleting at 2K rpm 
for 5 minutes. RNA was isolated using Qiagen RNeasy and quantified by 260nm absorbance 
and quality assessed by agarose gel electrophoresis. RNA was converted to cDNA using the 
Bio-Rad iScript Select cDNA Synthesis kit. Presence of full-length PIMP transcripts in the cDNA 
library was probed by PCR using total cDNA as template and primers for1 (5’-
aaggtgttcgagtaccgcc-3’), rev1 (5’-ggagtcaccgcctctcc-3’), for2 (5’- ggcctcgtcgacgtctcc-3’), rev2 
(5’-agcaggagaggcggtg-3’). 
 
Toxoplasma transfection and selection of transgenic parasites.  
Parasites were transfected by electroporation as previously described (Soldati and 
Boothroyd 1993). Briefly, ca. 107 tachyzoites (Toxoplasma gondii RH strain) were freshly 
purified from host cells and mixed with 20μg of plasmid in transfection buffer (120mM KCl, 
150µM CaCl2, 5mM MgCl2, 2mM EDTA, 25mM HEPES KOH, 10mM KPO4). For co-
transfections, 20µg of each plasmid were used. Parasite/DNA solution was subjected to an 
electrical pulse in 25uF and 1.3kV using the Bio-Rad Gene Pulse II electroporation apparatus. 
Parasites were allowed to recover on MRC or HFF monolayer in the absence of drug for 24 
hours after which transgenic cells were selected in the presence of 20µM chloramphenicol.  
 
Immunofluorescence imaging of Toxoplasma.  
MRC or HFF host cells were seeded onto glass-bottom dishes and infected with 
parasites for 18-24hrs. Monolayers containing intracellular parasites were washed twice with 
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PBS, fixed with 4% paraformaldahyde (v/v) for 15min at RT, permeabilized with 0.2% Triton-X 
(v/v) for 4min at RT, blocked with 2% BSA in PBS 1hr at RT or overnight at 4°C, incubated with 
primary antibody diluted in blocking buffer (mouse GRA3 at 1:500, mouse MIC3 at 1:500, or rat 
TgSORTLR at 1:250) over night at 4°C, washed 3X with PBS, incubated with fluorophore-
conjugated anti-mouse or anti-rat secondary antibody at 1:1000 – 1:2000 dilution in blocking 
buffer for 1hr at RT, washed 3X with PBS, and imaged in PBS without mounting within 24hrs. 
 
Confocal imaging.  
Confocal imaging was performed using NikonA1R and Olympus FV-1000 confocal 
microscopes. Images were processed in Nikon Elements Viewer 4.0, ImageJ and Adobe 
Photoshop CS. The styryl dye FM4-64 was used to label yeast vacuolar membranes as 
previously described (Vida and Emr 1995). Coverslips for imaging yeast were coated with 
0.5mg/mL concanavalin A (Sigma-Aldrich L7647) and washed with PBS. 
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Results 
Toxoplasma PIMP couples PITP, PH and OSBP domains. 
The coding of adjacent PITP and OSBP genes on chromosome IX suggests 
transcriptional co-regulation of these two modules. Indeed, these were annotated as a single 
open reading frame (gene ID TGME49_289570), predicted to be transcribed as a 5739bp 
mRNA whose primary translation product is a 1912-amino acid protein with a molecular mass of 
ca. 210kDa (Figure 2.1A). What is striking about the modular organization of this PITP 
Multidomain Protein (PIMP) is that the predicted primary translation product physically joins 
three distinct domains -- all of which fall into families of known inositol lipid binding proteins. 
Proceeding from the N-terminus, the three domains include: (1) the N-terminal 347 residues that 
share 28% primary sequence identity and 40% similarity to the mammalian single-domain 
START-like PITPα (PITPPIMP), (2) a putative pleckstrin homology (PH) domain for binding of 
phosphoinositides (residues 482-581; PHPIMP), and (3) a C-terminal OSBP-domain (residues 
1605-1912; OSBPPIMP) that shares 19.5% primary sequence identity and 29.3% similarity, 
across the entire 434 residue sequence, to one of the seven yeast ORPs Kes1/Osh4. In 
addition, PIMP harbors what is predicted to be a four-helix hydrophobic domain that separates 
The PITPPIMP and PHPIMP domains from the OSBP domain, as well as three potential HT ("host 
targeting") sequences (or PEXEL in Plasmodium) that reside immediately upstream of the 
OSBPPIMP domain. The three potential HT sequences in PIMP 1603RGLVD1607, 1556RRLPE1560, 
and 1433RWLGE1437 conform closely to the HT consensus sequence RxLxD/E (Figure 2.1A) 
(Hiller et al. 2004; Bhattacharjee et al. 2008; Haase et al. 2010; Hsiao et al. 2013).  
To confirm that the predicted transcript is produced in vivo, parasites were cultured in 
mammalian cells to egress, total RNA fractions were prepared, and PIMP-specific cDNAs were 
produced by reverse transcription. Along with a complete 5.7kb transcript, two overlapping 
fragments representing the 5` 5056bp of the predicted transcript as well as the terminal 927bp 
were recovered (Figure 2.1B). Thus, we conclude the entire PIMP gene is transcribed in 
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Toxoplasma with the potential to encode the predicted PITP-PH-OSBP polyprotein. That 
Toxoplasma can translate a full-length PIMP polypeptide was confirmed by immunoblotting 
experiments using extracts prepared from transgenic parasites expressing the full-length cDNA 
at elevated levels (data not shown). 
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Figure 2.1. PIMP domains are co-transcribed as a single mRNA. (A) A diagram of the PIMP 
domain structure. PIMP is comprised on a PITP domain (residues 1-347), PH domain (residues 
482-581), a region containing predicted hydrophobic helices (HpH) (residues 862-994), and an 
OSBP domain (residues 1608-1912). Three predicted HT sites are identified: HT1 
(1433RWLGE1437), HT2 (1556RRLPE1560), and HT3 (1603RGLVD1607). Location of lipid-binding 
residues for the PITP and PH domains are designated (T65 and R503, respectively). (B) 
Overlapping primer pairs used to confirm PIMP transcript are depicted below (1Frd/1Rev and 
2Frd/2Rev) with the predicted product size. PIMP gene is transcribed in a single transcript. 
Toxoplasma RH RNA was converted to cDNA and used as a template for PCR using primer 
pairs 1Frd/1Rev and 2Frd/2Rev. The resulting PCR products (5056bp and 927bp for PCR2) are 
shown in the lower panel.  
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The PITPPIMP domain exhibits PITP-like activities 
 Threading of the PITPPIMP primary sequence onto a high resolution PITPα crystal 
structure predicted significant structural similarity between these polypeptides (Figure 2.2A). 
Like PITPα, the LBD of PITPPIMP is composed of β sheets that form the hydrophobic pocket floor 
onto which the phospholipid binds. These are flanked by three α helices and a lipid exchange 
loop that acts as a “lid” to the binding cavity. The lipid exchange loop is formed between β 
strand 3 and 4 of PITPPIMP, however, unlike PITPα there is another small insertion in PITPPIMP 
which forms a loop between β-strand 2 and α-helix and is next to lipid exchange loop. Another 
distinguishing feature of PITPPIMP is a 77-residue insertion loop between β-strand 7 and 8 
(Figure 2.2A). Residues in the lipid-binding pocket of PITPs that specifically coordinate the 
inositol headgroup of bound PtdIns are referred to as the PtdIns-binding bar code. These are 
highly conserved between the members of a PITP family. Indeed, superimposition of the 
modeled PITPPIMP lipid binding pocket onto that of PITPα revealed conservation of this structural 
motif (Figure 2.2B). The PtdIns-binding barcode involves residues T59, K61, E86, N90 for PITPα, 
and T65, K67, E92 and N96 for PITP
PIMP, respectively (Figure 2.2B) (Alb et al. 1995; Tilley et al. 
2004).  
Two independent assays were used to assess whether PITPPIMP has intrinsic 
phospholipid exchange activity. One, we used a biological assay where the ability of PITPPIMP 
expression to act as functional surrogate for the essential yeast PITP Sec14 was tested. There 
were two versions of the biological assay. The first experimental paradigm took advantage of 
yeast strains carrying a conditional sec14ts allele where the essential Sec14 PITP is rendered 
nonfunctional at 37°C -- resulting in an inability of the yeast mutant to grow at that restrictive 
temperature (Figure 2.2C, left panel). Expression of either wild-type Sec14 (the positive control) 
or of PITPPIMP rescued growth of sec14ts cells at 37°C. As the essential function of Sec14 
depends on its ability to bind PtdIns (Schaaf et al. 2008), these data indicated PITPPIMP has 
intrinsic ability to bind and/or exchange PtdIns. Mammalian PITPα residue T59 is required for 
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coordination of the PtdIns headgroup within the lipid-binding pocket, and missense substitutions 
at that position selectively inactivate the PtdIns binding activity of the protein with no 
compromise of PtdCho-binding (Alb et al. 1995; Tilley et al. 2004). This residue is invariant 
amongst the metazoan START-like PITPs and, in the cases where the experiment has been 
done, it is required for PtdIns-binding and biological function of these proteins (Milligan et al. 
1997; Alb et al. 2007; Ile et al. 2010). The corresponding residue in PITPPIMP is T65 (Figure 
2.2B). Expression of the PITPPIMP (T65E) mutant, which is expected to be ablated for PtdIns-
binding activity, failed to rescue sec14ts mutant growth at restrictive temperatures (Figure 2.2C, 
left panel). 
These results were reproduced using a second, more rigorous, biological paradigm 
where the ability of PITPPIMP to restore viability to sec14Δ mutants was tested using a well-
characterized plasmid shuffle assay (Phillips et al. 1999; Schaaf et al. 2008). In this system, 
viability of sec14Δ cells is supported by a plasmid-borne copy of a wild-type SEC14 gene. A 
second plasmid driving high-level expression of a query PITP is introduced into the yeast strain, 
and all nutritional selection pressures maintaining either plasmid are subsequently relieved by 
culturing cells in rich medium. Loss of the SEC14 plasmid is recorded by white colonies and 
white colony sectors in a background of red colonies. This outcome reports viability of the white 
segregants in the absence of any Sec14 contribution, and is only possible if expression of the 
query PITP fulfills all essential Sec14 functions. While ectopic high-level expression of 
mammalian PITPα supported high frequency loss of the SEC14 plasmid, introduction of a 
PITPPIMP expression plasmid was only able to do so at low frequency (Figure 2.2C, right panel). 
Given PITPPIMP expression was driven by a constitutive and powerful PMA1 promoter, and the 
expression cassette was maintained on a high copy episomal plasmid, the shuffle data suggest 
PITPPIMP, while having PITP activity, is an inefficient PITP -- at least when expressed in yeast. 
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PITPPIMP exhibits both PtdIns- and PtdCho-exchange activities 
Biochemical assays with recombinant PITPPIMP demonstrated this module catalyzes 
significant transfer of both [3H]-PtdIns and [3H]-PtdCho between membranes in vitro in a 
concentration-dependent manner (Figure 2.2D, E). In the membrane system employed, and 
consistent with the plasmid shuffle data, PITPPIMP scored as an inefficient PtdIns-transfer protein 
relative to Sec14. Whereas Sec14 transferred ca. 30% of input [3H]-PtdIns in assays with 10µg 
of protein, PITPPIMP assays saturated at 8% [3H]-PtdIns transfer with 200µg of protein. PITPPIMP-
mediated PtdCho-transfer activity was more efficient as ~30% of input [3H]-PtdCho was 
transferred with 200µg of protein. In accord with previous demonstrations, the T65E PITP
PIMP 
mutant domain was completely inactive for PtdIns-transfer activity in vitro (Figure 2.2D) while 
maintaining undiminished PtdCho-transfer activity (Figure 2.2E). Moreover, missense 
substitution of the neighboring PITPPIMP T61 residue did not reduce PtdIns- or PtdCho-transfer 
activity -- further confirming PITPPIMP residue T65 is orthologous to the PtdIns headgroup 
coordinating PITPα residue T59 (data not shown). 
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Figure 2.2. PITPPIMP is a bona fide START PITP. (A) PITPPIMP retains the START PtdIns-
binding barcode. The PIMP PITP domain (residues 1-347) was threaded onto the crystal 
structure of RnPITPα bound to PtdIns (PDB 1UW5) using SWISS-MODEL 
(http://swissmodel.expasy.org). The structure was visualized in UCSF Chimera. The crystal 
structure of PITPα is shown in red, and the predicted PITPPIMP is shown in blue. (B) PtdIns-
coordinating residues (in PITPα: T59, K61, E86, N90; for PITPPIMP: T65, K67, E92, N96) are 
high-lighted. (C, left panel) PITPPIMP complements Sec14 deficiency in yeast in a PtdIns-
barcode dependent manner. PITPPIMP or PITPPIMP (T65E) was over-expressed in Sec14ts (CTY1-
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1A) cells from an episomal plasmid under the PMA1 promoter. Cells were grown in selective SD 
media and spotted onto YPD agar in 10-fold dilutions starting with OD 1. Plates were incubated 
at 30°C or 37°C for two days and imaged with ChemiDoc (Bio-Rad). Images were processed in 
Bio-Rad ImageLab software. (C, right panel) PITPPIMP substitutes for SEC14 in yeast in a 
PtdIns-barcode dependent manner. PITPPIMP or PITPPIMP(T65E) was over-expressed in 
CTY558 from an episomal plasmid under the PMA1 promoter. Cells were grown in SD media 
and spotted onto YPD agar in 10-fold dilutions starting with OD 1. Plates were incubated at 
room temperature for three days and imaged with ChemiDoc (Bio-Rad). Purified recombinant 
8xHis-PITPPIMP transfers (D) 3H-PtdIns and (E) 3H-PtdCho between membranes in vitro in a 
concentration-dependent manner (amounts of PITP tested: 10, 25, 50, 75, 100, 200μg). The 
predicted PtdIns-barcode mutant T65E ablates PtdIns transfer but not PtdCho transfer.  
 
 
PITP-like genes in Toxoplasma 
The PIMP PITP domain belongs to the START structural family, though it cannot be 
clearly assigned to either Class of PITPs currently defined in that family (Figure 2.3A). The 
Toxoplasma genome database identifies three candidate PITPs other than PIMP, all of which 
belong to the Sec14-like protein superfamily (Figure 2.3A). These Sec Fourteen Homologs are 
designated TgSfhA (TGME49_246330), TgSfhB (TGME49_269390), and TgSfhC 
(TGME49_213790). Primary sequence similarity comparisons to the Saccharomyces Sec14-like 
PITPs show TgSfhA is most homologous to the yeast Sfh3 and Sfh4 PITPs exhibiting ca. 29% 
primary sequence similarity to both (E values: 1e-23 and 2e-23, respectively). These yeast Sfh 
PITPs are involved in control of fatty acid mobilization from lipid droplet stores and in 
decarboxylation of phosphatidylserine to phosphatidylethanolamine in TGN/endosomal 
compartments, respectively. While TgSfhB shares most primary sequence homology to Sec14 
(E value: 1e-10), that level of primary sequence homology was also apparent in comparisons of 
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TgSfhB to all of the Sfh PITPs (22-25%) excluding Sfh5. Thus, we cannot confidently assign a 
yeast ortholog for TgSfhB. TgSfhC is most homologous to Sec14 and Sfh1 sharing 28-30% 
primary sequence similarity to each (E value: 7e-05 when aligned with Sfh1). However, in no 
case could we demonstrate PITP-like activities in functional complementation experiments 
where the abilities of these proteins to act as functional surrogates for yeast Sec14 was 
assayed (Figure 2.3B). The PIMP PITP domain, therefore, is the only Toxoplasma PITP that 
can function in the Sec14 cellular context. 
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Figure 2.3. Toxoplasma PITPs. (A) Circular cladogram of Toxoplasma PITPs and known 
orthologs. Sequences from BLAST homology searches (http://www.ncbi.nlm.nih.gov/BLAST) 
against either HsPITPβ (for the START family) or ScSec14p (for the Sec14 family) were aligned 
in VectorNTI to define node distances. Data were visualized using EvolView software 
(www.evolgenius.info/evolview). The Sec14 family is in red/pink, where yeast Sfhs and 
Arabidopsis AtSfh1 are in red, and the Toxoplasma Sec14 homologs (TgSfha, TgSfhb and 
TgSfhc) are in pink. The START family is in blue/grey, where human and Drosophila Class I 
PITPs are in dark blue, human and Drosophila Class II PITPs are in light blue, and T.g. PIMP 
and its Plasmodium ortholog are in grey. (B) Toxoplasma Sfhs do not complement Sec14 
deficiency in yeast. TgSfhA, TgSfhB or TgSfhC were over-expressed in Sec14ts (CTY1-1A) cells 
from an episomal plasmid under the PMA1 promoter. Cells were grown in selective SD media 
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and spotted onto YPD agar in 10-fold dilutions starting with OD 1. Plates were incubated at 
30°C or 37°C for two days and imaged with ChemiDoc (Bio-Rad). Images were processed in 
Bio-Rad ImageLab software.  
 
 
PHPIMP is a PtdIns4P and PtdIns(4,5)P2 binding module 
PH domains are phospholipid-binding modules with varying selectivity and affinity for 
individual phosphoinositide species (Lemmon et al. 1995; Lemmon 2007). The PHPIMP domain 
was threaded onto the known crystal structures of homologous proteins, the pleckstrin 
homology domain containing protein family A member 5 (PDB I.D. 2DKP) and the PH domain of 
FAPP1. A consensus model was built from the two templates (Figure 2.4A). Similar to the 
PHFAPP1 structure, PHPIMP domain folds into seven-strand β-barrel flanked by an α-helix and β 
loops highlighting the overall fold similarity. Residue Arg503 is predicted to lie within the PH
PIMP 
domain lipid-binding pocket and this residue is conspicuous as it is highly conserved among PH 
domains (Figure 2.4A). Structural studies of the PH domain of GRP1 provide a rationale for this 
conservation by demonstrating that the orthologous Arg residue coordinates phosphoinositide 
headgroup binding within the PHGRP1 lipid binding pocket (He et al. 2008).  
To determine whether PHPIMP has the capacity to bind phosphoinositides, the isolated 
domain was tagged with GFP and expressed in a series of yeast strains that exhibited 
deficiencies in specific phosphoinositide pools. PHPIMP localized to the plasma membrane and 
punctate structures reminiscent of TGN/endosomal compartments in WT yeast cells (Figure 
2.4B). That this localization was dependent on phosphoinositide binding was suggested by the 
inability of the PHPIMP(R503A) mutant to target to those compartments (Figure 2.4B). This defect in 
membrane targeting was not the trivial result of proteolysis of the chimeric proteins as 
immunoblot analyses confirmed stability of the GFP-tagged PHPIMP(R503A). 
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PHPIMP localization profiles recorded in WT yeast cells resembled the distribution of 
PtdIns4P as read out by a variety of PH domain-based PtdIns4P biosensors (Roy and Levine 
2004; Baird et al. 2008; Wood et al. 2009; Dowler et al. 2000: Garcia et al. 2000). To determine 
whether PHPIMP has PtdIns4P binding activity, we tested its response to perturbations of specific 
PIP enzymes in yeast (Figure 2.5). First, we determined whether accumulation of PtdIns4P in 
ER membranes could effect a relocalization of GFP- PHPIMP to that compartment. To that end, 
the chimera was expressed in sac1 mutants defective for the Sac1 phosphatase, the major 
PtdIns4P phosphatase of yeast. These mutants accumulate high levels of PtdIns4P in 
precocious compartments such as ER membranes (Li et al., 2002; Nile et al., 2014). Indeed, a 
significant localization of PHPIMP to ER membranes was scored in the Sac1-deficient cells 
(Figure 2.5A, quantified in 2.5C). As expected, PHPIMP(R503A) was unable to localize to 
membranes in this strain, indicating that the lack of PtdIns4P binding ability of this mutant is the 
property that affects plasma membrane and endosomal localization in WT cells (Figure 
2.5C). Though there are also PtdIns3P pools on endosomal membranes, we found that the 
PHPIMP domain was not sensitive to these. PHPIMP localization to either the plasma membrane or 
the punctate compartments was unaffected in vps34Δ mutants genetically ablated for the single 
yeast PtdIns 3-OH kinase activity and therefore completely devoid of 3-OH phosphorylated 
phosphoinositides (i.e. PtdIns3P and PtdIns(3,5)P2) (Figure 2.5A, quantified in 2.5C).  
In a second approach to determine the PIP binding capacity of the PIMP PH domain, we 
tested whether PtdIns4P is required for membrane binding by PHPIMP. The two major PtdIns 4-
OH kinases of yeast are Pik1, which is primarily responsible for producing TGN/endosomal 
pools of this PHPIMP, and Stt4, the enzyme required for synthesis of plasma membrane pools of 
PtdIns4P. Thus, GFP- PHPIMP was expressed in yeast mutants carrying either pik1-101ts or stt4ts 
alleles, and localization of the reporter was analyzed by GFP imaging. The pik1-101ts is a strong 
allele that exhibits PtdIns4P deficits even at temperatures permissive for growth of the mutant 
strain (Walch-Solimena & Novick 1999). Indeed, PHPIMP failed to localize to punctate 
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compartments in the pik1-101ts mutant -- even when cells were cultured at a growth-permissive 
temperature of 30°C. The effect was specific in that plasma membrane targeting was unaffected 
under those same conditions (Figure 2.5A). When queried in the stt4ts mutant challenged with 
the restrictive temperature of 37°C for 1.5hrs, a partial loss of PHPIMP from the plasma 
membrane was scored, while localization to the punctate TGN/endosomal compartments 
remained uncompromised (Figure 2.5B, quantified in 3.5C).  
Because the plasma membrane PtdIns4P pool is a major source of metabolic precursor 
for PtdIns(4,5)P2 synthesis, we considered the possibility that PtdIns(4,5)P2 and not PtdIns4P is 
the primary determinant for PHPIMP targeting to that membrane system. Consistent with this 
idea, PHPIMP failed to bind to the plasma membrane of mss4ts mutants conditionally defective for 
the single yeast PtdIns4P 5-OH kinase activity upon shift of those cells to the restrictive 
temperature of 37°C for 30 min (Figure 2.5B, quantified in 2.5C). Taken together, the data 
demonstrate PHPIMP exhibits significant affinity and selectivity for both PtdIns4P and 
PtdIns(4,5)P2 when functionally queried using an authentic biological system as experimental 
platform. 
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Figure 2.4. The PHPIMP domain localizes to membranes in yeast in a manner dependent on 
a predicted PIP-binding residue. (A) The PHPIMP domain was modeled on the crystal structure 
of human PEPP2 PH domain (PDB 2DKP) as described in materials and methods. The 
structure was visualized in UCSF Chimera. Predicted lipid-binding residue Arg503 is highlighted 
in blue. (B) GFP-tagged PHPIMP or PHPIMP (R503A) was expressed in WT cells by removal of Dox 
from the media and culturing at 30°C. The PH domain localizes to plasma membrane and 
puncta in an R503-dependent manner. Quantification of GFP- PHPIMP and GFP- PHPIMP (R503A) in 
wild-type yeast. Localization is quantified as percent of cells localized to the specified 
compartment, with at least 100 cells counted. DIC and GFP confocal image panels are shown. 
Scale bars: 2 μm   
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Figure 2.5. The PHPIMP domain PI4P and PI(4,5)P2 in vivo. (A) GFP- PH
PIMP expressed in 
PtdIns-4-P phosphatase sac1-26 cells at 30ºC relocalizes to the ER. GFP- PHPIMP is delocalized 
from puncta when expressed in the PtdIns-4-OH kinase mutant Pik1-101 strain at 30°C while 
retaining localization to the plasma membrane Localization in the Stt4ts strain at 30°C permissive 
temperature is WT with some loss from the plasma membrane at 37C (1hr). (B) Localization of 
GFP- PHPIMP in PtdIns-3-OH kinase vps34Δ cells at 30°C does not change localization from the 
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WT pattern.  Plasma membrane-bound GFP- PHPIMP is delocalized to the cytoplasm in PtdIns-
4P 5-OH kinase mss4ts cells with 30min incubation at 37°C restrictive temperature. (C) 
Quantification of GFP- PHPIMP and GFP- PHPIMP (R503A) in yeast. Localization is quantified as 
percent of cells localized to the specified compartment, with at least 100 cells counted. DIC and 
GFP confocal image panels are shown. Scale bars: 2 μm   
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Toxoplasma secretory pathway is coded by specific PtdIns4P pools 
How might a PITP with specific PIP sensing capacity affect signaling in Toxopaslama? 
To address this question, it was necessary to map PtdIns4P and PtdIns(4,5)P2 distribution in 
Toxoplasma. Other than superficial description of a presumptive PtdIns4P pool on an 
unidentified membrane compartment in Plasmodium (McNamara et al. 2013), neither the nature 
nor the distribution of phosphoinositide pools has been characterized in Apicomplexans. 
Although PH domains are useful biosensors for phosphoinositide availability in living cells, the 
PIP-dependent membrane-binding activities of these proteins are also modulated by other, often 
undefined, variables that diversify their organelle targeting properties beyond those that can be 
explained by lipid-binding specificity. To that end, we engineered a series PtdIns4P biosensors 
using well-characterized PIP-binding domains for expression in Toxoplasma. These included 
the PtdIns4P biosensors PHFAPP1 (Dowler et al., 2000), GOLPH3 (Wood et al. 2009), and 
Legionella SidM-P4M (Hammond et al. 2014), the PtdIns(3,4)P2 biosensor PH
TAPP1 (Thomas et 
al. 2001), and the PtdIns(4,5)P2 reporter PH
PLC (Garcia et al. 2000). 
Discrete PtdIns4P pools were detected on specific Toxoplasma secretory organelles 
including the dense core granules and Golgi/endosome-like compartments, as well as higher-
order PIP pools on the plasma membrane. Moreover, consistent with the behaviors of these 
reporters in other cell types, different PtdIns4P biosensors reported different pools of this 
phosphoinositide. For instance, PHFAPP1 homed onto structures situated both anterior and 
posterior to the cell nucleus, and these organelles were marked with GRA3 -- identifying them 
as dense granules (Figure 2.6A). Dense granule targeting of PHFAPP1 was dependent on 
PtdIns4P binding as substitution of R18L and K7A (i.e., substitutions previously shown to ablate 
binding of PHFAPP1 to PtdIns4P in vitro and in vivo, abolished PHFAPP1 targeting to Toxoplasma 
membranes (Figure 2.6A) (He et al. 2011). PHFAPP1 was mostly excluded from SORTLR-marked 
Golgi/endosomal compartments and MIC3-positive micronemes, indicating that the PtdIns4P 
pool on dense granules is specific among the Toxoplasma secretory pathway (Figure 2.6A). 
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This pool was confirmed with a second PtdIns4P-specific biosensor, the Legionella SidM-P4M 
domain, which also localized to GRA3-positive dense granules (Figure 2.6A, bottom panel). 
Representative line scan analysis confirms co-localization of PHFAPP1 and SidM-P4M with GRA3, 
while PHFAPP1 does not co-localize with TgSORTLR (Figure 2.6B). In Toxoplasma, DAPI stains 
both the nucleus and the apicoplast genome, and none of the biosensors tested co-localized 
with DAPI (data not shown).  
We identified distinct PtdIns4P pools on other secretory membranes. PHGOLPH localized 
to SORTLR-marked Golgi/endosomal compartments (Figure 2.7A). A striking feature of this 
PtdIns4P biosensor was the exquisite intercalation of PHGOLPH-containing membranes with those 
marked by SORTLR, suggesting the existence of PtdIns4P pools in membranes of earlier stage 
secretory pathway organelles (Figure 2.7A). Eukaryotic cells have a pool of PtdIns4P at the 
plasma membrane that is used to replenish higher order PIPs, and this pool is recognized by 
the SidM(P4M) domain in mammalian cells (Hammond et al. 2014). In our studies, this domain 
localized only to dense granules, suggesting that the plasma membrane PtdIns4P pool is 
Toxoplasma has some unique properties compared to other eukaryotes, or perhaps that the 
dense granule PtdIns4P levels are high enough to sequester this biosensor. We were able to 
identify phosphorylated derivatives of PtdIns4P, PtdIns(4,5)P2 and PtdIns(4,3)P2, at the 
Toxoplasma plasma membrane (Figure 2.7B). Though in mammalian cells, these can be 
generated by phosphorylation of PtdIns5P, or the degradation of PtdIns(3,4,5)P3, the major 
contribution to either pool comes from PtdIns4P phosphorylation (Czech 2000). These data offer 
indirect evidence of a PtdIns4P pool at the plasma membrane. We conclude that the 
Toxoplasma secretory pathway is coded by distinct PtdIns4P pools, and that these are likely 
used in regulation of secretory functions.  
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Figure 2.6. There are specific PtdIns4P pools on dense granules in Toxoplasma.  
(A) Immunofluorescence of Toxoplasma cells transiently expressing either the PHFAPP1-YFP or 
SidM (P4M)-YFP biosensors, stained against TgGRA3, TgSORLR, or TgMIC3. The PtdIns4P-
binding mutant of PHFAPP1-YFP (K7A/R18L) is delocalized to the cytoplasm. TRITC or far red 
and YFP confocal image panels are shown. TRIC/YFP co-localization appears yellow, far 
60 
 
red/YFP co-localization appears blue. Scale bars: 2 μm. (B) Representative line scan analysis, 
where the line is defined in the respective overlay image in (A).  
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Figure 2.7. There are distinct PtdIns4P pools on early and late secretory membranes in 
Toxoplasma. (A) Immunofluorescence against TgGRA3 or TgSORTLR of Toxoplasma cells 
expressing GOLPH3-YFP reveals a PtdIns4P pool on early secretory membranes but not on 
dense granules. (B) Biosensors that recognize higher order PIPs: PtdIns(4,5)P2 (PH
PLC-YFP, 
top panel shown against DIC) or PtdIns(3,4)P2 (PH
TAPP1-YFP, bottom panel shown against cell 
surface marker Inner Membrane Complex (IMC)) localize to the plasma membrane. TRITC and 
YFP confocal image panels are shown, co-localization appears yellow. Scale bars: 2 μm.   
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PHPIMP preferentially registers a dense-granule pool of phosphoinositide 
To determine whether PHPIMP displays an in vivo localization profile that overlaps with 
any of the PtdIns4P biosensors, we expressed YFP-tagged PHPIMP in Toxoplasma. Indeed, 
PHPIMP co-localized with the GRA3 dense granule marker, as well as with RFP-tagged PHFAPP1 
when the two constructs are co-expressed (Figure 2.8A). Localization of PHPIMP to dense 
granules was sensitive to missense substitution of Arg503 as the mutant R503A domain exhibited 
a cytoplasmic distribution under those same experimental conditions (Figure 2.8B). Taken 
together, the collective data suggest PHPIMP is alert to a pool of PtdIns4P deployed on the 
surface of dense granules, and suggest PHPIMP functions primarily as a PtdIns4P binding 
module in Toxoplasma. Though we did not detect PtdIns(3,4)P2 and PtdIns(4,5)P2 pools on 
dense granules, it’s possible that a PI(4,5)P2 pool exists on dense granules to which our 
biosensors are insensitive, and that the PIMP PH domain recognizes this pool together with, or 
in exclusion of, PtdIns4P. 
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Figure 2.8. PHPIMP senses PIP pools on dense granules in Toxoplasma. PHPIMP -YFP was 
expressed in Toxoplasma and immune-stained against TgGRA3, showing co-localization in the 
overlay. PHPIMP(R503A)-YFP did not bind membranes in live cells. Co-expression of PHPIMP-RFP 
and PHFAPP1-YFP confirmed the PIP pools detected by both domains overlap (overlay). TRITC 
or far red and YFP confocal image panels are shown. TRIC/YFP co-localization appears yellow, 
far red/YFP co-localization appears blue. Scale bars: 2 μm.   
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PIMP is a dense granule protein 
Does PHPIMP contribute to PIMP recruitment to specific Toxoplasma secretory organelles 
as a function of PtdIns4P and/or PtdIns(4,5)P2 availability? We exogenously expressed full-
length PIMP tagged on the C-terminus and immunostained against GRA3. Full length PIMP 
does indeed localize to dense granules, as well as other intracellular structures not marked with 
GRA3 (Figure 2.9A). The coincidence of PIMP localization with that of its isolated PH domain 
suggested that the PtdIns4P-binding activity of PHPIMP might contribute to the spatial and 
temporal recruitment of the full-length protein to the surface of dense granules. That hypothesis 
was tested by incorporating the R503A missense substitution into the context of the full-length 
PIMP and assessing the consequences on PIMP localization. Inactivation of the PtdIns4P-
binding activity of the PHPIMP domain compromised targeting of the full-length PIMP to GRA3(+) 
dense granules (Figure 2.9B). PIMPR503A still localized to distinct intracellular structures, but 
these were separate and adjacent to GRA3(+) membranes (Figure 2.9B). These data indicate 
PIMP is recruited to dense granules, or to a certain subset of dense granules, in a manner 
dependent on the PIP-binding activity of its PH domain. Other double-label experiments showed 
that PIMP does not localize to Golgi/ECL membranes, rhoptries, or micronemes as marked by 
SORTLR (Sloves, et al. 2012), TgROP1-RFP (Hajj et al. 2007) and TgMIC3 (Garcia-Reguet et 
al. 2000), respectively (Figure 2.10).  
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Figure 2.9. PIMP is a dense granule protein. (A) PIMP-YFP was expressed in Toxoplasma 
and immune-stained against TgGRA3. (B) PIMPR503A-YFP was expressed in Toxoplasma and 
immune-stained against TgGRA3. TRITC or far red and YFP confocal image panels are shown. 
TRIC/YFP co-localization appears yellow, Far red/YFP co-localization appears blue. Z-
projection indicates signal along the z-stack horizontal to the indicated cross-hairs.  
Scale bars: 2 μm.  
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Figure 2.10. PIMP is unique to dense granules. PIMP-YFP was expressed in Toxoplasma 
and immune-stained against TgSORTL or TgMIC3, or co-expressed with rhoptry marker 
construct ROP1-RFP. TRITC or far red and YFP confocal image panels are shown. TRIC/YFP 
co-localization appears yellow, Far red/YFP co-localization appears blue. Z-projection indicates 
signal along the z-stack horizontal to the indicated cross-hairs. Scale bars: 2 μm.  
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Discussion 
Toxoplasma are obligate intracellular parasites with a complex life cycle that includes 
several stages of differentiation, multiple hosts and a wide host cell range (Boothroyd and Grigg 
2002). Many eukaryotic signaling pathways are conserved in Toxoplasma and adapted to its 
unique requirements (Liendo and Joiner 2000; Nagamune et al. 2008; Tomavo 2014). We can 
therefore use what’s known about other eukaryotes as a template from which to understand 
Toxoplasma signaling pathways. We identify for the first time PtdIns4P pools in Toxoplasma, 
including a pool on specialized secretory organelles that are involved directly in pathogenesis, 
the dense granules. PIMP is a multi-domain PITP/PH/OSBP protein, which senses PtdIns4P 
and PtdIns(4,5)P2 through its PH domain and localizes to dense granules. PIMP is a bona fide 
PITP with PtdIns/PtdCho transfer activity. We propose a model wherein PIMP represents the 
hub of an Apicomplexan signaling network that mirrors the Sec14/Kes1 network in yeast.  
 
PIP signaling in the Toxoplasma secretory system 
 Though Toxoplasma acquire many essential biomolecules from their host cells, they are 
capable of synthesizing their own PIP network as evidenced by the presence of a functional 
PtdIns Synthase encoded in the Toxoplasma genome (Schwab 1994; Coppens et al. 2000; 
Seron et al. 2000; Charron and Sibley 2002). However, phosphoinositide signaling networks 
within Apicomplexa are poorly understood. Analysis of PtdIns3P signaling in Toxoplasma has 
focused on the prediction that this PIP will regulate late secretory signaling (Tawk et al. 2011). 
Surprisingly, PtdIns3P pools in Toxoplasma were only detected at the apicoplast, a non-
photosynthetic chloroplast that is not part of the secretory pathway (Tawk et al. 2011; Daher et 
al. 2015). Though this work reveals an important function of PtdIns3P, the question of how PIP 
signaling regulates late secretory membranes in Toxoplasma remained unanswered.  
PtdIns4P signaling is also a major regulator of secretion in eukaryotes (Bankaitis et al. 
2010; Cleves et al. 1989). PtdIns4P networks have hitherto not been described in Toxoplasma. 
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Using PtdIns4P biosensors known to recognize their substrate in the context of different 
membranes in yeast or mammalian cells, we show distinct pools of PtdIns4P associated with 
the Toxoplasma Golgi/ELC (according to GOLPH3 domain), and on dense granules (according 
to SidM-P4M and the FAPP1 PH domain) (He et al. 2011; Dippold et al. 2009; Hammond et al. 
2014). The GOLPH3 domain also localizes to cytoplasmic structures distinct from rhoptries, 
micronemes, the apicoplast, or the nucleus. The positive identification of these structures will 
further reveal processes subject to regulation by the PtdIns4P network. We also describe a 
plasma membrane pool of the higher order PIP, PtdIns(4,5)P2, which is generated in other 
eukaryotes by the phosphorylation of PtdIns4P (and to a lesser extent, the phosphorylation of 
PtdIns5P), implying the presence of a plasma membrane PtdIns4P pool. These analyses show 
that distinct pools of PtdIns4P are used to code the Toxoplasma secretory pathway, and open 
novel avenues for study of Apicomplexan secretory processes, especially how these relate to 
secretion of specialized parasite effector proteins from the dense granules.  
 
PIMP as the hub of a Sec14/Kes1-like signaling network in Apicomplexa 
The physical coupling of the PITP and OSBP modules in PIMP suggests conservation of 
the privileged Sec14/Kes1 relationship not only between eukaryotes, but also across 
mechanism. Sec14 and Kes1 are separate gene products, and there is no evidence they ever 
physically interact. Furthermore, the PIMP PITP domain is a START domain with no homology 
to Sec14 proteins. This suggests that PIMP in Toxoplasma and the Sec14/Kes1 signaling hub in 
yeast came to exist by distinct evolutionary paths, converged on a common useful mechanism. 
How much of what we know about the Sec14/Kes1 signaling hub can be translated to PIMP 
function in Toxoplasma? 
Evidence that PIMP is found on dense granules and binds PtdIns4P through its PH 
domain mirrors aspects of how Sec14/Kes1 regulate late secretory signaling in yeast in a way 
that centers on the production and availability of PtdIns4P (Bankaitis et al. 1990; Bankaitis et al. 
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1989; Cleves et al. 1991a; Fang et al. 1996). The PITP domain of PIMP can substitute for 
Sec14 in yeast. Like Sec14, and some START PITPs, PITPPIMP transfers both PtdIns and 
PtdCho between membranes in vitro, making it capable, at least on principle, of stimulating 
PtdIns4P synthesis in response to membrane DAG levels as per PtdCho proxy. The GTPase 
Arf1 controls vesicle biogenesis at Golgi membranes by recruitment of coat proteins (Serafini et 
al. 1991). ARF-GTPase activating proteins (ARFGAPs) Gcs1p and Age2p are downstream 
effectors of Sec14 signaling (Yanagisawa et al. 2002). The Toxoplasma ortholog of Arf1 has 
been identified and localized to the Golgi (Liendo et al. 2001). Exogenous expression of 
dominant negative mutants of TgArf1 inhibit transport of a reporter protein to dense granules, 
while supplementation of wild-type TgArf1 into a permeabilized cell system augments dense 
granule secretion, suggesting that dense granule biogenesis as well as secretion are regulated 
by an Arf1-dependent mechanism (Liendo et al. 2001). This pathway might work in parallel with 
PIMP signaling, as yeast Arf1 does with Sec14 to coordinate PtdIns4P and vesicle biogenesis.  
The yeast OSBP Kes1 binds both sterol and PtdIns4P (Li et al. 2002; Im et al. 2005; de 
Saint-Jean et al. 2011). The instability of the PIMP OSBP domain when expressed in isolation of 
the full-length protein has precluded our ability to assay its antagonism of PITPPIMP or of Sec14. 
We have also been unable to test its capacity to bind sterol or PtdIns4P. Several features of the 
OSBP primary sequence suggest that the domain is competent to bind sterol and an inositol 
lipid, though perhaps not PtdIns4P. The Kes1 PtdIns4P-binding bipartite motif including 
K109/K336 and H142/H144 are mostly aliphatic in OSBPPIMP, and are likely not able to stabilize 
the PtdIns4P inositol phosphate groups (de Saint-Jean et al. 2011). OSBPPIMP may be able to 
accommodate a different inositol lipid, however, as the orthologous residues that stabilize the 
general inositol structure in Kes1 are conserved. Some “long ORPs” fulfill the PIP binding 
function through an N-terminal PH domain, and indeed that may be the case for the binding 
PHPIMP.  
70 
 
The two residues of Kes1 known to stabilize sterol H202/E204 lose sterol-binding 
capacity when mutated to aliphatic residues (de Saint-Jean et al. 2011). The cognate residues in 
the PIMP OSBP domain are K1755 and S1757, which retain the ability to form hydrogen bonds 
and may therefore be capable of binding sterol. Toxoplasma is considered an obligate 
intracellular parasite because it requires certain key essential nutrients that it cannot itself 
synthesize and must therefore scavenge from the host cell. A key role of effector proteins 
secreted from dense granules is to maintain the intracellular compartment in which the parasite 
divides and scavenge nutrients from the host cell. Cholesterol is one essential metabolite that 
the parasites cannot efficiently synthesize themselves, and Toxoplasma acquires cholesterol 
from the host cell by concentrating low density lipoprotein-derived cholesterol into the 
parasitophorous vacuole from the host cell (Coppens et al. 2000). Sterol sensing in Toxoplasma 
may therefore be coupled directly to nutrient scavenging pathways. If OSBPPIMP has the 
capacity to bind sterol, it may translate this metabolic input to PtdIns4P-regulated secretion 
pathways on dense granules to stimulate secretion of effector proteins involved in nutrient 
scavenging pathways. 
 
PIMP architecture is suited for specific coding of membrane signaling pixels 
Eukaryotic cells use membranes as signaling platforms to organize specific biological 
events, such as exchange of material between the cell and the environment, polarity, and 
developmental control of cell morphogenesis (Lecuit and Pilot 2003). Because these events 
demand spatial and temporal precision, a signaling membrane cannot be a blanket of signaling 
components. In the case of PIP signaling, PITPs have emerged as important organizers of 
membrane signaling “pixels” across eukaryotes (Bankaitis et al. 2010; Ghosh et al. 2015).  
The PIMP PH domain is a PtdIns4P-binding domain, with co-specificity for PtdIns(4,5)P2. 
When expressed exogenously in live Toxoplasma, PHPIMP localizes exclusively to dense 
granules in a PIP-binding dependent manner as evidenced by delocalization to the cytoplasm of 
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the PIP-binding mutant (R503A). Though we did not identify any pools of higher order PIPs 
anywhere but on the cell membrane in our biosensor analysis, the possibility remains that a 
PI(4,5)P2 pool exists on dense granules, and that PH
PIMP senses both this pool and the PtdIns4P 
pool, perhaps to their mutual exclusion. Mutation of the PH domain at Arg503 in the context of 
full-length PIMP delocalizes PIMP from GRA3(+) structures. The mutant protein remains 
associated with cytoplasmic structures that resemble dense granules, though it’s not clear 
whether these structures are some other organelle or a distinct subset of dense granules. This 
suggests that the PIMP PH domain has a function as a localization determinant that targets 
PIMP to a specific PtdIns4P pool, i.e., one that is present on dense granules or a subset thereof. 
The ability to distinguish between PtdIns4P pools equips PIMP with the capacity to specify a 
membrane signaling pixel.  
The PIMP PH domain may regulate PIMP function as a PIP sensor. PHPIMP domain 
binding of PtdIns4P on dense granule membranes may inhibit the PIMP PITP domain as a 
mechanism for controlling PtdIns4P production. Conversely, lack of PHPIMP binding to the 
membrane may activate the PITP domain in an effort to replenish the PtdIns4P pool. This could 
happen through PH domain-mediated induction of conformational changes to the full-length 
protein. Alternatively, PHPIMP may bind directly to the PIMP PITP domain, wherein PITPPIMP and 
dense granule PtdIns4P effectively compete for PHPIMP. There is precedent for regulatory 
interactions of PITP and PH domains. The mammalian multi-domain Rho-GEF Dbs has an N-
terminal Sec14 domain and a downstream PH domain. In this protein, intramolecular contacts 
between the Sec14 and PH domains must be alleviated for Dbs to affect a cellular function 
(Kostenko et al. 2005). The PIMP PITP domain has a unique insertion that is well-poised to 
interact with other proteins and represents a possible platform for intramolecular interactions 
with the PH domain (described below). An ability to sense PtdIns4P levels and affect 
downstream synthesis of PtdIns4P may therefore be another mechanism by which PIMP can 
specify a signaling pixel on dense granule membranes. 
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The PIMP PITP domain exhibits a “loop” region (residues 193-261) that does not align 
with any known mammalian START PITP. PITPPIMP with the loop deleted did not substitute for 
Sec14 in the yeast complementation assay, suggesting that the loop is important for PITP 
activity or proper folding (data not shown)/ A marked feature of the loop is a highly charged tract 
(203-REETEEKREETEEKREET-220) that may serve as an interaction domain for a PIMP 
effector protein. The full 77-residue loop does not exist in the Aconoidasida Plasmodium and 
Babesia orthologs of PIMP, nor does it exist in a putative PITP from Perkinsus, a protozoan 
outside of, but related to, the Apicomplexa. Two Coccidia closely related to Toxoplasma, 
Neospora and Eimeria, encode for START PITPs that do have an insertion in this region; 
however, each sequence is unique, and only Toxoplasma PIMP exhibits the full charged tract 
described above. Toxoplasma, Neospora and Eimeria all infect a wide range of mammalian 
hosts, but each has a unique definitive host (felines, canines, and chickens, respectively). 
Furthermore, each preferentially infects a different tissue and causes a different disease: 
encephalitis with Toxoplasma, neuromuscular degeneration with Neospora, and diarrhea with 
Eimeria (Donahoe et al. 2015). The lack of homology to other START proteins suggests that this 
region is suited to a function specific to Toxoplasma, and may reflect binding to specific 
effectors that contribute to its unique host and cellular tropisms. Conformational exposure of the 
loop may allow PITPPIMP to bind an effector protein or to one of the other PIMP domains, which 
could contribute to the pixel identity of a specific signaling domain on dense granule 
membranes.  
 
Regulation of PIMP signaling by coupling of the PITP and OSBP domains 
Immediately N-terminal to the OSBP domain in PIMP are three HT consensus sites 
(Figure 2.1A). Called PEXELs in Plasmodium for Plasmodium Export Elements, these are 
protease cleavage sites recognized by the Apicomplexan-specific aspartic acid protease 
Plasmepsin V (Horrocks and Muhia 2005). PEXEL sequences target their proteins to the ER by 
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specifically binding PtdIns3P on ER membranes, which makes the site accessible to ER-
resident Plasmepsin V (Bhattacharjee et al. 2012; Bullen et al. 2012; Goldberg 2012). Following 
cleavage, these proteins are targeted for secretion and export to the host cell (Horrocks and 
Muhia 2005; Bhattacharjee et al. 2012). HT sequences in Toxoplasma are also protease 
cleavage sites; however, these proteins are not exported into the host cell following cleavage 
but rather remain cytoplasmic (Hsiao et al. 2013). Most of the HT-containing proteome in 
Toxoplasma are dense granule proteins, wherein the N-terminal domains of the proteins remain 
associated with the dense granules following protease cleavage of the HT sequences, and the 
cleaved C-terminal domains remain in the Toxoplasma cytoplasm (Hsiao et al. 2013).  
HT sites do not exist anywhere else in PIMP but in the ~175 residues upstream of the 
OSBP domain, and are consistent with the identity of PIMP as a dense granule protein. These 
sites pose two interesting possibilities for PIMP regulation: (1) that PIMP integrates PtdIns3P 
signaling into the dense granule circuit, and (2) that the PIMP OSBP domain is evicted from the 
full length protein under certain signaling conditions. We were unable to express or purify a 
stable recombinant region that encompasses these sites specifically, and were therefore unable 
to assay its ability to bind PtdIns3P directly. Our preliminary experiments argue that at least one 
of these sites is cleaved in vivo when PIMP is exogenously expressed in Toxoplasma (data nor 
shown).  
Interestingly, two of the three HT sites are coded for on exon/intron boundaries of the 
PIMP gene: at the boundary of exons 15 and 16, and at the start of exon 17, raising the 
possibility that these regions are also subject to regulation on the transcriptional level. We did 
not detect distinct splice forms in our reverse-transcriptase experiments; however, that does not 
exclude the possibility that such regulation occurs at stages of the parasite life cycle not 
included in our analyses.  
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The biological role of PIMP in Toxoplasma 
Herein, we describe a multi-domain PITP that has the potential to act as a platform for 
the integration of parasite metabolism sensing pathways with secretion of dense granule 
proteins specialized for maintaining pathogenesis. How does PIMP regulate dense granule 
functions? And how is this translated to the cell biology of Toxoplasma and other Apicomplexa? 
We discuss these questions, our findings, and future directions in greater detail in Chapter 4. 
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CHAPTER 3: ATOMISTIC INSIGHTS INTO THE DYNAMICS AND ENERGETICS OF 
THE MAMMALIAN PHOSPHATIDYLINOSITOL TRANSFER PROTEIN 
PHOSPHOLIPID EXCHANGE CYCLE 
 
Introduction 
Phosphatidylinositol (PtdIns) is a metabolic precursor of phosphoinositides, and these 
lipids function as critical intracellular chemical signals in eukaryotes. While much effort is 
invested in understanding the enzymes that produce and consume phosphoinositides, 
fundamental aspects for how phosphoinositide production is regulated and physically 
organized define unappreciated gaps in our understanding of how inositol lipid signaling is 
prosecuted in cells. It is in those contexts that PtdIns transfer proteins (PITPs) command 
increasing interest as activities that functionally channel lipid metabolic information to 
dedicated and tightly integrated phosphoinositide signaling circuits. It is therefore no surprise 
that the biological importance of PITPs is on striking display in both uni- and multi-cellular 
organisms. Phenotypes associated with defects in individual PITPs include: (i) non-
redundant functions of individual PITPs in channeling phosphoinositide signaling to 
Golgi/endosomal membrane trafficking, lipid droplet metabolism, and endosomal 
phosphatidylserine metabolism in yeast (Bankaitis et al. 1990; Cleves et al. 1991; Wu et al. 
2000; Ren et al. 2014), (ii) collapse of ‘extreme’ polarized plant membrane growth programs 
required for tissue organogenesis (Vincent et al. 2005; Huang et al. 2013; Ghosh et al. 
2015), (iii) defects in embryogenesis and retinal degeneration disease in both Drosophila and 
zebrafish (Vihtelic et al. 1991; Milligan et al. 1997; Giansanti et al. 2006; Ile et al. 2010), and 
(iv) neurodegeneration, chylomicron retention disease, liver steatosis, and hypoglycemia in 
neonatal mice (Hamilton et al. 1997; Alb et al. 2003; Alb et al. 2007). 
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The biological importance of these proteins notwithstanding, PITPs remain poorly 
characterized with respect to how these proteins work as molecules. PITPs are not enzymes, 
but proteins that mobilize energy-independent transfer of PtdIns and PtdCho between 
membranes in vitro (Helmkamp et al. 1974; Wirtz 1991). On the basis of this operational 
assay, PITPs have historically been described to function as lipid carriers that transport 
PtdIns from its site of synthesis in the endoplasmic reticulum to the plasma membrane where 
agonist-stimulated phospholipase C-dependent pathways consume phosphoinositides -- for 
which PtdIns is a metabolic precursor (Wirtz 1991). An alternative mechanistic framework for 
thinking about how PITPs function as molecules is gaining strong momentum, however, and 
it conceptualizes a very different mechanism which does not involve inter-membrane PtdIns-
transfer at all. Rather, PITPs are proposed to chaperone a tightly channeled ‘on-demand’ 
synthesis of privileged, and spatially highly organized, phosphoinositide pools dedicated to 
specific biological outcomes (Schaaf et al. 2008; Bankaitis et al. 2010; Grabon et al. 2015). 
Regardless of whether PITPs function as PtdIns presentation modules, or as bona 
fide PL-transfer proteins, there is no question that the PL-exchange reaction is central to their 
biological activity. The exchange reaction, in summary, includes the PITP ejecting bound PL 
upon docking onto a membrane surface, followed by reloading of the PITP with another PL 
molecule prior to its disengagement from the surface. Studies in purified systems with 
defined liposomes and recombinant PITP show that abstraction of PL from a membrane 
bilayer during the exchange reaction occurs in the absence of any co-factors or ATP 
(Helmkamp et al. 1974; Wirtz 1991). Thus, PITPs lower the activation energy of PL 
desorption from the bilayer and couple protein conformational transitions to a cycle of PL 
unloading and loading. However, the fundamental details of the protein and PL dynamics 
associated with the exchange reaction are proving exceptionally challenging to dissect using 
conventional wet biochemistry approaches. 
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Initial insights into the conformational dynamics of PL-exchange were obtained from 
unrestrained MD simulations and biochemistry of the yeast PITP Sec14 (Ryan et al. 2007). 
Although the MD time course was short (32 ns), oscillations between ‘open’ and ‘closed’ 
Sec14p conformers were simulated and Sec14 structural elements were identified that control 
the conformational pathway associated with such oscillations (Ryan et al. 2007; Schaaf et al. 
2011). While informative, those simulations are limited. First, the MD simulations were 
conducted in the absence of a membrane bilayer, revealing no information about PL::PITP 
interactions during the exchange reaction (Ryan et al. 2007). It is those interactions that must 
be understood. Second, the detailed information from the Sec14 MD does not translate to the 
START-domain PITPs since the two classes of PITPs are structurally unrelated. This issue 
takes on added force given the severe developmental and neurodegenerative phenotypes 
associated with genetic deficiencies in START-domain PITP function in vertebrates and other 
metazoans (Vihtelic et al. 1991; Milligan et al. 1997; Giansanti et al. 2006; Ile et al. 2010; 
Hamilton et al. 1997; Alb et al. 2003). As first address of these major gaps in our knowledge, 
we describe MD simulations that reveal the protein and PL dynamics, and the free energy 
landscape, of PtdIns and PtdCho exchange by the mammalian START-domain PITPα. The 
MDS offers key descriptions of PITPα mechanism: (1) interaction of PITPα with the membrane 
is spontaneous and mediated by four specific substructures, (2) the ability of PITPα to close 
around the phospholipid ligand correlates to loss of flexibility of two helix/loop regions as well 
as the C-terminal helix, (3) extraction of the phospholipid by PITPα is stabilized mostly by 
hydrogen bonds, and (4) the trajectory of PtdIns or PtdCho into the lipid binding pocket is 
mediated by overlapping but unique sets of PITPα residues. We rationally engineered altered 
versions of PITPα based on MDS predictions and tested them for function in vivo and in vitro. 
These analyses support the MDS predictions. Together, the data provide a platform from 
which START PITP phospholipid exchange can be understood and further analyzed. 
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Materials and Methods 
Atomistic molecular dynamics simulations.  
Molecular dynamics simulations (MDS) were performed for PITPα in a system 
reconstituted with a lipid bilayer consisting of either pure 1,2-dioleoyl-PtdCho (DOPC) or a 
90%/10% molar mixture of DOPC and PtdIns. PITPα structures in the open (PDB 1KCM) and 
closed (PDB 1FVZ) conformations were retrieved from the RCSB Protein Data Bank (Yoder 
et al. 2001; Schouten et al. 2002). The former structure is lipid-free whereas the latter 
describes PITPα in complex with a single bound PtdCho molecule. These two starting 
structures were each introduced into each of the two bilayer systems to generate a total of 
four systems that were run in 1 µs all-atom simulations. In all cases, PITPα was positioned 
above the bilayer in the water phase. Simulations were run at physiological salt 
concentrations (150 mM KCl) and counter ions were introduced to neutralize the total charge 
of the system. Details of the compositions of each simulated system are provided in Table 
3.1. 
 
Table 3.1. Composition of simulated systems. 
System/number 
of molecules 
PITP DOPC PI water K+ Cl- Simulation time 
(microseconds) 
1 1 (1FVZ – 
closed) 
192 0 27593 81 77 1 
2 1 (1FVZ – 
closed) 
190 18 26235 93 73 1 
3 1 (1KCM – 
open) 
192 0 27519 79 77 1 
4 1 (1KCM – 
open) 
190 18 27212 98 76 1 
 
 
 The OPLS all-atom force field was used to describe the interactions between all 
molecules (Jorgensen and Tirado-Rives 1988). For water, the TIP3P model that is 
compatible with the OPLS parameterization was employed (Jorgensen et al. 1983). The 
system structure used in this study is identical to those employed in our previous simulations 
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of lipid bilayers (Kaiser et al. 2011; Orlowski et al. 2011). Further, to parameterize lipid 
molecules, improved parameters specifically derived for lipids were used (Maciejewski et al. 
2014; Kulig et al. 2015; Kulig et al. 2016). Periodic boundary conditions with the usual 
minimum image convention were employed in all three dimensions. The length of each 
hydrogen atom covalent bond was preserved by the LINCS algorithm (Hess et al. 1997). The 
integration time step was set to 2 fs and the simulations were carried out at constant 
pressure (1 bar) and temperature (310 K). The temperature and pressure were controlled by 
the Parrinello-Rahman and velocity-rescale methods, respectively (Parrinello and Rahman 
1981; Bussi et al. 2007). The temperatures of the solute and the solvent were coupled 
separately. For pressure, a semi-isotropic scaling was employed. The Lennard-Jones 
interactions were cut off at 1.0 nm. For the electrostatic interactions, the particle mesh Ewald 
method (Essmann et al. 1995) was employed with a real space cut-off at 1.0 nm, beta-spline 
interpolation (6th order), and a direct sum tolerance of 10-6. The simulations were performed 
with the GROMACS 4.5.5 simulation package (Hess et al. 2008; Pronk et al. 2013). 
 
Free energy calculations.  
Free energies of DOPC and PtdIns uptake by PITPα were obtained by umbrella 
sampling simulations of two model systems. The starting structure of the first system was 
obtained from the final structure after a 1 µs production run of simulation 3 (Table 3.1). The 
second system was generated from the first by replacing the DOPC molecule positioned 
closest to the binding site with a PtdIns molecule. 
 Free energy profiles for DOPC and PtdIns uptake by PITPα were calculated using the 
umbrella sampling method (Kästner 2011). The starting structures were obtained as follows. 
First, a single PL (DOPC or PtdIns) was pulled from the bilayer towards the PITPα lipid-
binding pocket along the z-axis (membrane normal) in 20 ns simulation with a constant 
pulling force constant of 1000 kJ x mol-1 x nm-2 and a pulling rate of 0.00075 nm x ns-1 
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exerted on the lipid headgroup. Next, the position of the lipid headgroup was adjusted by 
lateral pulling such that it was positioned in the near vicinity of PITPα residues Cys95 and 
Phe225 reported to be important for PtdCho binding (Yoder et al. 2001; Garner et al. 2012), of 
residues Thr59, Lys61, Glu86, and Asn90 known to coordinate the inositol headgroup (Alb et al. 
1995; Tilley et al. 2004). After the PLs were optimally positioned within the PITPα binding 
pocket, the constraints imposed on the respective headgroups were released. The DOPC 
and PtdIns systems were then simulated for an additional 150 and 240 ns, respectively.  
 In umbrella sampling simulations, 28 and 26 windows with a spacing of 0.1 nm were 
employed for PtdIns and DOPC systems, respectively. The reaction coordinate () was 
chosen as z-coordinate of the lipid headgroup with boundaries at the plane of the membrane-
water interface and at the upper regions of the lipid binding pocket. In each window, a 
harmonic restraining potential of 1000 kJ x mol-1 x nm2 was applied in the z-direction on the 
distance between the center of mass of the given headgroup and the DOPC bilayer bound 
with PITPα. Finally, the free energy profile for both PLs was constructed with the weighted 
histogram analysis method (WHAM) (Kumar et al. 1992) based on the biased distribution of 
the given PL and magnitude of the umbrella biasing potential along the reaction coordinate. 
All free energy calculations were performed with an identical set of simulation parameters as 
described above for the equilibrium simulations. 
 
Visualization.  
All the snapshots and movies presented in this work were prepared using the VMD 
package (Humphrey et al. 1996). Molecular graphics and analyses of PITPNA single-
nucleotide polymorphisms were performed with the UCSF Chimera package developed by 
the Resource for Biocomputing, Visualization, and Informatics at the University of California, 
San Francisco. 
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Lipid reagents.  
For radiolabeled lipid transfer assays, preparation of [3H]-PtdIns rat liver microsomes 
has been described (Bankaitis et al. 1990; Schaaf et al. 2008). [3H]-PtdCho (L-α-dipalmitoyl 
[choline methyl-3H], ART 0284) was purchased from American Radiolabeled Chemicals, Inc. 
(ARC). For fluorescence-based lipid transfer assays, L-α-PtdCho and L-α-phosphatidic acid 
from chicken egg of highest available quality, were purchased from Avanti Polar Lipids 
(Alabaster, AL, USA), and used without further purification. 1-Palmitoyl-2-decapyrenyl-sn-
glycero-3-phosphocholine (PyrPtdCho) was synthesized from 1-palmitoyl-2-hydroxy-sn-
glycero-3-phosphocholine (Avanti Polar Lipids) and parinaroyl anhydride (Salinger and 
Lapidot 1966; Gupta et al. 1977), and purified by reverse phase HPLC chromatography 
(Beckman Ultrasphere ODS outfitted with 4.6 x 25 cm column (Patton et al. 1982). 1-
Palmitoyl-2-decapyrenyl-sn-glycero-3- phosphoinositol (PyrPtdIns) was prepared from yeast 
PtdIns and parinaroyl anhydride as described (Somerharju et al. 1982). 2,4,6-trinitrophenyl-
phosphatidylethanolamine (TNP-PtdEtn) was prepared as described (Gordesky and Marinetti 
1973), and purified by silica gel column chromatography. Stock solutions of lipids were 
prepared in methanol and kept at -20 °C. The concentrations of PyrPtdIns and PyrPtdCho 
were determined spectroscopically, while the concentrations of L-α-PtdCho, L-α-phosphatidic 
acid and TNP-PtdEtn solutions were determined according to Rouser et al. (Rouser et al. 
1970). All lipid solutions were taken to ambient temperature before use. All other chemicals 
used were of highest available quality and the organic solvents were of spectroscopic grade. 
 
Yeast strains and media.  
Yeast were grown in YPD liquid media (1% yeast extract, 2% bactopeptone, and 3% 
glucose), or SD liquid media (0.67% nitrogen base, 3% glucose with appropriate amino acids 
supplemented) (Sherman et al. 1983). The respective plate media included 2% agar. Yeast 
strains CTY182 (MATa ura3-52 lys2-801 Δhis3-200), and CTY1-1A (MATa ura3-52 lys2-801 
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Δhis3-200 sec14-1ts) were previously described (Bankaitis et al. 1990; Cleves et al. 1991; 
Bankaitis et al. 1989). PITPNA–expressing yeast strains were constructed by genomic 
integration of a single copy cassette where the PITPNA open reading frame was expressed 
under the control of the powerful and constitutive PGK1 promoter (PPGK) and configured in 
tandem with a functional HIS3 selection marker. The integration cassette was recombined 
into the LEU2 locus of the appropriate recipient yeast strain by standard lithium acetate 
transformation methods (Gietz et al. 2002). Transformants were selected on media lacking 
histidine and correct integration of the cassette was confirmed by screening for leucine 
auxotrophy as unselected phenotype. PITPNA over-expression strains were generated by 
transformation of the PITPNA expression cassette (driven by the powerful constitutive PMA1 
promoter) subloned into a yeast URA3 episomal plasmid pDR195 (Rentsch et al. 1995) by 
the lithium acetate method. Transformants were selected on uracil-free media. 
 
Site-directed mutagenesis.  
The Rattus norvegicus PITPNA gene was mutated by site-directed mutagenesis in the 
PPGK1-PITPNA HIS3::LEU2 yeast integration vector, the pDR195 (PPMA1-PITPNA) vector, and 
in the pET28b-His8-PITPNA protein expression plasmid. Mutations were confirmed by DNA 
sequencing. Nucleotide sequences for primers for the site-directed mutagenesis experiments 
are available from the authors by request. 
 
Protein purification.  
Recombinant PITPα and mutant versions were expressed from pET28b-His8-PITPNA 
vectors propagated in E.coli BL21 (RIL/DE3; New England BioLabs Inc, Ipswich, MA). 
Bacteria were cultured in 4L TB + kanamycin/chloramphenicol media for 4hrs at 37°C, shifted 
to 16°C and induced for recombinant protein expression with IPTG (100µM final 
concentration). Cultures were harvested after 18hrs, and cells disrupted by passage through 
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a French Press in low-phosphate lysis buffer (300mM NaCl, 25mM Na-phosphate, 5mM 2-
mercaptoethanol, pH 7.5). Clarified lysates were incubated with TALON metal affinity beads 
(Clontech, Mountain View, CA), and bound proteins step-eluted with imidazole (25mM–
200mM). Proteins were concentrated using the Amicon Ultra filter system (EMD Millipore), 
and concentration determined by SDS-PAGE and comparison against a BSA standard mass 
series.  
 
Lipid transfer assays.  
End-point assays measured transport of [3H]-PtdIns from rat liver microsomes to 
PtdCho liposomes or [3H]-PtdCho from liposomes (98 mol% PtdCho, 2mol% PtdIns) to 
bovine heart mitochondria as described (Bankaitis et al. 1990; Schaaf et al. 2008).  
Pyrene-labeled PtdCho (PyrPtdCho) and PtdIns (PyrPtdIns) binding and transfer 
measurements were performed using a real-time de-quenching assay as described by 
Somerharju et al. (Somerharju et al. 1987) with modification. For the transfer measurements 
two vesicle populations were used. The donor (with TNP-PtdEtn quencher) and acceptor 
(without TNP-PtdEtn quencher) vesicles were prepared as follows. For the acceptor vesicles 
stock solutions of egg PtdCho and egg phosphatidic acid were mixed in a 291/9 nmol (97/3 
mol%) ratio and dried under a stream of N2. The resulting lipid film was then hydrated with 2 
ml low phosphate buffer (25 mM Na2HPO4, 300 mM NaCl, pH 7.5) and sonicated on ice for 
10 min. For the donor vesicles stock solutions of egg PtdCho, PyrPtdCho/PyrPtdIns and 
TNP-PtdEtn were mixed in a 4/0.5/0.5 nmol ratio, solvent was evaporated and the lipid film 
re-suspended in 10 μl EtOH. The solution was injected into the buffer containing the acceptor 
vesicles. After a 5-10 min equilibrium period, the fluorescence intensity (excitation 346 nm, 
emission 378 nm) was measured as a function of time at 37°C using a ISS K2 fluorimeter 
(ISS Inc., Champaign, IL).  
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To measure transfer from donor to acceptor, 1 μg protein was injected every 250 s for 
a total of 4 injections. To obtain relative transfer efficiency, the initial slope after each protein 
injection was calculated and the mean slope values for each protein (n=4) was normalized to 
that calculated for purified PITPα. For binding measurements, donor vesicles were injected 
into 2 ml low phosphate buffer. After a 5-10 min equilibrium period the solution was titrated 
10x with 0.1 nmol recombinant protein and fluorescence intensity was measured as a 
function of wavelength (excitation 343 nm, emission 360-450 nm) at 37 °C (K2 fluorimeter). 
The intensity at 348 nm was then plotted against protein amount and the slope value for 
each protein was calculated and normalized against PITPα in order to obtain the relative 
binding efficiency. 
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Results 
PITPα binding to the membrane bilayer.  
Both open apo-PITPα and closed PtdCho-bound holo-PITPα forms have been 
crystallized and the structures solved (Yoder et al. 2001; Schouten et al. 2002). The protein 
consists of four domains. The PL-binding cavity includes: (i) an 8-stranded β-sheet capped 
by two long α-helices, (ii) a regulatory loop speculated to be involved in mediating protein 
interactions, (iii) the C-terminal domain suggested to participate in closure of the PL-binding 
pocket, and (iv) a small lipid exchange loop speculated to form a lid over the PL binding 
pocket and thereby gate access to it. To examine the PITPα lipid exchange cycle at an 
atomistic level, extensive all-atom MD simulations of both the open and closed PITPα 
conformers were run in systems reconstituted with bilayers consisting of DOPC or 
PtdIns/DOPC. Root mean square deviation (RMSD) and Root mean square fluctuation 
(RMSF) plots of PITPα Cα-atoms showed that both conformers were stable during the 
simulations (Figure 3.1A & B). Higher flexibility was observed for the open conformer in the 
presence of the DOPC/PtdIns membrane (Figure 3.1A, blue line), and this was primarily 
accounted for by the increased flexibility of the PITPα extreme C-terminus (Figure 3.1B – 
blue line). That is, the substructure suggested to gate access to the PITPα hydrophobic 
pocket. Two substructures bounded by residues 25-38 and 65-83, respectively, similarly 
exhibited enhanced flexibilities in the open conformer relative to the closed holo-PITPα. 
Indeed, it is in that latter substructure that the most striking conformational change was 
observed during the MD simulations. This region bounded by residues 65-83, which 
corresponds to the lipid-exchange loop, was in the form of a turn in the starting structure and 
transformed into a 310-helical conformation during the MD. As described below, this 
conformational change coincided with insertion of that loop into the bilayer upon PITPα 
association with the membrane. 
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 Firm and spontaneous PITPα binding to membrane was observed for both conformers, 
in both membrane systems, within the first 200-300 ns of simulation -- as scored by the 
number of H-bonds established between protein and PL (Figure 3.1C). Initial (0 ns) and final 
(1000 ns) snapshots for all four simulations are presented in Figure 3.2. Detailed analyses of 
the occurrence of H-bond interactions between individual PITPα residues and PLs are 
compiled in Table 3.2. Although the residues identified for membrane binding differed 
between the open and closed conformers in the DOPC systems, some residues were 
consistently highlighted and these identified three common regions involved in membrane 
association. Those regions were defined by: (i) the lipid exchange loop (residues 68-81), (ii) 
residues 135-163, and (iii) residues 204-220. With regard to specific interactions, Tyr103 of 
the open conformer engaged DOPC in H-bond interactions whereas the C-terminal lid 
domain of the closed conformer (residues 259-264) interacted with DOPC. Parallel analyses 
in the DOPC/PtdIns systems identified residues 147-153 and 208-219 in PITPα-PtdIns 
interactions (Table 3.3). 
 Occurrence of contacts between PITPα and PL atoms were similarly monitored 
throughout the MD course where contact was set as an inter-atomic distance of < 0.35 nm 
(Figure 3.3A-C). Those analyses indicated that, in addition to the regions identified by H-
bond analyses, both conformers showed that residues 28-41 constituted another region of 
membrane association. Moreover, the open conformer uniquely presented one additional 
membrane interaction subdomain (residues 99-110), and this particular set involved 
interactions other than H-bonds (e.g. charge pairs). This unique membrane association area 
was able to interact with the bilayer surface due to the slightly different dock orientation of the 
open PITPα conformer on the membrane surface relative to that of the closed form -- a 
difference which renders this protein region more accessible to the membrane for binding. 
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Figure 3.1. PITPα is stable during simulations. (A) RMSD of open and closed PITPα 
conformers in MD simulations (as described in Table 3.1). (B) RMSF of open and closed 
PITPα conformers in MD simulations (as described in Table 3.1). (C) Overall number of 
hydrogen bonds between the protein and lipids in time for MD simulations (as described in 
Table 3.1).1 – black line, 2 – red line, 3 – green line, 4 – blue line. 
 
  
88 
 
 
Figure 3.2. PITPα changed conformations during simulations. Initial (0 ns – A, C, E, G) 
and final (1000 ns – B, D, F, H) snapshots from the simulations of systems: 1 (A, B), 2 (C, 
D), 3 (E, F) and 4 (G, H) - as described in Table 3.1. Lipids shown in licorice (PtdIns in yellow 
and PtdCho inside the binding pocket of PITPα in red) and transparent brown surface. PITPα 
is presented in new cartoon representation in colors representing secondary structure. Water 
molecules and ions not shown for clarity. 
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Table 3.2. Number of hydrogen bonds protein-DOPC lipids in 300-1000ns. The least frequent 
hydrogen bonds were neglected. 
 
Residue Closed in DOPC Closed in 
DOPC/PI 
Open in DOPC Open in 
DOPC/PI 
Lys68 - - - 1.39 (+/- 0.003) 
Thr71 - - 1.36 (+/- 0.005) 1.40 (+/- 0.005) 
Arg74 1.30 (+/- 0.005) - 0.95 (+/- 0.004) - 
Glu79 0.22 (+/- 0.002) - 0.51 (+/- 0.003) - 
Ala81 0.28 (+/- 0.003) - - - 
Tyr103 - - 0.86 (+/- 0.002) 0.51 (+/- 0.003) 
Lys135 - 1.42 (+/- 0.006) 0.54 (+/- 0.003) - 
Tyr141 - 1.14 (+/- 0.002) - - 
Arg147 - - - 1.97 (+/- 0.006) 
Ser152 - 1.93 (+/- 0.002) 1.36 (+/- 0.005) 1.88 (+/- 0.003) 
Lys153 - 1.87 (+/- 0.006) 1.82 (+/- 0.003) 0.93 (+/- 0.004) 
Tyr155 - - - 0.27 (+/- 0.002) 
Lys156 - - - 0.40 (+/- 0.003) 
Lys163 - - - 0.79 (+/- 0.003) 
Trp204 - 0.37 (+/- 0.003) 0.32 (+/- 0.002) - 
Gly205 - - 0.33 (+/- 0.002) - 
Gln207 - 0.46 (+/- 0.003) - - 
Asn208 - 1.00 (+/- 0.004) 1.77 (+/- 0.003) - 
Lys209 - 1.92 (+/- 0.004) 1.76 (+/- 0.003) 0.98 (+/- 0.004) 
Asn212 - 0.42 (+/- 0.003) 1.23 (+/- 0.003) - 
His215 - 0.88 (+/- 0.002) - - 
Lys216 - 0.63 (+/- 0.003) 1.80 (+/- 0.004) 0.78 (+/- 0.003) 
Gln217 - - - 0.30 (+/- 0.002) 
Lys219 - 0.73 (+/- 0.003) - - 
Arg220 - - 1.25 (+/- 0.004) 1.38 (+/- 0.003) 
Arg259 1.48 (+/- 0.003) - - - 
Gln260 1.18 (+/- 0.003) - - - 
Lys261 1.82 (+/- 0.002) - - - 
Val264 0.10 (+/- 0.002) - - - 
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Table 3.3. Number of hydrogen bonds protein-PI lipids in 200-1000ns. The least frequent 
hydrogen bonds were neglected. 
 
Residue Closed in DOPC/PI Open in DOPC/PI 
Arg147 - 0.50 (+/- 0.003) 
Ser148 0.11 (+/- 0.002) - 
Lys153 0.12 (+/- 0.002) - 
Gln207 - 0.13 (+/- 0.003) 
Asn208 - - 
Lys209 - 1.72 (+/- 0.003) 
Asn212 0.32 (+/- 0.003) - 
His215 0.13 (+/- 0.002) - 
Lys216 0.35 (+/- 0.003) 0.56 (+/- 0.003) 
Lys219 0.11 (+/- 0.002) - 
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Figure 3.3. PITPα interacts with the membrane during simulations. Number of contacts 
between protein residues and lipids defined as the occurrence of the distance < 0.35 nm 
between any atom of protein residues and bilayer’s lipids atoms in each frame of simulation 
(count as 1 contact) (A, B, C). Number of the protein – PtdCho contacts in the systems (as 
described in Table 3.1): 3 – black, 4 – red (A), 1 – black, 2 – red (B); and number of protein – 
PtdIns contacts in the systems: 2 – red, 4 – black (C). Distance between C-alpha atoms of 
Ser30-Glu41 residues in time in the systems 1 – black, 2 – blue, 3 – green, 4 – blue (D). 
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PITPα dynamics upon membrane association.  
After membrane binding, the closed PITPα molecule remained relatively inert 
throughout the remainder of the simulation. No unloading of bound PtdCho or opening of the 
lid was observed. Specific conformational motions were observed upon membrane binding 
for the open conformer, however, and it is for this reason that focus is trained on the MD of 
open PITPα. As described above, residues 25-38 were implicated in membrane binding and 
exhibited enhanced mobility in the open form. Interestingly, using the inter-atomic distance 
between residues Ser30 and Glu41 as ruler for pocket closure, that distance decreased 
dramatically after 700 ns of simulation to the point that the inter-atomic Ser30-Glu41 distance 
approached that observed in the closed conformer (Figure 3.4A, B; Figure 3.3D). The lipid 
exchange loop was also inserted into the cytoplasmic leaflet of the bilayer at this time where 
it underwent a transition from a turn to a 310-helix, and adopted a more extended 
conformation according to RMSF calculations (Figure 3.1B) and visual inspection (Figure 
3.4A, B).  
Most interestingly, bilayer insertion of the lipid exchange loop and the partial closure 
of the hydrophobic pocket initiated at 700 ns coincided with partial loading of a single DOPC 
molecule into the pocket opening (Figure 3.4C, D). We interpret the simulation data to 
conceptualize engagement of the lipid exchange loop with one DOPC molecule with the 
result that the engaged DOPC is extracted from the membrane bilayer and is moved towards 
the hydrophobic pocket/water interface. PITPα was unable to consolidate those movements 
into vectorial transfer of PL into the hydrophobic pocket, however. Rather, the partially 
extracted PLs either slid back into the bilayer or engaged in bobbing movements at the cavity 
opening/water interface. A rationale for this behavior is presented below. 
 The role of PITPα residues Trp203 and Trp204 in the lipid exchange cycle is unclear. 
Several studies conclude these residues are essential for lipid exchange by PITPα and 
closely-related PITPs (Tilley et al. 2004; Yadav et al. 2015), whereas other studies argue for 
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only minor roles for Trp203Trp204 in lipid-exchange (Phillips et al. 2006). The MD simulations 
reported no significant conformational transitions associated with this motif, and no obvious 
membrane insertion. These residues were the first to interact with the lipid bilayer, however, 
and the Trp203Trp204 motif maintained interactions with membrane lipids throughout the MD 
time course. The MD data suggest those Trp residues, and the residues that surround them, 
interact primarily with PtdIns (Figure 3.3C). 
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Figure 3.4. PITPα extracts lipids from the virtual membrane during simulations. 
Snapshot of the open PITPα (blue and green new cartoon representation) from the 
simulation 4 (Table 3.1) in the (A) initial (0 ns) and (B) final (1000 ns) step. Loop consisting 
of residues 25-38 depicted in red, residues Ser30 and Glu41 depicted in orange licorice 
representation, and the distance between their C-alpha atoms as a black dashed line, lipid 
exchange loop colored in green, and DOPC lipid “grabbed” by the loop in yellow licorice 
representation. Water molecules and ions not shown for clarity. Other lipids are depicted as 
brown lines. (C) Snapshot from the simulation 4 (as described in Table 3.1) of the open 
PITPα (new cartoon representation) and a PtdCho molecule (in licorice representation) 
engaged by the lipid exchange loop in the final (1000 ns) step. Other lipids shown as brown 
sticks, water molecules and ions not shown for clarity. (D) Snapshot of the open PITPα (blue 
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surface) from the simulation 4 (as described in Table 3.1) in the final (1000 ns) step. A single 
PtdCho molecule (in licorice representation) is engaged by the lipid exchange loop which 
aligns its molecular surface with the lipid acyl chain. Water molecules, ions and bilayer not 
shown for clarity.  
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Free energies of PL loading/unloading by PITPα.  
The 1 µs atomistic MD runs were of insufficient length to describe a complete PL 
loading/unloading half-cycle. Thus, suitable free-energy calculation methods were employed 
to study the energetics of PL loading/unloading by PITPα. A steered MD approach was used 
to obtain a pathway for positioning of DOPC and PtdIns within the PITPα binding pocket 
through a short pulling simulation (see Materials and Methods). Once this regime yielded a 
PL-loaded conformer, the pulling constraints imposed on PL position were released, and 
subsequent trajectories were used to extract the windows for umbrella sampling simulations. 
These umbrella sampling simulations were analyzed with by WHAM. Our selection of the 
force constant, together with the window spacing (see Materials and Methods), provided 
sufficient sampling of the configuration space along the reaction coordinate as indicated by 
the satisfactory overlap of the histograms in Figure 3.5A, B. Although each window was 
simulated for 40 ns, the obtained PMF stabilized within 10 ns of simulation – indicating the 
free energy profile converged to a stable value. We interpret this rapid convergence to reflect 
the fact that the starting structures for the umbrella sampling windows were extracted from 
unbiased trajectories. This interpretation follows previous demonstrations that the qualities of 
the starting structures for umbrella sampling have a significant impact on subsequent free 
energy profile quality (Paloncỳová et al. 2012). 
Because the exchange cycle occurs efficiently with purified PITPα and pure 
liposomes, and without any ATP requirement, the activation energy for PL loading/unloading 
must be sufficiently low to be overcome by thermal fluctuations. Indeed, during the ensuing 
MD (150 and 240 ns for the systems with DOPC and PtdIns, respectively), bound PL was 
unloaded from the binding pocket and released into the bilayer (Figure 3.6). The PL 
unloading took place without any externally applied pulling forces. Taking advantage of these 
well-equilibrated starting configurations, umbrella sampling simulations were extracted from 
the unloading trajectories and the free energies related to PITPα interaction with DOPC and 
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PtdIns were calculated. The free energy profiles for both PLs as a function of the distance 
along the bilayer normal are presented in Figure 3.7A. Those profiles confirmed that PL 
loading into PITPα occurs within the realm of thermal fluctuation. The free energy of DOPC 
uptake by PITPα was ~ 20 kJ mol-1 (8 kBT) -- as calculated from the bottom of the global 
minimum to the maximum peak at 3 nm (Figure 3.7A). In the absence of PITPα the values for 
DOPC and PtdIns desorption from the membrane bilayer were 90 kJ mol-1 and 120 kJ mol-1, 
respectively (Table 3.4). The dramatic differences in the free energies of PL desorption in the 
presence vs absence of PITPα emphasize the remarkable role the protein plays in lowering 
the activation energy for that critical step. 
 For both DOPC and PtdIns, the free energy profiles identified two distinct minima. The 
first, at 1.5 nm, corresponded to the state where the PL was at equilibrium in the bilayer. The 
second was located in the membrane-distal region of the PL-binding cavity where the PL 
headgroups are coordinated by appropriate PITPα residues and the fatty acyl chains are 
incorporated into the most hydrophobic regions of the cavity. Unexpectedly, the free energies 
of loading for both PLs were similar – suggesting the affinity of PITPα for PtdIns in the initial 
loading stage(s) was not appreciably higher than PITPα’s affinity for PtdCho. This was a 
surprising outcome given reports that PITPα has a 16-fold higher affinity for PtdIns than for 
PtdCho (Helmkamp et al. 1974; Wirtz et al. 1991). Another remarkable feature of the 
calculated free energy profiles was that the minima at ~3.5 nm were very shallow. This 
property accounts for why PL molecules that had partially loaded, or were otherwise steered, 
into the PITPα pocket were spontaneously and efficiently released into the bilayer via a 
reverse unloading reaction during simulation – the energy barrier for unloading of bound PL 
is low. 
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Figure 3.5. The simulations are stable. Overlap of the umbrella sampling histograms from 
the umbrella sampling simulations of the PtdCho (A) and PtdIns (B) release from the protein 
to the bilayer. Horizontal axis describes the distance along the membrane normal, where 
zero is the center of the lipid bilayer. The vertical axis shows the occurrence of given 
configuration, i.e. umbrella window (colored lines). The sampling of configurations was 
increased corresponding to 2.75-3.3 nm in the (A) and 3.0-3.4 nm in (B) to ensure sufficient 
overlap in those initially inadequately sampled regions of the free energy curve. 
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Figure 3.6. Trajectory of lipids out of the PITP binding pocket. Snapshots of the lipid 
unloading after the release of pulling force on the lipid (highlighted in bright green) in the 
steered MD simulation. Individual panels correspond to: ~0 ns (A), ~75 ns (B), ~100 ns (C), 
and ~150 ns (D) after the release of pulling force. Lipids are shown in licorice and PITPα in 
new cartoon representation. Water molecules and ions not shown for clarity.  
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Figure 3.7. Hydrogen bonds stabilize the lipid during its trajectory through the PITP. 
(A) Top: Snapshot from one of the umbrella sampling simulations windows showing PtdCho 
(green VdW spheres) being unloaded back into the membrane by PITPα (new cartoon 
representation). Vertical axis represents the reaction coordinate ζ (nm) where ζ = 0 nm 
corresponds to the midplane of the lipid bilayer, ζ = 2 nm and ζ = 4 nm correspond to the 
membrane-water interface and the upper part of the binding pocket, respectively. The 
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horizontal gray helplines define the borderlines for lipid movement. The same lines depicted 
vertically on the bottom panel figure presents the free energy profiles for PtdCho (red) and 
PtdIns (blue) uptake/unload. (B) Top: PITPα and amino acid residues that form H-bonds with 
PtdCho and/or PtdIns. Residue projected to interact only with PtdCho is depicted in red 
(Lys68), only with PtdIns in yellow (Lys61, Glu86, Asn90, Thr114, Glu218), and in green residues 
that form H-bonds with both ligands (Tyr18, Gln22, Ser25, Tyr63, Asn101, Lys195, Gln217). Bottom: 
Average number of H-bonds interactions between PITPα and PtdCho (red) and PtdIns (blue), 
as indicated, as a function of time. Profiles are calculated as a function of the umbrella 
window which has been translated into the reaction coordinate ζ (nm). 
 
  Table 3.4. Free energies for the lipid desorption process. 
Pulled lipid PITP DOPC PI Free energy 
DOPC - 192 0 90 kJ/mol 
PI - 191 1 120 kJ/mol 
DOPC 1 (1KCM – open) 192 0 20 kJ/mol 
PI 1 (1KCM – open) 191 1 25 kJ/mol 
 
 
PITPα-PL interactions within the hydrophobic pocket.  
Lipid-protein H-bond interactions within the PITPα hydrophobic pocket are likely 
required for serial consolidation of the loading reaction so that vectoriality is imposed on this 
process which culminates in a complete loading reaction (i.e. rather than a reversible and 
futile partial loading reaction that we observed in the 1 µs MD). Indeed, both DOPC and 
PtdIns engaged in H-bonding within the PITPα binding pocket, and the highest peaks in 
average H-bond interaction coincided with minima in the free energy profiles (Figure 3.7A, 
B). Those results argue that H-bond interactions make critical contributions to the free energy 
landscapes of the DOPC and PtdIns loading/unloading reactions. 
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All pocket residues involved in H-bonding with DOPC and PtdIns are highlighted in 
Figure 3.7B. The unloading MD runs made the novel forecast that Lys68 interacts specifically 
with PtdCho, whereas Thr59, Lys61, Glu86, Asn90, Thr114, and Glu218 interact specifically with 
PtdIns. Satisfyingly, the former four residues were known from previous studies to engage 
PtdIns specifically (Alb et al. 1995; Tilley et al. 2004), while the latter two interactions 
represent new insights. Tyr18, Gln22, Ser25, Tyr63, Asn101, Lys195, and Gln217 formed H-bonds 
with both DOPC and PtdIns, and these residues had not previously been implicated in the 
PL-exchange cycle. The strong single H-bond interaction of Lys68 with DOPC is particularly 
noteworthy as it was observed early in the loading reaction sequence (Figure 3.8A) – 
suggesting this previously unsuspected interaction plays a role in the extraction process. 
PtdIns did not interact with PITPα residue Lys68. Rather, it formed two H-bonds with Glu218 -- 
another residue previously not suspected to play any role in lipid exchange (Figure 3.8B). 
The MD projected that interactions of DOPC and PtdIns with Lys68 and Glu218, respectively, 
defined the major contribution to peaks in the average H-bond plot at ~2.3 nm (Figure 3.7B). 
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Figure 3.8. PITPα interacts specifically with PtdIns and PtdCho. Snapshots of PtdCho 
interacting with the residue Lys68 (A) and PtdIns interacting with the residue Glu218 (B) during 
the umbrella sampling simulation. Residues Lys68, Glu218 and the respective phospholipids 
are shown as VdW spheres. PITPα is rendered in new cartoon representation. 
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Functional analyses of Ser25 in PITPα activity.  
A series of functional analyses were performed to test basic predictions of the MD 
data. Residues 25-38 define a conformationally flexible region predicted to be involved in 
membrane binding, and the boundary residue Ser25 is projected to be involved in H-bonding 
to DOPC and PtdIns within the PITPα hydrophobic pocket. To assess the importance of 
Ser25 to PITPα function, this residue was altered to Phe, Ala, Cys, Glu, Lys, and Thr. The 
mutant proteins were subsequently analyzed in in vivo and in vitro functional assays.  
 High-level expression of PITPα in yeast is sufficient to effect phenotypic rescue of the 
growth and membrane trafficking defects associated with temperature-sensitive mutations in 
the yeast SEC14 gene (Skinner et al. 1993), and this system enables a general assessment 
of whether a mutant PITPα is functional or not. Expression of PITPαS25A, PITPαS25C and 
PITPαS25T rescued sec14-1ts-associated growth defects at the restrictive temperature of 37°C 
nearly as efficiently as observed for PITPα (Figure 3.9A). By contrast, PITPαS25E was only 
partially functional in this assay whereas PITPαS25F and PITPαS25K scored as completely 
defective. Consistent with the in vivo results, purified recombinant PITPαS25F and PITPαS25K 
were also completely inactive for PtdIns and PtdCho-transfer in vitro in end-point assays 
using radiolabeled phospholipid substrates and a single clamped protein concentration 
(Figure 3.9B). Thus, while some substitutions are tolerated for Ser25, these do not correlate 
with H-bonding capacity (e.g. S25A scores as active). Rather, functionality correlated closely 
with the accessible surface area of the residue at that position. Residues compatible with 
efficient function (Ser, Ala, Cys and Thr) have small accessible surface areas (80Å2, 67Å2, 
104Å2, 102Å2, respectively), those that support partial function have larger values (Glu, 
138Å2), and residues not tolerated at position 25 have the largest side chains (Phe and Lys – 
accessible surface areas of 175Å2, 167Å2, respectively). 
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Figure 3.9. Functional consequences of missense substitutions for PITPα residue 
Ser25. (A) Phenotypic rescue assays. Top panel: isogenic SEC14 (CTY182) and sec14-1ts 
(CTY1-1A) strains served as positive and negative controls for PITP activity, respectively. 
The latter strain fails to grow at 37°C because activity of the major PITP is inactivated at that 
temperature (Bankaitis et al. 1989). Bottom panel: Isogenic sec14-1ts yeast strains carrying 
expression cassettes for RnPITPNA, or versions carrying the indicated substitutions for 
residue Ser25, integrated at the LEU2 locus, were spotted in 10-fold dilution series onto YPD 
agar plates and incubated at either permissive temperature of 30°C or restrictive temperature 
of 37°C for 48 hours. (B) Endpoint PtdIns and PtdCho transfer assays. Purified recombinant 
PITPα and indicated missense mutants (10µg protein per assay) were assayed for [3H]-
PtdIns and [14C]-PtdCho transfer, as indicated. Transfer efficiencies of PITPα were set at 
100% (n=3), and transfer of mutant PITPα proteins are normalized relative to PITPα activity 
values obtained from the same experiments. Assay efficiencies and backgrounds for these 
experiments are summarized in Table 3.5 and Table 3.6. 
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Table 3.5. Intrinsic PtdIns-transfer activities for mutant PITPα derivatives (cpm). 
Mutant % Transfer/Totals 
Total Input 
[3H]PtdIns 
Background 
PITPα 7-18% 8600-17400 190-870 
S25E -0.18-0.006% 8600-9100 190-350 
S25K -0.12-0.22% 8600-9100 190-350 
K68E 1.3-2.2% 8600-17400 190-870 
K68Q 5.6-6.9% 9000-17400 400-870 
E218A 8.8-14.4% 9000-14710 400-870 
E248K 0.3%-0.56% 14700-17400 540-870 
K248A 1.7-2.4% 11600-13290 570-780 
E248T 0.88%-1.8% 8900-13300 400-570 
M241T 33.2-57.8% 11600-13290 570-780 
 
  
Table 3.6. Intrinsic PtdCho-transfer activities for mutant PITPα derivatives (cpm). 
Mutant % Transfer/Totals 
Total Input 
[3H]PtdIns 
Background 
PITPα 9-30% 12550-19290 815-2600 
S25E -2.0-(-0.52)% 12550-19290 815-2460 
S25K 0.01% 16500 815 
K68E 5.7-9.8% 12550-14640 2460-2600 
K68Q 16-21% 16500-19290 815-1120 
E218A 12-22% 16500-19290 815-1140 
E248K 11-18% 7060-12550 925-2460 
E248A 17-30% 18140-18690 1140-1760 
E248T 17-29% 7060-12650 925-2460 
M241T 109-118% 12650-18140 1305-1760 
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Functional analyses of Lys195 in PtdIns and PtdCho-transfer and binding.  
Lys195 was identified in the MDS as a major contributor to the hydrogen bond-mediated 
stabilization of either PtdIns or PtdCho with PITPα (Figure 3.7). Lys195 occurs on the beta 
sheet that forms the lipid binding cavity of PITPα (Figure 3.10A), as such the residue is likely 
to interact with either lipid only once the lipid is fully extracted from the membrane. Analysis 
of the crystal structures of PtdIns or PtdCho bound PITPα reveals that the distance between 
Lys195 and the phosphate moiety of PtdIns is 2.3Å, and 2.7Å for PtdCho. As the average 
length of a hydrogen bond is between 1.5-2.5Å, these distances are consistent with a role for 
Lys195 with the stabilization of either lipid during binding within the PITP hydrophobic pocket. 
To test this prediction, we purified PITPαK195C and used real-time de-quenching approaches 
to measure PtdCho- and PtdIns-transfer rates and efficiencies of PtdCho- and PtdIns-binding 
(Figure 3.10B, C). In these assays, transfer is recorded as enhanced fluorescence of pyrene-
labeled phospholipid as it is mobilized from quencher-loaded donor vesicles to quencher-free 
acceptor vesicles, whereas binding is measured by shielding of pyrene-phospholipid from 
quencher by the PITP (see Materials and Methods). PITPαK195C was unable to bind or 
transfer either PtdIns (Figure 3.10B) or PtdCho (Figure 3.10C). This data supports the MD 
prediction that Lys159 stabilizes the binding of both ligands in the PITPα hydrophobic pocket 
through H-bond contributions.  
 
Functional analyses of Lys68 in PtdCho-transfer and binding.  
Lys68 is projected to engage in a significant H-bond interaction with DOPC early in the 
PITP loading reaction. Moreover, this is scored as a specific interaction as PtdIns is not 
projected to interact with Lys68. Analysis of various substitutions at this position did not 
support an essential role for Lys68 in PITPα activity, however. In the phenotypic rescue assay 
PITPαK68A, PITPαK68C, and PITPαK68Q scored as functional. By contrast, PITPαK68E and 
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PITPαK68R expression supported only diminished efficiencies of phenotypic rescue of sec14-
1ts–associated growth defects (Figure 3.11A).  
The biochemical properties of purified PITPαK68E were further examined in the end-
point PtdCho and PtdIns transfer assays and, as expected, PITPαK68E showed diminished 
PL-transfer activity (Figure 3.11B). However, whereas PITPαK68E showed a ~70% reduction 
in PtdCho-transfer activity, the mutant PITP was also strongly defective in PtdIns-transfer. In 
the real-time pyrene-label experimental systems, PITPαK68E again showed significantly 
reduced initial rates of PtdCho- and PtdIns-transfer and binding (Figures 3.11C, D). These 
collective data reported that Lys68 plays an important role in optimizing PtdCho- and the 
PtdIns-binding reactions. 
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Figure 3.10. Functional consequences of missense substitutions for PITPα residue 
Lys195. (A) The lipid-binding pocket of PITPα bound to PtdIns (left panel, PDB1UW5) or PITPα 
bound to PtdCho (right panel, PDB1T27) are shown with Lys195 highlighted. (B) Kinetic analyses 
of rates of PtdIns and PtdCho transfer. Purified recombinant PITPα and mutants were assayed 
using PyrPtdIns or PyrPtdCho transfer activity as indicated. Fluorescence intensities of 
PyrPtdIns or PyrPtdCho are plotted as a function of time. Black arrows mark addition of 1μg 
increment of the indicated protein. Following protein addition, the observed increase in 
fluorescence intensity was directly proportional to the relative transfer efficiency of the protein 
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being assayed. The initial slope after each addition was calculated to obtain relative transfer 
efficiencies (Table 3.7). Error bars were calculated from two independent determinations. (C) 
PtdIns and PtdCho binding assays. Recombinant PITPα and PITPαK195C were assayed for 
PyrPtdIns or PyrPtdCho binding as indicated. Fluorescence intensity of pyrene-PtdIns or 
pyrene-PtdCho is plotted as a function of protein amount (nmol) and the slope value for each 
protein was calculated to obtain relative binding efficiencies. Error bars were determined from 
two independent determinations. PITPαK195C was tested on a different fluorometer than the rest 
of the mutants, as such the fluorescence intensities depicted in this figure cannot be compared 
against mutants of other residues, but can be compared to the WT PITPα depicted within this 
experimental set. 
 
 
Table 3.7.  Activity is expressed as % of WT PITPα. 
 PtdIns Binding PtdIns Transfer PtdCho Binding PtdCho Transfer 
Protein Slope Activity Slope Activity Slope Activity Slope Activity 
PITPαK68E 1430 13.76 0.895 8.59 619 22.55 1.299 36.48 
PITPαE218A 4741 45.62 6.149 59.04 1416 51.60 3.489 97.98 
PITPαE248T 601 5.79 1.753 16.84 884 32.22 2.817 79.11 
PITPαE248A 1193 11.48 1.036 9.94 2082 75.83 3.736 104.91 
PITPαE248K 828 7.96 0.496 4.76 1166 42.49 1.847 51.88 
*PITPαK195C 15854 9.01 13.02 2.05 9615 13.94 18.23 4.12 
 
* PITPαK195C was tested on a different fluorometer than the rest of the mutants, as such the 
slope cannot be compared. The activity is normalized to WT PITPα tested during the same 
experiment. 
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Figure 3.11. Functional consequences of missense substitutions for PITPα residue 
Lys68. (A) Details of the phenotypic rescue assays for mutant PITPα versions carrying the 
indicated substitutions for Lys68, and the organization of this Figure, are described in the 
legend to Figure 3.9A. (B) Endpoint PtdIns and PtdCho transfer assays of purified 
recombinant PITPα and indicated missense mutants. Experimental details and organization 
of the Figure are described in the legend to Figure 3.9B. Assay efficiencies and backgrounds 
for these experiments are summarized in Table 3.5 and Table 3.6. (C) Rates of PyrPtdIns 
and PyrPtdCho-transfer (C), and efficiencies of PyrPtdIns and PyrPtdCho-binding (D) were 
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measured for the indicated PITPαK68E protein. Experimental details and organization of 
Figures is as described in Figures 3.10C and 3.10D, respectively. 
 
Functional analyses of Glu218 in PtdIns-transfer and binding.  
The MD studies identify residues Thr114 and Glu218 as interacting specifically with 
PtdIns, and the Glu218 is projected to be of particular significance given that it forms two H-
bonds with PtdIns. Analyses of Thr114 substitution mutants proved fruitless as the mutants 
were completely destabilized when expressed in yeast, and we were unable to recover 
recombinant mutant proteins from crude bacterial cytosol. In every case, the mutant proteins 
were quantitatively incorporated into inclusion bodies. Thus, our analyses focused on Glu218. 
In the phenotypic rescue assay PITPαE218A, PITPαE218D, and PITPαE218K scored as functional 
(Figure 3.11A). Both end-point and real-time PtdIns- and PtdCho-transfer de-quenching 
assays showed PITPαE218A was not significantly compromised for either PtdIns- or PtdCho-
transfer activity (Figures 3.12B, C). However, the mutant protein was defective in both 
PtdIns- and PtdCho-binding (Figure 3.12D). 
 
 
113 
 
 
Figure 3.12. Functional consequences of missense substitutions for PITPα residue 
Glu218. (A) Details of the phenotypic rescue assays for mutant PITPα versions carrying the 
indicated substitutions for Glu218, and the organization of this Figure, are described in the 
legend to Figure 3.9A. (B) Endpoint PtdIns and PtdCho transfer assays of purified 
recombinant PITPα and indicated missense mutants. Experimental details and organization 
of the Figure are described in the legend to Figure 3.9B. Assay efficiencies and backgrounds 
for these experiments are summarized in Table 3.5 and Table 3.6. Rates of PyrPtdIns and 
PyrPtdCho-transfer (C), and efficiencies of PyrPtdIns and PyrPtdCho-binding (D) were 
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measured for the indicated Glu218 substitution mutants. Experimental details and organization 
of Figures is as described in Figures 3.10C and 3.10D, respectively. 
 
Glu248 executes specific functions in PtdIns-transfer and binding.  
Although the MD simulations did not accurately predict Lys68 and Glu218 as residues 
that interact with PtdCho and PtdIns with absolute specificity, respectively, E248 was identified 
during the course of this study as a residue that showed strong selectivity for PtdIns-transfer 
and PtdIns-binding relative to PtdCho. In the phenotypic rescue assay, only PITPαE248D 
showed activity while PITPαE248K, PITPαE248A, and PITPαE248T all scored as strongly defective 
(Figure 3.13A). The defects from the rescue assay were recapitulated in end-point and real-
time PtdIns-transfer assays – even though these mutant proteins retained the ability to 
transfer/bind PtdCho (Figures 3.13B, C). Congruent results were obtained from real-time 
binding assays where PITPαE248A and PITPαE248K showed no measurable PtdIns-binding 
activity in the time-course of the assay (Figure 3.13D). The binding defects were not as 
specific as the transfer defects.  Both mutant proteins showed significant, albeit reduced, 
PtdCho-binding activity when compared to PITPα. Those data suggest that the binding 
reaction, at least as measured by the de-quenching assay, is not the rate-limiting step in PL-
exchange. 
It’s unlikely that Glu248 interacts with PtdIns when the lipid is fully bound in the PITP 
hydrophobic cavity due to the large distance between the C-terminal helix and the bound lipid 
(Figure 3.14A). A simple model posits that Glu248 H-bonds with the PtdIns headgroup while 
the lipid is in transition in or out of the PITP cavity; however, the MD does not predict a 
hydrogen bonding role for Glu248 with PtdIns, or in fact, any of the C-terminal helix with either 
lipid. There are two alternative non-mutually exclusive explanations: (1) the contribution of 
placing PtdIns into the lipid binding pocket by Glu248 is repulsive rather than attractive, and/or 
(2) Glu248 cooperates with other residues to exert its effect on PtdIns binding. Repulsive 
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contributions are not scored by the MD, and a cumulitive effect coordinated by a network of 
residues may be too complex to predict. Indeed, a polarity flip mutation of another residue on 
the C-terminal helix, Met241Thr, also results in a PtdIns-specific transfer defect (Figure 
3.14B). Like Glu248, M241 also faces into the hydrophobic cavity (Figure 3.14A).  
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Figure 3.13. PtdIns-selective defects associated with missense substitutions for PITPα 
residue Glu248. (A) Details of the phenotypic rescue assays for mutant PITPαs carrying the 
indicated substitutions for Glu248, and the organization of this Figure, are described in the 
legend to Figure 3.9A.  (B) Endpoint PtdIns and PtdCho transfer assays of purified 
recombinant PITPα and indicated missense mutants. Experimental details and organization 
of the Figure are described in the legend to Figure 3.9B. Assay efficiencies and backgrounds 
for these experiments are summarized in Table 3.5 and Table 3.6. Rates of PyrPtdIns and 
PyrPtdCho-transfer (C), and efficiencies of PyrPtdIns and PyrPtdCho-binding (D) were 
measured for the indicated Glu248 substitution mutants. Experimental details and organization 
of Figures are as described in Figures 3.10C and 3.10D, respectively.  
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Figure 3.14. PtdIns-selective defect associated with PITPα Met241Thr mutation. (A) 
Close-up of the crystal structure of PtdIns-bound PITPα (PDB 1UW5) as viewed from behind 
the beta sheet floor, which has been made transparent. Four residues on the C-terminal helix 
are shown in molecular detail and labeled. (B) Endpoint PtdIns and PtdCho transfer assays 
of purified recombinant PITPα and PITPαM241T. Experimental details and organization of the 
Figure are described in the legend to Figure 3.9B. Assay efficiencies and backgrounds for 
these experiments are summarized in Table 3.5 and Table 3.6.  
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Discussion 
The PL-exchange cycles of PITPs are essential to their critical functions in stimulating 
the activities of PtdIns 4-OH kinases for biologically sufficient production of 
phosphoinositides (Bankaitis et al. 2010). The basic form of this cycle, however, is not at all 
understood for any PITP. Herein, we describe a series of unrestrained MD simulations of 
mammalian PITPα binding to membrane surfaces to model the ensuing protein and PL 
dynamics involved in the initial stages of PL-exchange by this PITP. As the MD simulations 
focused primarily on the results obtained using a starting structure that represents an ‘open’ 
conformer of PITPα, the data most likely model interfacial processes associated with the 
initial steps in the reloading of PITPα with PL after having ejected a previously bound PL 
molecule. Moreover, the MD supported the first calculations of the free energy landscape of 
PtdIns and PtdCho exchange by the mammalian PITPα. Taken together, these studies report 
new atomistic insights into the initial stages of PL-exchange by PITPα, describe specific H-
bonding interactions between PL and protein within the PITPα hydrophobic pocket, and 
provide the first clues as to how PITPs lower the activation energy of PL desorption from the 
membrane bilayer. 
 
PITPα binding to membrane surfaces.   
Both the ‘closed’ and the ‘open’ PITPα conformers spontaneously bound membrane 
surfaces in equilibrium MD simulations, and the binding events were stable and occurred in 
the course of relatively short timescales (~200 ns). Membrane binding had three 
components. The first involved direct interactions of protein with lipid at the membrane 
surface as counted by the number of H-bonds established between protein and PL. This 
criterion identified two regions defined by residues Lys135-Lys163 and Trp204-Arg220 as 
membrane association domains. The second component was unique to the open PITPα 
conformer and involved a membrane insertion substructure (lipid exchange loop) that 
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penetrated deep into the bilayer and was defined by residues Lys68-Ala81. As described 
further below, this membrane penetration initialized the first steps of the PL-loading reaction 
of the PITP lipid exchange cycle. 
 The third component described PITPα conformational transitions that coincided with 
membrane binding/insertion events. One of these motions involved penetration of the lipid 
exchange loop (Lys68-Ala81) into the bilayer. The other involved increased conformational 
flexibility and membrane association of residues Ser25-Glu41. The importance of this region to 
PITPα biochemical and biological activity was confirmed by mutational analyses that showed 
Ser25 to be a functionally important residue where substitution with amino acids bearing large 
side-chains is incompatible with PITP activity. The mutational data are most consistent with 
Ser25 playing an important role in the conformational flexibility of this PITPα subdomain, and 
this flexibility being required for PL-exchange. 
 
Initial steps of PL-loading into apo-PITPα  
The MD predict that a consequence of lipid exchange loop insertion into a mixed 
bilayer is a partial loading of the open PITPα conformer with a single DOPC molecule at 700 
ns in the simulation. This partial extraction of DOPC from bilayer into the PITPα hydrophobic 
pocket is accompanied by a shielding of the fatty acyl chains from bulk membrane by the 
lipid exchange loop, and a partial closure of the unit that gates accessibility to the lipid 
binding pocket. Functional assays indicated amino acid substitutions in this substructure (i.e. 
substitutions for Lys68) compromise both PtdCho and PtdIns binding and exchange activities. 
Thus, the MD simulations provide the first mechanism for how the lipid exchange loop 
potentiates the early steps in the PL-exchange cycle. Indeed, it is both a reasonable and 
attractive proposition that the inserted lipid exchange loop is the first protein substructure to 
interact with a PL molecule and make it available to PITPα as a potential exchange ligand.  
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Under the simulation conditions employed, we failed to observe full incorporation of 
PL into the PITPα lipid binding pocket. Rather, the ‘chosen’ DOPC molecule ultimately slides 
back into the bilayer. Our interpretation of this behavior is that the partially loaded PL 
encounters a free energy well at this step, and that this barrier cannot be negotiated during 
1000 ns simulation windows. Complete uptake of PL into the PITPα lipid binding pocket 
requires extending simulation timescales sufficiently to allow conformational transitions that 
direct the ‘open’ PITPα from a shallow breathing conformational dynamics regime to a 
trajectory converging onto a closed conformer. Such motions are expected to consolidate the 
PL-extraction process. 
 
Free-energy landscape of PITPα interactions with lipid.  
Previous electron spin resonance studies rationalized the ATP-independence of yeast 
Sec14-driven exchange cycle as a system where a PL molecule is engaged in a simple 
partitioning between two chemically similar microenvironments -- the bilayer and, in that 
case, the PITP PL-binding cavity (Smirnova et al. 2006; Smirnova et al. 2007). The PITPα 
studies reported herein extend that overly simplistic concept. Snapshots from non-biased MD 
simulations in non-equilibrium umbrella sampling molecular dynamics simulations provide 
fundamental new insights into the characteristics of PL incorporation into the PITPα lipid 
binding cavity. First, umbrella sampling free energy calculations demonstrated that, 
consistent with the established abilities of PITPα and other PITPs to execute ATP-
independent lipid exchange reactions in the absence of any other co-factors, PITP 
dramatically lowers the free energy of PL desorption from the bilayer to within the realm of 
thermal fluctuation. This lowering of an otherwise very significant thermodynamic barrier is 
driven by specific H-bond interactions between PITPα residues and lipid headgroups. 
Second, free energy profiles for PtdIns and DOPC trajectories through the lipid binding 
pocket indicated that energy minima are shallow – thereby accounting for why PL molecules 
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that had partially loaded, or were otherwise steered, into the PITPα pocket were 
spontaneously and efficiently released into the bilayer via a reverse unloading reaction 
during simulation. This feature likely reflects the fact that no conformational transition of the 
protein from the open to the closed state was observed in the 1000 ns simulations. Such a 
conformational transition would dramatically impact the free energy landscapes and would 
also likely account for the 16-fold greater affinity of PITPα for PtdIns vs PtdCho. This 
experimentally determined difference in affinity was not at all apparent in our calculations that 
report the free energies of loading for both PLs to be similar. 
 
PITP::PL interactions during the exchange cycle.  
Umbrella sampling data of PL ‘unloading’ MD provided novel insights into which PITPα 
residues play direct roles in incorporation of PtdIns and PtdCho into the PITPα lipid binding 
pocket. These projected side-chain interactions were multiple and involved interactions both 
specific to PtdIns or PtdCho headgroups, and interactions common to both lipids. Of the set 
of identified specific interactions put to the functional test, the MD was not accurate in its 
description of headgroup-specific interactions. For example, the MD suggested a specific 
involvement of residue Lys68 in the interaction of the lipid exchange loop with DOPC, and not 
with PtdIns, while Glu218 was forecast to interact specifically with PtdIns and not PtdCho. In 
both cases, functional assays indicated amino acid substitutions at those respective positions 
affected both PtdCho and PtdIns binding and exchange activities. Nevertheless, the MD did 
accurately identify residues important for optimal lipid exchange activity whose functional 
involvement was invisible to analysis of PITPα crystal structures alone. 
 Superposition of the structural elements and residues identified in this study to play 
important roles in the PITPα PL-exchange cycle, with primary sequences of other members 
of the StART-like PITP family, lend further confidence in the veracity of the data. MD 
simulations project six residues of the PITPα lipid binding pocket interact with PtdIns 
122 
 
specifically (Thr59, Lys61, Glu86, Asn90, Thr114, Glu218) and, of those, all but Glu218 are 
absolutely conserved in evolutionarily distant members of the StART-like PITP family (Figure 
3.15). That one exception, Glu218, is invariant among evolutionarily distant Class 1 StART-like 
PITPs. MD simulations also identified seven residues of the PITPα lipid binding pocket as 
engaging both PtdIns and PtdCho in H-bond interactions (Tyr18, Gln22, Ser25, Tyr63, Asn101, 
Lys195, Gln217). Of those seven, three are absolutely invariant (Tyr18, Asn22, Lys195), one is 
invariant with a single exception involving a conserved substitution at that position (Tyr63), 
and two others are invariant from primates to flies among the Class 1 StART-like PITPs 
(Ser25, Asn101; Figure 3.10). We find this correspondence remarkable given MD simulations 
are agnostic to experiment and to primary sequence alignments.  
 
Rationale for headgroup-specific involvement for Glu248.   
The power of the MD notwithstanding, the data also clearly highlight an important need 
for genetics-based structure-function analyses of PITPα activity. This is amply demonstrated 
by the fact that PITPα residue Glu248, while not highlighted in the MD, plays an essential and 
specific role in PtdIns-exchange activity with no discernable involvement in PtdCho 
exchange. Moreover, that Glu248 is an invariant residue amongst the StART-like PITPs 
(Figure 3.15), further emphasizes its essential and conserved involvement in the activities of 
this entire family of proteins. Given our results with PITPα, we project such involvement 
reflects a specific role in PtdIns-exchange by all StART-domain PITPs. 
 At this point we cannot distinguish whether the effect of Glu248 mutations on PITPα 
PtdIns exchange activity reflect a conformational transition that occurs specifically during the 
PtdIns loading step, the unloading step, or at both steps. One interesting possibility is that 
directed motions of the Glu248 side-chain provide a ‘charge-push’ that leverages the 
incompatability of PtdIns and Glu248 electrostatics to propulsion of PtdIns into and/or out of 
the hydrophobic pocket. The observation that a mutation of another residue on the C-
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terminal helix, Met241, also exerts a PtdIns-specific defect suggests that Glu248 cooperates 
with other residues on the helix toward a PtdIns-specific function, but whether that function is 
repulsive or attractive is unknown. Importantly, these data indicate that though PtdIns and 
PtdCho bind in nearly identical space in the PITP hydrophobic cavity, at some point during 
the transfer reaction their trajectories diverge.  
 
 
 
Figure 3.15. Primary sequence alignments of selected regions of Class I and Class II 
StART-like PITPs. Sequences for Class I PITP genes were extracted from the NCBI database 
using the following protein ascension numbers: RnPITPNA (NP_058927.1), HsPITPNA 
(NP_006125.1), HsPITPNB (NP_036531.1), DmVibrator (NP_524404). Sequences for Class II 
PITP genes were extracted from NCBI as follows: HsPITPNC1 (NP_858057), HsPITPNM1 
(NP_004901.2), HsPITPNM2 (NP_065896.1). For the multi-domain PITPs HsPITPNM1 and 
HPITPNM2, only the PITP domain primary sequence is included in the alignment as guided by 
primary sequence homology to HsPITPα. Alignments were generated in VectorNTI using the 
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AlignX module set to default parameters. Indicated at bottom for purposes of reference are 
residue numbers according the RnPITPα primary sequence (initiator Met included). Color 
coding follows AlignX homology descriptors: identical residues (salmon), blocks of homology 
(grey), similar residues (orange), and nonsimilar residues (white). Residues predicted by MD to 
have PtdIns-specific interactions (*), PtdCho-specific interactions (#), and interactions with both 
PtdIns and PtdCho (+) are indicated at top. The (X) at top identifies residue Glu248 which has 
PtdIns-specific interactions that were invisible to the MD. 
 
Outstanding questions.   
While the studies reported here describe the initial steps in a pathway of conformational 
transition from an apo-PITPα to a phospholipid-bound holo-PITPα, there remain outstanding 
considerations that will impact the details in important ways. First, the most productive MD 
involved a membrane-docked PITPα conformer. At this point, we do not precisely know how PL-
unloading is spatially or temporally related to PL-loading. That is, are these concerted 
processes, or are these separable reactions that proceed through an apo-PITPα intermediate? 
While soluble probe accessibility experiments argue against the latter mode (our unpublished 
data), the MD data reported here do not explicitly consider concerted PL-loading/unloading 
exchange mechanisms. Whether the PL-loading and unloading reactions are perfectly 
symmetrical processes also remains to be determined, and such symmetry is unlikely if these 
are concerted reactions. Those open questions notwithstanding, the satisfying congruence of 
the MD data with the results of functional assays lend confidence that atomistic details of the 
PITPα PL-exchange reaction reported herein describe a reasonable approximation of the initial 
stages of this key biological reaction. Capitalizing on the membrane-docked apo- and holo-
PITPα models described in this report as starting structures in more extended MD production 
runs now define promising approaches for extracting new and fundamental atomistic details of 
the PITP lipid-exchange cycle. 
125 
 
CHAPTER 4: START PITPS REGULATE SIGNALING FROM LATE SECRETORY 
MEMBRANES IN EUKARYOTES 
 
Introduction 
START PITPs were historically considered proteins of higher order eukaryotes as they 
are entirely absent from S.cerevisae and largely absent from plants (Phillips et al. 2006). With 
the genome sequencing of other ancient eukaryotes, such as members of Alveolata and 
Diplomonadi, it is now clear that START PITPs are far more ancient than previously believed. 
Furthermore, functional studies of PITP genes reveal the importance of these molecules in a 
range of developmental and cellular processes (Nile et al. 2010). A theme emerging from the 
study of Sec14 proteins is that PITPs regulate specific phosphoinositide pools, and at least in 
some cases do so a highly localized way, creating membrane signaling “pixels” (Schaaf et al. 
2008; Bankaitis et al. 2010; Ghosh et al. 2015). In the first half of this chapter, we consider this 
concept in a review of START PITP signaling on secretory membranes. In the second half of the 
chapter, we will assess what we know about the Toxoplasma START PITP PIMP and its role in 
late secretory signaling from the dense granules. 
 
Physiology of START PITPs 
Loss of function studies of START PITPs from various eukaryotes reveal interesting 
roles for these proteins in development and physiology. The mammalian Class I PITPs are 
homologous to PITPα, and Class II PITPs are most similar to Drosophila RdgBα (Cockcroft and 
Garner 2011). An emerging theme, though not one without exception, is that when the 
physiology of START PITPs is queried in the context of a multi-cellular organism, often the  
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observed defects are associated with neuronal or sensory pathways. PITPα nullizygocity in mice 
results in spinocerebellar disease, in addition to intestinal and hepatic steatosis (Alb et al. 2003). 
The zebrafish PITPβ ortholog is not required for development, but knockdown of this PITP 
results in defective photoreceptor outer segment biogenesis and maintenance in double cone 
photoreceptor cells (Ile et al. 2010). The founding member of Class II PITPs, the Drosophila 
RdgBα (for retinal degeneration B mutant), is required for maintenance of photoreceptor cells in 
the fly retina (Harris and Stark 1977; Milligan et al. 1997). The C.elegens RdgBα ortholog, PITP-
1 is required for chemoattraction mediated by sensory neurons (Iwata et al. 2011). Do these 
neuronal and sensory pathologies occur because PITPs are required to maintain the high PIP 
demand of these systems? Or are the defects subtler, reflecting a disorganization of signaling 
molecules in membranes that most require efficiency? We don’t know, but the question is 
related to how we view PITP mechanism.  
 
Mechanisms of START PITPs 
PITPs transfer PtdIns between membranes in vitro in exchange for a second lipid ligand. 
How do we interpret this activity in cellular context? PITPs regulate specific PIP pools, and at 
least in some cases do so in a highly localized way, creating membrane signaling “pixels”. We 
work within two conceptual models for PITP mechanism. 
 The transporter or supply model posits that the main function of PITPs is to maintain 
supply of specific lipids to signaling or metabolic membranes. This mechanism is often invoked 
in discussion of the PtdIns(4,5)P2 cycle described in detail in Chapter 1 (Figure 1.2), which 
presents an important spatial problem (Michell 1975). Briefly, receptor signaling reactions at the 
plasma membrane activate PLC, which hydrolyzes PtdIns(4,5)P2 to DAG and IP3. In order to 
replenish these PtdIns(4,5)P2 pools for future reactions, plasma membrane PtdIns 4-OH kinases 
must be supplied with PtdIns (Michell 1975). PtdIns is synthesized at the ER, and a mechanism 
must exist to transport it to the plasma membrane. PITPs are historically considered to fulfill this 
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role (Van Paridon et al. 1987). The opposing model, the nanoreactor or instructive regulation 
model, was first described for the yeast Sec14 (Schaaf et al. 2008; Ile et al. 2006). In this 
mechanism, the main function of a PITP is extraction of a lipid from a membrane, not transport. 
During extraction, the lipid becomes accessible to a PtdIns 4-OH kinase for phosphorylation. 
This lipid “presentation” activates the kinase. PITP-mediated instructive regulation of PtdIns 
kinases is discussed in more detail in Chapter 1.  
The functions of START PITPs are often interpreted in the context of the supply model, 
though most of the available data are consistent with either mechanism. In this chapter, we will 
focus on the cellular functions of specific PITPs and how these can be interpreted in the context 
of the available functional models, and how this might contribute to the maintenance of PIP 
pools or their organization. 
 
Determinants of biological specificity in START-like PITPs 
With the high sequence identity between START PITPs within and between the two 
classes, and their common PtdIns-binding activity, what specifies the biological role of these 
proteins? And how would such characteristics feed into the models of PITP function? There are 
likely multiple factors, but we will focus on two major ones: (1) in all known cases, the PITP 
domain of START PITPs is on the N-terminus, and the C-termini may be diversified either by 
transcriptional regulation or by genetic coupling to additional domains; (2) while all PITPs bind 
and transfer PtdIns between membranes in vitro, the identities of the counter-ligand vary and 
contribute to cellular function. We will discuss these points in this section before reviewing how 
PITPs function in the late secretory pathway. 
 
Diversity in C-termini 
One of the most striking differences between PITP members is the length and 
composition of the C-terminus (Figure 1.5, Chapter 1). These regions are diversified either by 
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transcriptional regulation or by genetic coupling to other domains, and this contributes to cellular 
function. PITPβ is spliced into “canonical” and “alternative” splice variants that differ in their C-
termini, a pattern recapitulated in the transcript processing of PITPγ: a PITPβ-like Class I PITP 
unique to Zebrafish (Ile et al. 2010). For these two genes, it’s not clear what contribution splicing 
makes to regulation of the PITP. A direct role for regulation of protein function by splice variants 
has been shown for PITPnc1 (Garner et al. 2012). The C-terminus of PITPnc1 is spliced in two 
splice variants (Garner et al. 2012). This region contains a PEST (proline, glutamic acid, serine, 
threonine) sequence that promotes the turnover of the full-length protein. The PEST sequence 
is absent in the shorter splice variant of PITPnc1 (Garner et al. 2012). This is a good indication 
that transcriptional variants of PITPs are regulated differently. As such, future experiments must 
be careful to differentiate between the two isoforms. 
The multi-domain Class II PITPs contain N-terminal PITP domains with ~40% homology 
to Class I PITPs (Chang et al. 1997; Lu et al. 1999, Fullwood et al. 1999 Garner et al. 2012). In 
addition, they contain several unique domains, including a hydrophobic region that associates 
with membranes (Elagin et al. 2000), a FFAT motif that anchors PITPnm1 to the ER (Kim et al. 
2015), an LNS2 domain that binds PtdOH (Kim et al. 2013), and a DDHD domain of unknown 
function. The C-termini of Class II proteins also interact with the protein tyrosine kinase PYK2, a 
protein involved in signaling from cell surface receptors (Lev et al. 1999; Verma et al. 2015). As 
discussed in Chapter 2, the Toxoplasma PIMP links multiple domains associated with PtdIns4P 
signaling. Although the identity of the linked domains is novel, such a coupling strategy is 
commonly utilized by PITPs.  
Indicative of the C-terminal domains’ importance for at least some family members, the 
PITP domain of PITPnm1 is required for its role in Golgi trafficking, but it is not sufficient (Litvak 
et al. 2005). On the contrary, the PITP domain of C.elegens PITP-1 is both necessary and 
sufficient for performing the function of the full-length protein in chemosensory attraction and 
plasticity to extracellular cues (Iwata et al. 2011). These data suggest that the C-terminal 
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domains of PITPs may be important in some contexts but dispensable in others. Defects in 
human PITPNM3 (a homolog of PITPnm1 and PITPnm2 that lacks the entire PITP domain), 
result in an autosomal dominant retinal dystrophy called CORD5 wherein a cone photoreceptor 
dysfunction eventually leads to blindness in early adulthood (Reinis et al. 2012). This indicates 
that the non-PITP domains of PITPnm1 and PITPnm2 indeed have the capacity to participate in 
as-of-yet unidentified physiological contexts.  
The very length of the multi-domain Class II PITPs may allow them to function at 
membrane contact sites. Indeed, such a mechanism is proposed for Drosophila RdgB and 
human PITPnm1 (Lev 2012; Yadav et al. 2015; Kim et al. 2015). A membrane-associated PITP 
can still fulfill the transport/supply function if it’s part of a membrane contact site, and that is the 
mechanism postulated in these two cases. Because a key component of the nanoreactor 
mechanism is metabolic input that can then be translated to PtdIns presentation, multidomain 
PITPs are particularly suited to an instructive regulation model. We discuss the possibility of 
such a contact site role for Toxoplasma PIMP in the second half of this chapter. 
 
Ligand Specificity and Binding  
Class I PITPs use PtdCho as the counter-ligand to PtdIns. Class II PITPs are being 
increasingly recognized as PtdOH-transfer proteins, rather than PtdCho (Garner et al. 2012; 
Yadav et al. 2015; Kim et al. 2015). How does ligand specificity feed into the mechanistic 
models? The historical interpretation of PITPs as transporters dictates that PtdCho is simply an 
abundant lipid that acts as a placeholder while PITP transits back to the ER to pick up PtdIns. In 
this model, the cellular concentration of the counter-ligand is the critical consideration, rather 
than strictly the identity of the counter-ligand (Prinz 2010; Lev 2010). Why then should any PITP 
bind anything other than PtdCho? One explanation may be the second half of the PtdIns(4,5)P2 
cycle (Figure 1.2, Chapter 1). When PLC is activated by receptor stimulation, one product of 
PtdIns(4,5)P2 hydrolysis is DAG, which is converted to PtdOH at the plasma membrane. PtdOH 
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is converted back to PtdIns at the ER. A PITP that binds PtdOH is conceptually suited to 
transport this lipid from the plasma membrane back to the ER. The nanoreactor model, on the 
other hand, posits that the counter-ligand is a critical regulator of PITP function and confers 
“metabolic sensor” status onto the PITP (Ile et al. 2006). For example, Sec14 binds PtdCho as a 
proxy for DAG, which allows coincidence detection for two factors critical in vesicle biogenesis, 
DAG and PtdIns4P (Bankaitis et al. 2010). 
Though START PITPs and Sec14 PITPs share a common biochemical function, they 
belong to distinct structural families (Figure 4.1). The two families of PITPs have in common a 
globular structure with α-helices folded over a β-sheet floor (Figure 4.1A, C). Sec14 has distinct 
binding sites for the inositol or choline headgroup, wherein the PtdIns headgroup is exposed to 
solvent and the acyl chains are buried in the Sec14 cavity (Figure 4.1B, orange lipid). The 
kinetic trap model of Sec14 instructive regulation of PtdIns 4-OH kinase posits that slow egress 
of PtdCho from the Sec14 lipid binding pocket stalls PtdIns extraction from the membrane and 
allows PtdIns 4-OH kinase access to the headgroup (Schaaf et al. 2008; Bankaitis et al. 2010). 
In the START PITP structure, PtdIns and PtdCho bind in nearly identical conformations, such 
that the lipid headgroups are deep within the lipid-binding pocket (Figure 4.1D). If START PITPs 
do act in instructive regulation of PtdIns kinases, the mechanism of presentation would likely be 
unique compared to that of Sec14.  
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Figure 4.1. Comparison of the structures of Sec14 PITPs and START PITPs. (A, B) Crystal 
structures Sfh1 with (B) or without (A) bound lipids shown (PDB 3B7Z), and (C, D) PITPα (PDB 
1T27 and 1UW5) with (D) or without (C) bound lipids shown. (A, C) Both structures feature a 
large B-sheet floor (blue) onto which the lipid binds and a-helices (orange) that define the 
closing mechanism. (B, D) PtdIns is shown in orange and PtdCho is shown in blue.  
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The Cellular Roles of START-Like PITPs in Membrane Signaling  
PITPs as regulators of vesicular biogenesis 
A number of studies have suggested roles for START PITPs in secretory trafficking. 
Reconstitution of vesicle budding from the trans-Golgi network, scission of coatomer-coated 
vesicles, and cis-to-medial intra-Golgi vesicular transport in a cell-free system are all PITP-
dependent (Ohashi et al.1995; Jones et al.1998; Simon et al. 1998; Paul et al. 1998). PtdIns 
and PtdCho transfer activity of PITPβ is required for retrograde trafficking from the Golgi to the 
ER (Carvou et al. 2010). We will discuss one case of PITPs in vesicular biogenesis in particular: 
that of PITPnm1 as a regulator of DAG levels at the TGN. 
 PITPnm1 promotes membrane fission to allow vesicular biogenesis from the TGN 
(Litvak et al. 2005). Acute siRNA-mediated depletion of PITPnm1 in HeLa cells causes Golgi 
membranes to become dispersed and swollen, resulting in retention of secretory cargo in the 
trans-Golgi network and a subsequent delay of transport to the plasma membrane. Cargo 
retained in the TGN under the PITPnm1-deficient condition localizes to highly tubular 
membranes, and there is a marked decrease in intermediate carriers emerging from the Golgi.  
These trafficking defects stem from a reduction of DAG pools at the TGN (Litvak et al. 
2005). PITPnm1 is required for maintenance of the DAG pool used in the CDP-choline pathway 
for PtdCho biosynthesis, but is not involved in the sphingolipid biosynthesis pathway. The 
specificity for sensing the CDP-choline pathway is analogous to that of yeast Sec14, for which 
the PtdCho counter-ligand is derived from the CDP-choline pathway only (Bankaitis et al. 2010; 
Kearns et al. 1997; Ile and Schaaf 2006). PITPnm1 may be involved in such a coincidence 
detection mechanism for Golgi PtdIns4P and DAG, wherein in the absence of PITPnm1, Golgi 
membranes eliminate DAG by conversion to PtdCho to avoid initiation of vesicular biogenesis 
for which there is inadequate PtdIns4P co-signal. The authors excluded an effect of PITPnm1 
depletion on Golgi PtdIns4P levels due to the insensitivity of a PtdIns4P reporter (the OSBP PH-
domain) to PITPnm1 knockdown. Because there are multiple pools of PtdIns4P at the Golgi, 
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and PH domains are sensitive to these differences, analysis of a single biosensor does not 
exclude an effect of PITPnm1 depletion on Golgi PtdIns4P levels. Furthermore, PIP biosensors 
with high affinities for their substrates report only large changes in substrate concentration 
(Lemmon 2008). Decreases in PtdIns4P on Golgi membranes may be underestimated in these 
experiments.  
Truncation studies show that the PITP domain of PITPnm1 is required, but not sufficient, 
to restore cargo trafficking from the TGN in the PITPnm1-silenced condition (Litvak et a. 2005). 
Though the full length PITPnm1 restores DAG pools at the TGN, the truncation mutants were 
not tested in this context, so it remains formally possible that the PITP domain is not responsible 
for maintenance of DAG pools – that, in fact, one of the other domains is responsible for this 
effect – and the PITP domain performs a distinct as-of-yet unidentified function that is critical to 
anterograde trafficking from the TGN, perhaps contribution to phosphoinositide pools (PtdIns4P 
or otherwise) not excluded by the OSBP-PH PtdIns4P biosensor. In such a model, PITPnm1 
would be involved in instructive regulation of PtdIns4P synthesis in response to PtdOH as a 
proxy for DAG. This mechanism may be used to determine if TGN membranes in general are 
competent for trafficking, or in coincidence detection at specific sites where vesicular biogenesis 
machinery is accumulating. 
  
START PITPs in non-cell autonomous physiology 
Both PITPα and PITPnc1 have been found to promote secretion of specific soluble 
factors (Snoek et al. 1999; Kostenis 2004; Schenning et al. 2004; Bunte et al. 2006; Png et al. 
2012). We will focus on PITPnc1 as example of this function. PITPNC1 is part of the miR-126 
microRNA (miRNA) regulon involved in cancer cell metastasis (Guo et al. 2008; Feng et al. 
2010; Png et al. 2012). Silencing of miR-126 in MDA-MB-231 human breast cancer cells 
promotes recruitment of endothelial cells in a non-cell autonomous fashion, and induction of 
angiogenesis that facilitates colonization of cancer cells in sites remote from the original tumor 
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(Png et al. 2012). PITPNC1 is one gene targeted for regulation by miR-126. Knockdown of 
PITPNC1 from breast cancer cells decreases secretion of IGFBP2, insulin growth factor binding 
protein 2, which is involved in endothelial recruitment, tumor colonization and angiogenesis 
(Png et al. 2012). An extended analysis showed that PITPnc1 is involved in the secretion of 
multiple factors that might contribute to metastasis, including metalloproteases and a pro-
angiogenic growth factor (Halberg et al. 2016). Liposome binding experiments identified 
PITPnc1 as primarily a PtdIns4P binding protein, with negligible PtdIns and PtdOH binding 
capacity, and mutation analysis argued that PtdIns4P binding occurs in the lipid binding pocket. 
The proposed model posits that PITPnc1 binds PtdIns4P on Golgi membranes and, through an 
unspecified mechanism that involves association with RAB1B, increases PtdIns4P levels and 
promotes recruitment of GOLPH3, which tubulates Golgi membranes and promotes vesicular 
biogenesis (Halberg et al. 2016). These conclusions stand in contention to previous reports that 
define PtdIns and PtdOH as the primary ligands for PITPnc1 (Garner et al. 2012; Cockcroft et 
al. 2016). Furthermore, it’s unlikely that a phosphorylated inositol headgroup could be 
accommodated by the known structures of START PITPs (Figure 4.1B). Until a Class II PITP is 
crystalized, however, we can’t exclude the possibility that the lipid binding pocket of PITPnc1 
presents a more sterically favorable environment than that of the Class I proteins. The ability of 
a PITP to directly sense PdtIns4P is reminiscent of that ability in the PIMP PH domain. It’s not 
clear however, how the PITPnc1 PITP domain can itself both sense and upregulate PtdIns4P 
levels at the Golgi. The transporter model would postulate that PITPnc1 transfers PtdIns4P to 
the Golgi from another membrane.  
 
START PITPs in PtdIns(4,5)P2 signaling 
 START PITPs have been proposed to function on both sides of the PtdIns(4,5)P2 cycle: 
as transporters of PtdIns required to supply plasma membrane PtdIns(4,5)P2 pool for PLC 
substrate, and as transporters of PtdOH required to remove the downstream product of PLC 
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activation from the plasma membrane (Figure 1.2, Chapter 1). PITPα has been reported to 
function in the forward supply of PtdIns to the plasma membrane for Epidermal Growth Factor 
Receptor (EGFR) and for netrin receptor signaling (Kauffmann-Zeh et al. 1995; Xie et al. 2005). 
PITPnm1 has recently been described in the reverse cycle, where it functions at ER-plasma 
membrane contact sites to remove PtdOH following PLC activation by angiotensin receptor (Kim 
et al. 2015). We will review this case, as well as that of the worm PITP-1. 
 PITPnm1 has been identified as a component of ER-PM contact sites in human cells 
(Kim et al. 2015). The cellular system used in these experiments were HEK293T cells stably 
over-expressing angiotensin receptor (HEF293T-AT1 cells), in which the plasma membrane 
PtdIns(4,5)P2 cycle was stimulated by addition of angiotensin II (AngII). Unstimulated HEK293T-
AT1 cells knocked down for PITPnm1 have a lower basal level of PtdIns(4,5)P2, PtdIns, and 
PtdIns4P, suggesting that PITPnm1 plays a role in maintaining signaling lipid pools at basal 
conditions (Kim et al. 2015). When cells are stimulated, PITPnm1 is required for sustained 
signaling through PLC as measured by intracellular calcium as well as FRET-based biosensors 
of DAG and PtdOH. Depletion of PITPnm1 with siRNA leads to the accumulation of PtdOH, and 
these cells are unable to convert PtdOH to CDP-DAG and PtdIns.  
At steady-state, PITPnm1 localizes to the cytoplasm and the ER. Following stimulation 
of cells with AngII, PITPnm1 translocated to ER-plasma membrane contact sites, as reported by 
the contact site marker STIM1. The C-terminal regions of PITPnm1 are important for plasma 
membrane association, while the PITP domain is inhibitory (Kim et al. 2016). Considering that 
the LNS2 domain of PITPnm1 binds PtdOH (Kim et al. 2013), it’s possible that this domain 
mediates the plasma membrane interaction of full length PITPnm1 following PLC activation in 
these cells. This does not preclude the model wherein the PtdOH-transfer activity of the 
PITPnm1 PITP domain is responsible for propagation of the PtdIns(4,5)P2 cycle.  
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 PITP-1, a protein orthologous to Class II START-like PITPs, was identified in a genetic 
screen for C. elegens mutants that are defective in plasticity at the ASER gustatory neuron 
(Iwata et al. 2011). ASER is a sensory neuron responsible for sensing salt under attraction and 
avoidance conditions. C. elegens chemotaxis is dependent on prior experience, e.g. worms 
normally exhibit attractive behavior to NaCl but convert to avoidance behavior by prior-exposure 
to NaCl in a starvation environment (Saeki et al. 2001). This conditioning is reversible and 
dependent on two opposing phosphoinositide signaling cascades: (1) DAG/PKC signaling for 
attractive cues, such that high DAG levels are associated with attraction and low levels with 
avoidance, and (2) PtdIns(3,4,5)P3/PI3K signaling for plasticity and repulsive chemotaxis. 
Genetic or pharmacological activation of DAG signaling pathways results in constitutive 
attraction to salt, and mutations of the PI3K pathway eliminate plasticity (Adachi et al. 2010; 
Tomioka et al. 2006).  
The PITP-1 mutant identified in this screen, called pitp-1(pe1209), exhibits overall 
reduced attraction to NaCl and ablated plasticity in response to starvation conditioning (Iwata et 
al. 2011). PITP-1 localizes to RAB-3 positive synaptic vesicles in the axon of presynaptic 
regions in ASER, and is also localized presynaptically in AIB interneurons. Unlike with the rdgB 
mutant in Drosophila, which results in light-induced degeneration of photoreceptor cells, pitp-1 
mutations in worms did not result in degeneration of ASER when exposed to stimulatory cues 
(Harris and Stark 1977; Iwata et al. 2011). The PITP-1 PITP domain was necessary and 
sufficient to rescue the chemoattraction defects. Whether PITP-1 is capable of PtdIns transfer 
has not been tested experimentally, as such it is formally possible that PITP-1 modulates 
chemotactic signaling though some other mechanism.  
Mutations in DAG kinase suppress attraction defects in pitp-1(pe1209) worms but not 
plasticity defects (Iwata et al. 2011), suggesting that PITP-1 mediates the interface between two 
separate signaling pathways that determine attractive or repulsive responses to a specific cue: 
(1) a DAG-dependent pathway, possibly due to regulation of PtdIns(4,5)P2  pools, and (2) a 
137 
 
pathway insensitive to DAG pools (at least those subject to regulation by DAG kinase), possibly 
through PtdIns(3,4,5)P3 signals that mediate starvation responses in worms. These data 
suggest conservation of the ability of RdgBs to promote DAG signaling. Though the data were 
interpreted from the perspective that the role of PITP-1 is to provide PtdIns substrate from the 
ER to the synaptic membrane during signaling reactions, we suggest that this work fits more 
closely with the nanoreactor model. PITP-1, perhaps START-like PITPs in general, may shift 
phosphoinositide signaling between opposing pools of phosphoinositide-modifying enzymes that 
compete for substrate, such as between PLC and PI3K. Such a mechanism requires PITP-1 to 
choose a specific phosphoinositide pool to activate through direct interface with PI4K, thereby 
activating distinct membrane pixels (Figure 4.2). 
 
Summary 
 The functions of START PITPs on the cellular and multicellular levels are being 
elucidated with increasing interest. Often these roles are interpreted in light of the supply model 
of PITP function, though none of the data distinguish between this mechanism and that 
postulated by the nanoreactor model. There are several key questions that will provide insight. 
First, further molecular dynamics simulations that build on the initial steps of extraction we’ve 
described in Chapter 3 will address whether the START PITP transfer process is conducive to 
instructive regulation, i.e., is there a spatial and temporal chance for a kinase to interact with the 
PtdIns headgroup as it is being extracted from the membrane? Secondly, can we demonstrate a 
physical interaction between a PITP and a kinase? The lack of such an interaction does not 
exclude instructive regulation, but its presence argues strongly against a supply model. Finally, 
can we distinguish contributions of PITPs to specific PIP pools? This is a necessary prediction 
of instructive regulation.   
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Figure 4.2. Model of how PITP-1 might specify PIP pixels in worms. Distinct membrane 
pixels are depicted in blue or red. Both include PtdIns 4-OH kinase and PtdIns4P 5-OH kinase, 
but they are distinguished by the presence of either PLC or PtdIns(4,5)P2 3-OH kinase (PI3K). 
PITP-I chooses which PtdIns 4-OH kinase to stimulate by associating with a specific effector 
protein (blue or red star). The effect is to activate the entire pixel, which results in production of 
IP3 and DAG (PLC activation, blue) or of PtdIns(3,4,5)P3 (PIP3) (PI3K activation, red), resulting 
in distinct neuronal program: chemoattraction or plasticity, respectively. 
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Cellular Role of PIMP in Toxoplasma 
 The linkage of PITP and OSBP modules in PIMP, and the ability of the full length protein 
to recognize, and associate with, distinct PtdIns4P pools on specific secretory membranes, 
suggests that PIMP may modulate these pools to affect trafficking of dense granules. Is this 
really the case? What role does PIMP play in the Toxoplasma secretory pathway, and how does 
that contribute to parasite biology? These are outstanding questions we are currently 
addressing experimentally. In the following section, we discuss our insights so far. 
 
Regulation of PIMP signaling by coupling of the PITP and OSBP domains 
There are multiple avenues through which PIMP might receive cellular information and 
integrate it into a PIP signaling circuit. As discussed in Chapter 2, the presence of HT/PEXEL 
sequences N-terminal to the OSBP domain suggest that the linkage between the PITP and 
OSBP domains may itself be subject to regulation. Of the Apicomplexa with reliably sequenced 
genomes, Toxoplasma, Hammondia, Neospora and Eimeria PIMP orthologs encode an ORF 
where the PITP domain is coupled to an OSBP domain. In Plasmodium and Babesia it is not 
(Figure 4.3). All three organisms belong to the Class Conoidasida, while Plasmodium and 
Babesia belong to the Class Aconoidasida. The key distinction is the ability of these parasites to 
form spores: all three members of the Conoidasida belong to the Coccidia subclass, which form 
spores, while Plasmodium and Babesia are vector-borne parasites (Lau 2009). It’s possible that 
PIMP mediates a biological process related to the specific differentiation or infection cycle of 
these parasites, and that the coupling of the PITP and OSBP domains is an important 
component of this regulation. Furthermore, this pattern correlates to that seen with the unique 
insertion loops found in the PIMP PITP domain and PITP domains of PIMP orthologs in other 
Coccidia. 
The coupling and de-coupling of antagonistic domains in PIMP and its orthologs is 
reminiscent of the transcriptional regulation of a Lotus Sec14 homology gene. LjPLP-IV is the 
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Lotus ortholog of Arabidopsis AtSfh1 (Vincent et al. 2005; Ghosh et al. 2015). In plants, Sec14-
domain containing proteins are coupled to nodulin domains. Nodulins are expressed in 
leguminous plants during a developmental program that establishes a symbiotic relationship 
with N2-fixing rhizobia bacteria in the plant root hairs (Long 2001; Brewin 2002; Desbrosses et 
al. 2011; Suzaki et al. 2014). In Arabidopsis, the Sec14-homology PITP, AtSfh1, controls 
polarized membrane morphogenesis in the context of root hair development by organizing 
PtdIns(4,5)P2 patterns (Vincent et al. 2005; Ghosh et al. 2015). AtSfh1 is expressed in root 
hairs, and localizes most strongly to the root hair tip as well as discrete plasma membrane 
domains (Vincent et al. 2005). Genetic ablation of AtSfh1 results in disorganization of root hair 
PIP polarity that disrupts the cytoskeleton, vesicle trafficking, and calcium responses (Vincent et 
al. 2005).  
AtSfh1 has an N-terminal PITP domain and a C-terminal nodulin domain (Vincent et al. 
2005). The PITP domain supports synthesis of PtdIns4P. The nodulin domain, when expressed 
by itself, is a potent PtdIns(4,5)P2 sink (Vincent et al. 2005; Ghosh et al. 2015). Nodulin domain 
binding to PtdIns(4,5)P2 is required for the biological activity of AtSfh1 in the context of the full 
length protein (Ghosh et al. 2015). Thus, AtSfh1 can promote PIP synthesis via its PITP domain 
and then use the nodulin domain to arrange the PIP pools into relevant foci. Together with 
specific effector proteins, this process generates a signaling pixel that can polarize the root hair 
at specific sites of the plasma membrane and initiate membrane morphogenesis (Ghosh et al. 
2015). 
During nodulation, the cell polarity required for root hair development is turned off in 
favor of creating a nodule in which symbiotic bacteria can fix nitrogen. In this context, the 
transcription of the Sec14 domain of AtSfh1 is potently blocked, whereas the nodulin domain 
continues to be made (Gage 2004; Kapranov et al. 2001). In this case the nodulin domain would 
act as a PtdIns(4,5)P2 sink to depolarize the root hair (Ghosh et al. 2015). This regulated 
coupling of antagonistic domains is a good example of how a multidomain PITP can regulate 
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PIP-based membrane pixels or specific developmental needs. It’s possible that decoupling of 
the PITP and OSBP domains in PIMP differentially organizes the dense granule PtdIns4P pools 
during specific points of the Toxoplasma life cycle to regulate secretion of effector proteins.  
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Figure 4.3. Domain structure of PIMP orthologs among Apicomplexa. The proteins are 
grouped according to phylogenetic Class: Conoidasdia or Aconoidasida. The protein denoted as 
Toxoplama gondii is PIMP, and the others were derived from BLAST homology searches 
(http://www.ncbi.nlm.nih.gov/BLAST) against full length PIMP. The sequences used are as 
follows: Neospora caninum (XP_003881140.1); Hammondia hammondi (XP_008889127.1); 
Eimeria tenella (CDJ42839.1); Plasmodium falciparum (XP_001350223.2); Babesia bovis 
(XP_001609056.1). Identification of domains as PITP (blue), PH (green), or ORP (orange) was 
derived directly from NCBI annotations.  
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PIMP at the membrane interface 
Dense granules must interact with at least one other membrane, the plasma membrane, 
in order to affect exocytosis. Dense granule secretion is complicated by the fact that the 
cytoplasmic leaflet of the Apicomplexan plasma membrane is nearly covered by a distinct 
membrane-cytoskeleton scaffold called the inner membrane complex (IMC). It’s likely that 
exocytosis of dense granules occurs in breaks in the IMC called micropores, though the 
mechanics of targeting and membrane-dense granule interaction are not well understood 
(Joiner and Roos 2002; Mercier et al. 2005). What is the biochemical composition of the plasma 
membrane adjacent to a micropore? Is the entire plasma membrane competent for dense 
granule exocytosis, or only the micropore-adjacent plasma membrane? These questions raise 
the possibility of highly localized membrane signaling suited to pixel-type regulation.  
It’s possible that PIMP functions at such sites, wherein the PITP domain samples one 
membrane and the OSBP another. Hydrophobicity prediction software scored four potential 
transmembrane helices in the center of the full length protein (data not shown, Figure 2.1). We 
have no evidence that PIMP is an integral membrane protein, and these hydrophobic regions 
may represent the interior of the folded full-length PIMP or of an as-of-yet unidentified domain. 
Nonetheless, it’s possible that PIMP domains integrate signals from membranes other than just 
the dense granules. 
 
Genetic analysis of PIMP 
 In order to understand the role of PIMP in Toxoplsama biology, we have attempted 
several loss-of-function studies. Toxoplasma have a limited siRNA processing pathway that has 
some demonstrated functionality but cannot be reliably exploited to silence endogenous 
transcripts (Kolev et al. 2011). Direct gene editing approaches are the primary strategy for loss 
of function studies in Toxoplasma. Though wild-type Toxoplasma normally repair DNA damage 
through Non-Homologous End Joining (NHEJ) pathways, these cells can be engineered to favor 
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homologous recombination (HR) by deletion of the ku80 gene involved in NHEJ (Fox et al. 
2009). Parasites replicating as tachyzoites in tissue culture are haploid, so knock-out of a gene 
requires only a single homologous recombination event, and this is efficient for non-essential 
genes (Fox et al. 2009). We attempted to replace a portion of the PIMP ORF with a 
dihydrofolate reductase (DHFR) cassette (confers resistance to pyrimethamine) by homologous 
recombination, but we could not recover resistant parasites. Technical explanations include the 
possibility that our construct design or the region of the genome that encodes PIMP are not 
optimal for homologous recombination. 
 CRISPR associated protein 9 (Cas9) is a DNA endonuclease targeted to a specific site 
of eukaryotic genomes by a guide RNA sequence. Double-stranded DNA cleavage by Cas9 
edits the genome, and this technique has been successfully adapted to Toxoplasma (Shen et al. 
2014; Sidik et al. 2014). This strategy does not depend on HR (Shen et al. 2014). We designed 
guide RNA constructs against the PIMP exon 1 and exon 5. Though both of these target the 
region coding for the PITP domain, the editing event is predicted to disrupt the entire ORF. We 
co-transfected these with Cas9 and a linear DHFR cassette amplicon. In both cases, all 
resistant clones were modified at a non-specific site. 
 One possible explanation for the failures of these approaches is that PIMP is an 
essential gene, or its presence confers a significant competitive advantage to parasites growing 
in vitro. To this end, we have modified a promoter insertion cassette for conditional transcription 
of the PIMP gene. This cassette includes the Toxoplasma SAG gene promoter under the control 
of a TET-repressible element, the DHFR gene for clonal selection. These are flanked by 
homologous regions to the PIMP 5’UTR and exon 1 to appropriately orient the insertion 
cassette. We have generated guide RNA to target Cas9 to the PIMP promoter to facilitate gene 
editing and promoter replacement. We anticipate that this approach will allow us to test the 
functional contribution of PIMP to dense granule trafficking. 
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PIMP loss-of-function studies  
 We will assay the effect of PIMP knockdown on PtdIns4P pools in Toxoplasma as well as 
on dense granule structure and function. One strategy will be to query PHFAPP1 and SidM-P4M 
localization in the PIMP knockdown condition. A problem with the biosensors in such an 
experiment is that their high affinity for PtdIns4P may mask moderate deficits of PIP pools in the 
PIMP knockdown condition (Lemmon 2008). As such, it’s fortunate that PHPIMP is fairly sensitive 
to PtdIns4P derangements (Figure 2.5. Chapter 2), so we can use this domain itself as a 
PtdIns4P sensor. We can assume that the threshold of PtdIns4P that PHPIMP senses is 
functionally relevant to the one we predict PIMP maintains, though we would not be able to 
resolve whether PHPIMP localization defects stem from a PtdIns4P or PtdIns(4,5)P2 deficit. 
Dense granules have not been isolated with high purity, so a biochemical analysis of PIPs on 
these membranes is not ideal.  
We might expect PIMP-deficient parasites to phenocopy defects associated with TgArf1 
dominant negative expression (discussed in Chapter 2), namely inefficient loading of proteins 
into dense granules, and subsequent defects in dense granule exocytosis (Liendo et al. 2001). 
Significant defects in dense granule secretion would be manifested by derangements in the 
vacuole in which the parasites reside during intracellular replication. We do not expect defects in 
infection of, or egress from, host cells, as these processes are mostly mediated by microneme 
and rhopty secretion pathways (Mercier et al. 2005). It’s possible that cellular defects may be 
masked in the relatively non-competitive in vitro environment in which these parasites are 
cultured. It will be productive to test whether PIMP knockdown affects the efficiency of 
Toxoplasma to infect rodents.  
Our inability to generate a full knockout of the PIMP gene suggests it may be essential. 
The absence of the OSBP domain from PIMP orthologs among the Aconoidasida, however, 
implies that the coupling of these domains cannot be necessary for basic cellular functions. It’s 
possible that the PITP domain of these proteins is essential, but that the OSBP domain is not. 
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The PIMP conditional expression system will allow us to test this idea, to assay the general 
function of the PIMP OSBP domain, and to query the concept that the PITP and OSBP domains 
are antagonistic. 
 
Summary 
Our identification of PtdIns4P pools on distinct late secretory membranes in Toxoplasma 
contributes to the understanding of signaling events that regulate secretion of Apicomplexan 
effector proteins during the parasite infection cycle. As yeast PtdIns4P signaling and 
TGN/endosomal secretion can be potently and specifically interrupted by targeting Sec14 (Nile 
et al. 2014; Tripathi et al. 2014), our identification of a cognate signaling system adapted to the 
unique secretory requirements of Toxoplasma opens novel avenues of therapy for parasitic 
infections. Dense granules are specialized organelles found only in Apicomplexa; as such, 
PITPs that regulate dense granule secretory signaling are promising targets of drug and 
immune intervention. 
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